<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>JP2013532722A - 
  Particulate preparation for transpulmonary drug delivery of anti-infective molecules for treatment of infectious diseases
 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/JP2013532722A/en">
    <meta name="description" content="
   
    &nbsp;&nbsp;The present invention comprises a compound of formula I obtained by fermentation of a microbial Streptomyces sp. (PM06262271 / MTCC 5447) and a biodegradable lipid for drug delivery as described in International Publication No. WO2011-027290. Biodegradable inhalable microparticle formulation, wherein the drug (compound of formula I) to lipid ratio is from 1:15 to 1:25. The invention also provides a process for preparing the formulation and a therapeutically effective amount of the formulation to a mammal in need thereof for pulmonary tuberculosis, multidrug resistant tuberculosis (MDRTB), methicillin resistant yellow grape The present invention relates to the treatment of cocci (MRSA) pneumonia and methicillin-sensitive S. aureus (MSSA) pneumonia. The invention further relates to a method of delivering a particulate formulation to a mammal in need thereof, wherein the formulation is administered by inhalation or intratracheal infusion for pulmonary delivery.
   
 
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="
  Particulate preparation for transpulmonary drug delivery of anti-infective molecules for treatment of infectious diseases
 
       ">
    <meta name="DC.date" content="2011-08-04" scheme="dateSubmitted">
    <meta name="DC.description" content="
   
    &nbsp;&nbsp;The present invention comprises a compound of formula I obtained by fermentation of a microbial Streptomyces sp. (PM06262271 / MTCC 5447) and a biodegradable lipid for drug delivery as described in International Publication No. WO2011-027290. Biodegradable inhalable microparticle formulation, wherein the drug (compound of formula I) to lipid ratio is from 1:15 to 1:25. The invention also provides a process for preparing the formulation and a therapeutically effective amount of the formulation to a mammal in need thereof for pulmonary tuberculosis, multidrug resistant tuberculosis (MDRTB), methicillin resistant yellow grape The present invention relates to the treatment of cocci (MRSA) pneumonia and methicillin-sensitive S. aureus (MSSA) pneumonia. The invention further relates to a method of delivering a particulate formulation to a mammal in need thereof, wherein the formulation is administered by inhalation or intratracheal infusion for pulmonary delivery.
   
 
   ">
    <meta name="citation_patent_application_number" content="JP:2013522337A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/ab/5d/3b/64394934c5b02f/JP2013532722A.pdf">
    <meta name="citation_patent_publication_number" content="JP:2013532722:A">
    <meta name="DC.date" content="2013-08-19">
    <meta name="DC.contributor" content="チモテ・ジータンジャリ・チャンドラシェクハール" scheme="inventor">
    <meta name="DC.contributor" content="マハジャン・ジリシュ・バドリナス" scheme="inventor">
    <meta name="DC.contributor" content="バスデバン・アラビンダン" scheme="inventor">
    <meta name="DC.contributor" content="ハリハラン・シバラマクリシュナン" scheme="inventor">
    <meta name="DC.contributor" content="Piramal Enterprises Ltd" scheme="assignee">
    <meta name="DC.relation" content="JP:S63502899:A" scheme="references">
    <meta name="DC.relation" content="JP:2001524930:A" scheme="references">
    <meta name="DC.relation" content="JP:2002529393:A" scheme="references">
    <meta name="DC.relation" content="JP:2003520815:A" scheme="references">
    <meta name="DC.relation" content="JP:2005530704:A" scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            
  Particulate preparation for transpulmonary drug delivery of anti-infective molecules for treatment of infectious diseases
 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result">translated from Japanese</div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA120468306" lang="EN" load-source="google" class="style-scope patent-text">
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  本発明は、国際公開ＷＯ２０１１−０２７２９０号公報に記載されているように、微生物ストレプトマイセス種（ＰＭ０６２６２７１／ＭＴＣＣ ５４４７）の発酵によって得られる式Ｉの化合物と薬物送達用生分解性脂質とを含む生分解性の吸入可能微粒子製剤であって、脂質に対する薬物（式Ｉの化合物）比が１：１５〜１：２５である微粒子製剤に関する。また本発明は、上記製剤を調製するためのプロセスおよび治療上効果的な量の上記製剤をそれを必要とする哺乳類に投与することによる、肺結核、多剤耐性結核（ＭＤＲＴＢ）、メチシリン耐性黄色ブドウ球菌（ＭＲＳＡ）肺炎およびメチシリン感受性黄色ブドウ球菌（ＭＳＳＡ）肺炎の治療法に関する。本発明はさらに、微粒子製剤をそれを必要とする哺乳類に送達する方法であって、上記製剤は肺送達のために吸入または気管内注入によって投与される送達方法に関する。</span>&nbsp;&nbsp;The present invention comprises a compound of formula I obtained by fermentation of a microbial Streptomyces sp. (PM06262271 / MTCC 5447) and a biodegradable lipid for drug delivery as described in International Publication No. WO2011-027290. Biodegradable inhalable microparticle formulation, wherein the drug (compound of formula I) to lipid ratio is from 1:15 to 1:25. The invention also provides a process for preparing the formulation and a therapeutically effective amount of the formulation to a mammal in need thereof for pulmonary tuberculosis, multidrug resistant tuberculosis (MDRTB), methicillin resistant yellow grape The present invention relates to the treatment of cocci (MRSA) pneumonia and methicillin-sensitive S. aureus (MSSA) pneumonia. The invention further relates to a method of delivering a particulate formulation to a mammal in need thereof, wherein the formulation is administered by inhalation or intratracheal infusion for pulmonary delivery.</span>
  </p>
</abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K9/00"><a id="link" href="#" class="style-scope state-modifier">A61K9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by special physical form</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K9/14"><a id="link" href="#" class="style-scope state-modifier">A61K9/14</a></state-modifier>
                  <span class="description style-scope classification-tree">Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="A61K9/16"><a id="link" href="#" class="style-scope state-modifier">A61K9/16</a></state-modifier>
                  <span class="description style-scope classification-tree">Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K38/00"><a id="link" href="#" class="style-scope state-modifier">A61K38/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing peptides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K38/04"><a id="link" href="#" class="style-scope state-modifier">A61K38/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="A61K38/12"><a id="link" href="#" class="style-scope state-modifier">A61K38/12</a></state-modifier>
                  <span class="description style-scope classification-tree">Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/00"><a id="link" href="#" class="style-scope state-modifier">A61K31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing organic active ingredients</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/33"><a id="link" href="#" class="style-scope state-modifier">A61K31/33</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/395"><a id="link" href="#" class="style-scope state-modifier">A61K31/395</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/435"><a id="link" href="#" class="style-scope state-modifier">A61K31/435</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/47"><a id="link" href="#" class="style-scope state-modifier">A61K31/47</a></state-modifier>
                  <span class="description style-scope classification-tree">Quinolines; Isoquinolines</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/4738"><a id="link" href="#" class="style-scope state-modifier">A61K31/4738</a></state-modifier>
                  <span class="description style-scope classification-tree">Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/4745"><a id="link" href="#" class="style-scope state-modifier">A61K31/4745</a></state-modifier>
                  <span class="description style-scope classification-tree">Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/00"><a id="link" href="#" class="style-scope state-modifier">A61K31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing organic active ingredients</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/33"><a id="link" href="#" class="style-scope state-modifier">A61K31/33</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/395"><a id="link" href="#" class="style-scope state-modifier">A61K31/395</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/435"><a id="link" href="#" class="style-scope state-modifier">A61K31/435</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/47"><a id="link" href="#" class="style-scope state-modifier">A61K31/47</a></state-modifier>
                  <span class="description style-scope classification-tree">Quinolines; Isoquinolines</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/4748"><a id="link" href="#" class="style-scope state-modifier">A61K31/4748</a></state-modifier>
                  <span class="description style-scope classification-tree">Quinolines; Isoquinolines forming part of bridged ring systems</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K9/00"><a id="link" href="#" class="style-scope state-modifier">A61K9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by special physical form</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K9/0012"><a id="link" href="#" class="style-scope state-modifier">A61K9/0012</a></state-modifier>
                  <span class="description style-scope classification-tree">Galenical forms characterised by the site of application</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K9/007"><a id="link" href="#" class="style-scope state-modifier">A61K9/007</a></state-modifier>
                  <span class="description style-scope classification-tree">Pulmonary tract; Aromatherapy</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K9/0073"><a id="link" href="#" class="style-scope state-modifier">A61K9/0073</a></state-modifier>
                  <span class="description style-scope classification-tree">Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K9/0078"><a id="link" href="#" class="style-scope state-modifier">A61K9/0078</a></state-modifier>
                  <span class="description style-scope classification-tree">Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K9/00"><a id="link" href="#" class="style-scope state-modifier">A61K9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by special physical form</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K9/10"><a id="link" href="#" class="style-scope state-modifier">A61K9/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Dispersions; Emulsions</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K9/127"><a id="link" href="#" class="style-scope state-modifier">A61K9/127</a></state-modifier>
                  <span class="description style-scope classification-tree">Liposomes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P11/00"><a id="link" href="#" class="style-scope state-modifier">A61P11/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for disorders of the respiratory system</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/04"><a id="link" href="#" class="style-scope state-modifier">A61P31/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibacterial agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/04"><a id="link" href="#" class="style-scope state-modifier">A61P31/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibacterial agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/06"><a id="link" href="#" class="style-scope state-modifier">A61P31/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibacterial agents for tuberculosis</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 8 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Chemical &amp; Material Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Chemical &amp; Material Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">JP2013532722A</h2>
                  <p class="tagline style-scope patent-result">Japan</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Published unexamined patent application (based on international application)</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/ab/5d/3b/64394934c5b02f/JP2013532722A.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;formula&quot;,&quot;compound&quot;,&quot;formulation&quot;,&quot;drug&quot;,&quot;methicillin&quot;]" data-before="20100805"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/JP2013532722A"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2013532722A/ja"><a id="link" href="#" class="style-scope state-modifier">Japanese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="チモテ・ジータンジャリ・チャンドラシェクハール"><a id="link" href="#" class="style-scope state-modifier">チモテ・ジータンジャリ・チャンドラシェクハール</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="マハジャン・ジリシュ・バドリナス"><a id="link" href="#" class="style-scope state-modifier">マハジャン・ジリシュ・バドリナス</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="バスデバン・アラビンダン"><a id="link" href="#" class="style-scope state-modifier">バスデバン・アラビンダン</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ハリハラン・シバラマクリシュナン"><a id="link" href="#" class="style-scope state-modifier">ハリハラン・シバラマクリシュナン</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    Piramal Enterprises Ltd
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2011</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/MX2013001325A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">MX</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: MX2013001325A</div>
                <div class="style-scope application-timeline">Filing date: 2011-08-04</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2011287205A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU2011287205A</div>
                <div class="style-scope application-timeline">Filing date: 2011-08-04</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/TW201208716A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">TW</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: TW100127712A</div>
                <div class="style-scope application-timeline">Filing date: 2011-08-04</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2807357A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA2807357A</div>
                <div class="style-scope application-timeline">Filing date: 2011-08-04</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2012017405A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/IB2011/053470</div>
                <div class="style-scope application-timeline">Filing date: 2011-08-04</div>
                <div class="style-scope application-timeline">Legal status: Application Filing</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN103442694B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CN201180043763.9A</div>
                <div class="style-scope application-timeline">Filing date: 2011-08-04</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/BR112013002641A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">BR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: BR112013002641A</div>
                <div class="style-scope application-timeline">Filing date: 2011-08-04</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2013532722A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline" this="">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2013522337A</div>
                <div class="style-scope application-timeline">Filing date: 2011-08-04</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/RU2013109384A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">RU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: RU2013109384/15A</div>
                <div class="style-scope application-timeline">Filing date: 2011-08-04</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/KR20130109106A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">KR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: KR1020137005739A</div>
                <div class="style-scope application-timeline">Filing date: 2011-08-04</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US8697653B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US13/813,470</div>
                <div class="style-scope application-timeline">Filing date: 2011-08-04</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP2600842A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP11757941.7A</div>
                <div class="style-scope application-timeline">Filing date: 2011-08-04</div>
                <div class="style-scope application-timeline">Legal status: Withdrawn</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/IN2013MN00329A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">IN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: IN329MUN2013</div>
                <div class="style-scope application-timeline">Filing date: 2011-08-04</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2013</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ZA201301662B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">ZA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ZA2013/01662A</div>
                <div class="style-scope application-timeline">Filing date: 2013-03-05</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application JP2013522337A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2011-08-04</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Piramal Enterprises Ltd"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Piramal Enterprises Ltd</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2013-08-19</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2013532722A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of JP2013532722A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Pending</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (8)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (3)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=JP&amp;NR=2013532722A&amp;KC=A&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/JP/2013532722/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/JP2013532722A">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Japanese</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES61463304" lang="EN" load-source="google" class="style-scope patent-text">
  <technical-field class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、国際公開ＷＯ２０１１−０２７２９０号公報に記載されているように、微生物ストレプトマイセス種（ＰＭ０６２６２７１／ＭＴＣＣ ５４４７）の発酵によって得られる化合物（本明細書では、式Ｉの化合物と呼ぶ）と、薬物送達用生分解性脂質とを含む生分解性の吸入可能微粒子製剤であって、脂質に対する薬物（式Ｉの化合物）比が１：１５〜１：２５である微粒子製剤に関する。本発明はまた、治療上効果的な量の当該製剤をそれを必要とする哺乳類に投与することによる、肺結核、多剤耐性結核（ＭＤＲＴＢ）、メチシリン耐性黄色ブドウ球菌（Staphylococcus aureus）（ＭＲＳＡ）肺炎およびメチシリン感受性黄色ブドウ球菌（ＭＳＳＡ）肺炎の治療法に関する。本発明はまた、肺結核、ＭＤＲＴＢ、ＭＲＳＡ肺炎およびＭＳＳＡ肺炎の治療のための当該微粒子製剤の使用に関する。
</span>
&nbsp;&nbsp;The present invention relates to a compound obtained by fermentation of a microorganism Streptomyces sp. (PM06262271 / MTCC 5447) (referred to herein as a compound of formula I) as described in International Publication WO2011-027290. And a biodegradable inhalable microparticle formulation comprising a biodegradable lipid for drug delivery, wherein the ratio of drug to lipid (compound of formula I) is from 1:15 to 1:25. The present invention also provides pulmonary tuberculosis, multidrug resistant tuberculosis (MDRTB), methicillin resistant Staphylococcus aureus (MRSA) pneumonia by administering a therapeutically effective amount of the formulation to a mammal in need thereof. And methicillin-sensitive Staphylococcus aureus (MSSA) pneumonia treatment. The present invention also relates to the use of the microparticle formulation for the treatment of pulmonary tuberculosis, MDRTB, MRSA pneumonia and MSSA pneumonia.
</span>
    </p>
  </technical-field>
  <background-art class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  結核は身体の器官に影響を及ぼし、いくつかの異なる症状が現れるが、初期感染部位は肺である。肺に影響を及ぼす結核は肺結核として知られている。肺結核は結核の最も圧倒的に起こり得る形態である（「結核」（Tuberculosis）、２００５年、８５、ｐ．２２７−２３４）。肺結核を治療するための現在の化学療法レジメンは、４か月間にわたって１次抗結核薬（イソニアジド、リファンピシン、エサンブトールおよび／またはピラジナミド）の同時投与を行い、その後、イソニアジド、リファンピシンおよび／またはエサンブトールで２か月間治療を行うことからなるが、結核の種類によっては、治療期間はさらに延長され９か月から２年の範囲であり得る。この化学療法レジメンは、１日に一度経口投与の形態で行われ、短い血漿内半減期（「薬剤学の国際学術雑誌」（International Journal of Pharmaceutics）、２００４年、２７６、ｐ．４１−４９）と、過剰用量による副作用（「抗菌化学療法の学術雑誌」（Journal of Antimicrobial Chemotherapy）、２００４年、５４、ｐ．７６１−７６６）とに関係する。これらの副作用は望ましくない体内分布特性に起因する。さらに、経口投与薬については、少量の薬物のみが作用部位（即ち、肺）に到達し、数時間のうちになくなる（「結核」（Tuberculosis）、２００５年、８５、ｐ．２２７−２３４）ということが観察されている。上記の問題は、患者の服薬遵守不良に関連し、多剤耐性結核（ＭＤＲＴＢ）の発生につながる。
</span>
&nbsp;&nbsp;Tuberculosis affects the body's organs and several different symptoms appear, but the site of initial infection is the lungs. Tuberculosis that affects the lungs is known as pulmonary tuberculosis. Pulmonary tuberculosis is the most prevalent form of tuberculosis (Tuberculosis, 2005, 85, p. 227-234). Current chemotherapeutic regimens for treating pulmonary tuberculosis include co-administration of primary anti-tuberculosis drugs (isoniazid, rifampicin, esambutol and / or pyrazinamide) for 4 months, followed by isoniazid, rifampicin and / or esambutol 2 Depending on the type of tuberculosis, the treatment period can be further extended and can range from 9 months to 2 years. This chemotherapeutic regimen is administered once a day in an oral dosage form with a short plasma half-life ("International Journal of Pharmaceutics, 2004, 276, pp. 41-49). And side effects due to overdose (Journal of Antimicrobial Chemotherapy, 2004, 54, p. 761-766). These side effects are due to undesirable biodistribution characteristics. Furthermore, for orally administered drugs, only a small amount of drug reaches the site of action (ie, lungs) and disappears within a few hours (Tuberculosis, 2005, 85, p. 227-234). It has been observed. The above problems are related to poor patient compliance and lead to the development of multi-drug resistant tuberculosis (MDRTB).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＭＤＲＴＢは少なくとも２つの最良の抗結核薬（イソニアジドおよびリファンピシン）に対して耐性を有する結核の形態である（「多剤耐性結核ファクトシート」（Multidrug resistant tuberculosis fact sheet）、疾病管理センター、２００８年）。ＭＤＲＴＢはフルオロキノロン、アミカシン、カナマイシンやカプレオマイシンのようなアミノグリコシド、ｐ−アミノサリチル酸およびチオアセタゾンのような２次抗結核薬で治療される（「薬物耐性結核の治療、ファクトシート」（Treatment of drug resistant tuberculosis, fact sheet）、疾病管理センター、２００７年）。２次結核薬は、用量に関連した副作用や、肺における生物学的利用能不良と係わっており、疾病の根絶の障害となっている。
</span>
&nbsp;&nbsp;MDRTB is a form of tuberculosis that is resistant to at least two of the best anti-tuberculosis drugs (isoniazid and rifampicin) ("Multidrug resistant tuberculosis fact sheet", Center for Disease Control, 2008) . MDRTB is treated with fluoroquinolones, amikacin, aminoglycosides such as kanamycin and capreomycin, secondary anti-tuberculosis drugs such as p-aminosalicylic acid and thioacetazone ("Treatment of drug resistant" tuberculosis, fact sheet), Center for Disease Control, 2007). Secondary tuberculosis drugs are associated with dose-related side effects and poor bioavailability in the lungs and are an obstacle to eradication of the disease.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  肺結核の問題に類似して、薬物の生物学的利用能不良や多量投与によって引き起こされる副作用という問題は、ＭＲＳＡやＭＳＳＡ肺炎の治療においても起こる。ＭＲＳＡによる院内肺炎と人工呼吸器関連肺炎は高い死亡率と関係があり（「抗菌剤の国際学会雑誌」（International Journal of Antimicrobial Agents）、２００７年、３０、ｐ．１９−２４）、それは不十分な治療でによる。
</span>
&nbsp;&nbsp;Similar to the problem of pulmonary tuberculosis, the problem of side effects caused by poor bioavailability of drugs and high doses also occurs in the treatment of MRSA and MSSA pneumonia. Nosocomial pneumonia due to MRSA and ventilator-associated pneumonia are associated with high mortality (International Journal of Antimicrobial Agents, 2007, 30, p. 19-24), which is insufficient Depends on the treatment.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＭＲＳＡ肺炎を治療するために用いられる１次薬はバンコマイシンとリネゾリドを含む。ＭＲＳＡ肺炎を治療するために選択される薬物であるバンコマイシンは、肺組織における不十分な薬物動態学的な特性と係わりがあり、ちょうど血漿濃度２０％である肺濃度を有する（「抗菌剤化学療法」（Antimicrob. Agents Chemother.）、１９９９年、３７、ｐ．２８１−２８６）。さらに、バンコマイシンの長期投与は用量規制因子である腎毒性と係わっている（「臨床微生物学と感染症」（Clin. Microbiol Infect.）、２００６年、１２、ｐ．９２−９５）。ＭＲＳＡ肺炎療法のために受け入れられているリネゾリドは、良好な経口生物学的利用能（１日当たり２回６００ｍｇが経口で投与される）を示すが、胃腸の副作用、血小板減少症および可逆性貧血に関係がある（「臨床感染症」（Clinical Infect. Dis.）、２００３年、３７、ｐ．１６０９−１６１６）。まれに、リネゾリドの投与は視神経症や末梢神経障害にも係わっている（「抗菌化学療法の学術雑誌」（J Antimicrob. Chemother.）、２００４年、５３、ｐ．１１１４−１１１５）。
</span>
&nbsp;&nbsp;Primary drugs used to treat MRSA pneumonia include vancomycin and linezolid. Vancomycin, a drug selected to treat MRSA pneumonia, is associated with poor pharmacokinetic properties in lung tissue and has a lung concentration that is just 20% plasma concentration (“antibacterial chemotherapy” (Antimicrob. Agents Chemother.), 1999, 37, p. 281-286). In addition, long-term administration of vancomycin has been associated with nephrotoxicity, a dose limiting factor (Clin. Microbiol Infect., 2006, 12, p. 92-95). Linezolid, accepted for MRSA pneumonia therapy, shows good oral bioavailability (600 mg given orally twice a day), but for gastrointestinal side effects, thrombocytopenia and reversible anemia There is a relationship (Clinical Infect. Dis., 2003, 37, pp. 1609-1616). Rarely, the administration of linezolid is also associated with optic neuropathy and peripheral neuropathy ("Antibacterial Chemotherapy Journal" (2004, 53, pp. 1141-1115).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ベータラクタム剤（アンピシリンやセファロスポリンなど）は１次療法としてＭＳＳＡ肺炎に対して非常に効果的である。バンコマイシンは次の療法として考えられているが、ＭＳＳＡによって引き起こされる感染においてはベータラクタムほど効果的ではない。また、バンコマイシンは糸球体ろ過によって尿中に排出され、代謝されない。また、バンコマイシンは肺組織へ比較的浸透しない（「米国呼吸器疾患」（US Respiratory Disease）、２００６年、ｐ．６２−６４）。要約すると、ＭＲＳＡ／ＭＳＳＡ肺炎療法は、薬物の肺生物学的利用能不良、薬物の投与量に起因する毒性などのようないくつかの欠点がある。
</span>
&nbsp;&nbsp;Beta-lactams (such as ampicillin and cephalosporin) are very effective against MSSA pneumonia as first line therapy. Vancomycin is considered as the next therapy, but is not as effective as beta-lactam in infections caused by MSSA. Vancomycin is excreted in the urine by glomerular filtration and is not metabolized. In addition, vancomycin does not relatively penetrate into lung tissue ("US Respiratory Disease", 2006, p. 62-64). In summary, MRSA / MSSA pneumonia therapy has several drawbacks, such as poor pulmonary bioavailability of drugs, toxicity due to drug dosage, and the like.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  現在の標準的な治療レジメンと患者の服薬不履行に関連する問題点を克服するために、作用部位に直接達し、結核菌の住処である肺マクロファージを標的とする可能性および薬物関連の全身毒性を低減する可能性とを有する薬物送達システムを開発することが必要不可欠である。
</span>
&nbsp;&nbsp;To overcome the problems associated with current standard treatment regimens and patient non-compliance, the potential to reach the site of action directly and target the lung macrophages where M. tuberculosis resides and drug-related systemic toxicity It is essential to develop a drug delivery system with the potential to reduce.
</span>
    </p>
  </background-art>
  
  <summary-of-invention class="style-scope patent-text">
    <p num="0008" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、微生物ストレプトマイセス種（ＰＭ０６２６２７１／ＭＴＣＣ５４４７）の発酵によって得られる式Ｉ（本明細書に記載されるような）の化合物と、薬物送達用生分解性脂質とを含む生分解性の吸入可能微粒子製剤であって、脂質に対する薬物（式Ｉの化合物）の比が１：１５〜１：２５である微粒子製剤に関する。
</span>
&nbsp;&nbsp;The present invention relates to a biodegradable comprising a compound of formula I (as described herein) obtained by fermentation of a microbial Streptomyces species (PM06262271 / MTCC5447) and a biodegradable lipid for drug delivery. Inhalable particulate formulation, wherein the ratio of drug to lipid (compound of formula I) is from 1:15 to 1:25.
</span>
    </p>
    <p num="0009" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、微粒子製剤の調製のためのプロセスに関する。
</span>
&nbsp;&nbsp;The invention also relates to a process for the preparation of a microparticle formulation.
</span>
    </p>
    <p num="0010" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はさらに、治療上効果的な量の微粒子製剤をそれを必要とする哺乳類に投与することによる、肺結核、ＭＤＲＴＢ、ＭＲＳＡ肺炎およびＭＳＳＡ肺炎の治療法に関する。
</span>
&nbsp;&nbsp;The invention further relates to a method for treating pulmonary tuberculosis, MDRTB, MRSA pneumonia and MSSA pneumonia by administering a therapeutically effective amount of a microparticle formulation to a mammal in need thereof.
</span>
    </p>
    <p num="0011" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、微粒子製剤をそれを必要とする哺乳類に送達する方法であって、製剤は肺送達のために吸入または気管内注入によって投与される送達方法に関する。
</span>
&nbsp;&nbsp;The invention also relates to a method of delivering a particulate formulation to a mammal in need thereof, wherein the formulation is administered by inhalation or intratracheal infusion for pulmonary delivery.
</span>
    </p>
    <p num="0012" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はさらに、肺結核、ＭＤＲＴＢ、ＭＲＳＡ肺炎およびＭＳＳＡ肺炎の治療のための、式Ｉの化合物と薬物送達用生分解性脂質とを含み、脂質に対する薬物（式Ｉの化合物）の比が１：１５〜１：２５である微粒子製剤の使用に関する。
</span>
&nbsp;&nbsp;The invention further comprises a compound of formula I and a biodegradable lipid for drug delivery for the treatment of pulmonary tuberculosis, MDRTB, MRSA pneumonia and MSSA pneumonia, wherein the ratio of drug to lipid (compound of formula I) is 1: It relates to the use of microparticle formulations that are 15 to 1:25.
</span>
    </p>
    <p num="0013" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はさらに、肺結核、ＭＤＲＴＢ、ＭＲＳＡ肺炎およびＭＳＳＡ肺炎の治療のための薬剤の製造のための、式Ｉの化合物と薬物送達用生分解性脂質とを含み、脂質に対する薬物（式Ｉの化合物）の比が１：１５〜１：２５である微粒子製剤の使用に関する。
</span>
&nbsp;&nbsp;The present invention further comprises a compound of formula I and a biodegradable lipid for drug delivery for the manufacture of a medicament for the treatment of pulmonary tuberculosis, MDRTB, MRSA pneumonia and MSSA pneumonia, wherein the drug against the lipid (compound of formula I ) Ratio of 1:15 to 1:25.
</span>
    </p>
    <heading class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">発明の詳細</span>Details of the invention</span>
    </heading>
    <p num="0014" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の詳細を説明する前に、当然のことながら本発明は特定の実施形態に限定されるものではない。また、当然のことながら、本明細書において用いられる用語は、特定の実施形態を説明する目的のためであり、限定する意図はない。
</span>
&nbsp;&nbsp;Before describing the details of the present invention, it should be understood that the present invention is not limited to any particular embodiment. It will also be appreciated that the terminology used herein is for the purpose of describing particular embodiments and is not intended to be limiting.
</span>
    </p>
    <p num="0015" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書および請求項において用いられるように、文脈に特に明確に記載されない限り、単数形は複数表記を含む。
</span>
&nbsp;&nbsp;As used in the specification and claims, the singular forms include the plural unless the context clearly dictates otherwise.
</span>
    </p>
    <p num="0016" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  特段の断りがない限り、本明細書において使用される全ての技術的、科学的用語は、本発明が属する技術分野の当業者によって一般的に理解される用語と同様の意味を有する。<br class="style-scope patent-text">
<br class="style-scope patent-text">
  定義<br class="style-scope patent-text">
  封入効率：封入効率とは、溶液中における初期の薬物全量に対する微粒子製剤中に物理的に封入され結合した薬物の割合である。
</span>Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Definitions Encapsulation efficiency: Encapsulation efficiency is the ratio of drug physically encapsulated and bound in the microparticle formulation to the total amount of initial drug in solution.</span>
    </p>
    <p num="0017" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  薬物：薬物は、疾病の診断、治癒、緩和、治療または予防における使用を意図されたあるいは身体の構造や機能に影響を与えるように意図された任意の物質として定義される。本明細書にて用いられると、式Ｉの化合物は薬物である。
</span>
&nbsp;&nbsp;Drug: A drug is defined as any substance intended for use in the diagnosis, cure, alleviation, treatment or prevention of disease or intended to affect the structure or function of the body. As used herein, a compound of formula I is a drug.
</span>
    </p>
    <p num="0018" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  マスバランス：マスバランス（物質収支とも呼ぶ）とは、質量保存を物理系の分析へ適用することである。系に入る物質と系を出る物質を分析することによって、この手法なしでは未知であったかもしれぬ、または測定が困難であったかもしれぬマスフローを同定することができる。
</span>
&nbsp;&nbsp;Mass balance: Mass balance (also called mass balance) is the application of mass conservation to the analysis of physical systems. By analyzing the material entering and leaving the system, it is possible to identify mass flows that may have been unknown or difficult to measure without this approach.
</span>
    </p>
    <p num="0019" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  重量モル浸透圧濃度：重量モル浸透圧濃度とは、溶媒１キログラムあたりの溶質のオスモル数（ｍＯｓｍ）として定義される溶質濃度（ｍｏｓｍｏｌ／ｋｇまたはｍＯｓｍ／ｋｇ）の尺度である。
</span>
&nbsp;&nbsp;Osmolality: Osmolality is a measure of solute concentration (mosmol / kg or mOsm / kg) defined as osmoles of solute per kilogram of solvent (mOsm).
</span>
    </p>
    <p num="0020" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  相転移：相転移とは、物質の１つの相または状態から別の相または状態への熱力学系の変化である。物質の熱力学系の相と状態は、本質的に均一な物理的性質を有する。ある媒質の相転移の間、温度や圧力などのようないくつかの外部条件により、その媒質のある性質は、多くの場合不連続的に変化する。変化が起こる外部条件の測定値は、相転移点と呼ばれる。
</span>
&nbsp;&nbsp;Phase transition: A phase transition is a change in the thermodynamic system from one phase or state of matter to another. The phases and states of a material's thermodynamic system have essentially uniform physical properties. During the phase transition of a medium, certain properties of the medium often change discontinuously due to some external conditions such as temperature and pressure. The measured external condition at which the change occurs is called the phase transition point.
</span>
    </p>
    <p num="0021" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  エアロゾル化：エアロゾル化とは、エアロゾル、つまり微小粒子を含む微細ミストまたはスプレーの生成である。
</span>
&nbsp;&nbsp;Aerosolization: Aerosolization is the generation of an aerosol, ie a fine mist or spray containing microparticles.
</span>
    </p>
    <p num="0022" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  噴霧：噴霧とは、液状薬物をより即効性のある吸入ミストに変化させるプロセスを含む。噴霧は、喘息または嚢胞性繊維症のような呼吸器異常を治療するために用いられる。ネブライザーは、医薬を直接個人の呼吸気管に効果的に送達するので、医薬は迅速に肺に到達することができる。ネブライザーの非限定例は、圧縮器とマウスピースまたはフェイスマスクを備えた装置である。
</span>
&nbsp;&nbsp;Nebulization: Nebulization includes the process of turning a liquid drug into a more immediate inhalation mist. Nebulization is used to treat respiratory abnormalities such as asthma or cystic fibrosis. Nebulizers effectively deliver medication directly to the individual's respiratory trachea so that the medication can quickly reach the lungs. A non-limiting example of a nebulizer is a device with a compressor and a mouthpiece or face mask.
</span>
    </p>
    <p num="0023" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  粒径：粒径とは、固体粒子や液体粒子（液滴）の寸法を比較するために導入される概念である。液滴とエアロゾルには、「空気動力学径」および「空気力学的質量中位径（ＭＭＡＤ）」などの用語が用いられる。その定義を以下に記載する。
</span>
&nbsp;&nbsp;Particle size: The particle size is a concept introduced to compare the dimensions of solid particles and liquid particles (droplets). For droplets and aerosols, terms such as “aerodynamic diameter” and “aerodynamic median diameter (MMAD)” are used. The definition is described below.
</span>
    </p>
    <p num="0024" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  空気動力学径：当粒子と同一の終末沈降速度を有する単位密度球体の直径。これは、そのような粒子が呼吸気管のどこに沈着するかを予測するために用いられる。
</span>
&nbsp;&nbsp;Aerodynamic diameter: The diameter of a unit density sphere with the same terminal settling velocity as the particle. This is used to predict where such particles will deposit in the respiratory trachea.
</span>
    </p>
    <p num="0025" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  空気力学的質量中位径：幾何平均空気動力学径。粒子の５０重量％はＭＭＡＤよりも小さく、５０％は大きい。
</span>
&nbsp;&nbsp;Aerodynamic mass median diameter: geometric mean aerodynamic diameter. 50% by weight of the particles are smaller than MMAD and 50% are larger.
</span>
    </p>
    <p num="0026" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  粒子の分粒実験の間、懸濁液はサイズの異なる動いている無数の粒子を含む。分粒機がこれらの粒子を分析するとき、最小粒子（１ｎｍであり得る）から最大粒子（１００ミクロンであり得る）におよぶ全ての粒子サイズ範囲にわたる粒子分布曲線を形成する。粒径分布曲線において、粒子に対して累積度数が算出される。Ｄ<sub class="style-scope patent-text">10</sub>は、懸濁液中の粒子の１０％が、ある粒子直径以下の直径を有する場合のその粒子直径である。
</span>During particle sizing experiments, the suspension contains a myriad of moving particles of different sizes. When the sizer analyzes these particles, it forms a particle distribution curve over the entire particle size range from the smallest particle (which can be 1 nm) to the largest particle (which can be 100 microns). In the particle size distribution curve, the cumulative frequency is calculated for the particles. D <sub class="style-scope patent-text">10</sub> is the particle diameter when 10% of the particles in the suspension have a diameter less than or equal to a certain particle diameter.</span>
    </p>
    <p num="0027" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Ｄ<sub class="style-scope patent-text">50</sub>：Ｄ<sub class="style-scope patent-text">10</sub>と同様に、Ｄ<sub class="style-scope patent-text">50</sub>は製剤中の粒子集団の５０％に対するカットオフ直径であり、懸濁液中の粒子の５０％が、ある粒子直径以下の直径を有する場合のその粒子直径である。
</span>D <sub class="style-scope patent-text">50</sub> : Similar to D <sub class="style-scope patent-text">10</sub> , D <sub class="style-scope patent-text">50</sub> is the cut-off diameter for 50% of the population of particles in the formulation, and the particles when 50% of the particles in the suspension have a diameter less than or equal to a certain particle diameter Diameter.</span>
    </p>
    <p num="0028" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Ｄ<sub class="style-scope patent-text">90</sub>：Ｄ<sub class="style-scope patent-text">90</sub>は製剤中の粒子集団の９０％に対するカットオフ直径であり、懸濁液中の粒子の９０％が、ある粒子直径以下の直径を有する場合のその粒子直径である。
</span>D <sub class="style-scope patent-text">90</sub> : D <sub class="style-scope patent-text">90</sub> is the cut-off diameter for 90% of the population of particles in the formulation and is the particle diameter when 90% of the particles in the suspension have a diameter less than or equal to a certain particle diameter.</span>
    </p>
    <p num="0029" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  噴霧での封入薬物保持率（entrapped drug retention）：噴霧プロセスの間に、ネブライザーによって誘導された力によって、一部のリポソームは破裂し、薬物は製剤から浸出し噴霧カップ自体の中に保持される。噴霧プロセスの間に製剤から浸出しない薬物は、噴霧中に製剤中に保持される実際の量の薬物であり、「封入薬物保持率」とされる。噴霧プロセスの間に失われたあるいは浸出した薬物は、噴霧カップから回収される。噴霧カップは適切な溶媒（この場合、メタノール）で洗浄され、カップ中に保持された薬物はＨＰＬＣまたはＬＣ−ＭＳによって定量化される。
</span>
&nbsp;&nbsp;Entrapped drug retention: During the spraying process, the force induced by the nebulizer ruptures some liposomes and leaches out of the formulation and is retained in the spray cup itself . Drug that does not leach out of the formulation during the spraying process is the actual amount of drug that is retained in the formulation during spraying and is referred to as “encapsulated drug retention”. Drug lost or leached during the spraying process is recovered from the spray cup. The spray cup is washed with a suitable solvent (in this case methanol) and the drug retained in the cup is quantified by HPLC or LC-MS.
</span>
    </p>
    <p num="0030" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  液晶相：結晶（固体）状態と等方性（液体）状態との間で観察される物質の明確な相である。
</span>
&nbsp;&nbsp;Liquid crystal phase: A distinct phase of a substance observed between a crystalline (solid) state and an isotropic (liquid) state.
</span>
    </p>
    <p num="0031" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  リップルゲル相：液体結晶相とゲル相の間の準安定状態である。
</span>
&nbsp;&nbsp;Ripple gel phase: A metastable state between a liquid crystal phase and a gel phase.
</span>
    </p>
    <p num="0032" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  気管内注入：肺への薬物送達のために、気管内チューブを通してまたは経皮注射によって、薬物が気管に投与される薬物投与の方法である。
</span>
&nbsp;&nbsp;Intratracheal infusion: A method of drug administration in which a drug is administered to the trachea through an endotracheal tube or by transdermal injection for drug delivery to the lungs.
</span>
    </p>
    <p num="0033" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  呼吸補助：医学では、機械的人工呼吸は、自発的呼吸を機械的に補助するまたはそれに替わる方法である。これは、罹患患者の気管内チューブを前述の目的のために設計された人工呼吸器に取り付けることによって達成される。人工呼吸器は、気管内チューブまたは気管切開チューブを通して、患者の気道内圧を変えることによって動作する。ＭＲＳＡ肺炎を含む劇症肺炎の患者は、気管切開され、組織の酸素投与が維持される。
</span>
&nbsp;&nbsp;Respiratory assistance: In medicine, mechanical ventilation is a method of mechanically assisting or replacing spontaneous breathing. This is accomplished by attaching the affected patient's endotracheal tube to a ventilator designed for the aforementioned purposes. Ventilators operate by changing the patient's airway pressure through an endotracheal tube or tracheostomy tube. Patients with fulminant pneumonia, including MRSA pneumonia, are tracheostomized and tissue oxygenation is maintained.
</span>
    </p>
    <p num="0034" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  生分解性脂質：生分解性脂質とは、酵素作用または脂質分子がその基礎的構成成分に分解される生得的に起こる生物的プロセスのいずれかによって、インビボ（体内において）で化学分解されやすい脂質である。
</span>
&nbsp;&nbsp;Biodegradable lipids: Biodegradable lipids are those that are susceptible to chemical degradation in vivo (in the body), either by enzymatic action or by innate biological processes in which lipid molecules are broken down into their basic components. It is.
</span>
    </p>
    <p num="0035" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  治療上効果的な量：治療上効果的な量とは、標的となる感染性生物をインビボ条件で治療または除去するために十分な薬物量である。微粒子製剤中に存在する式Ｉの化合物の治療量は、１％〜５％（ｗ／ｗ）の範囲である。
</span>
&nbsp;&nbsp;Therapeutically effective amount: A therapeutically effective amount is an amount of drug sufficient to treat or remove the targeted infectious organism under in vivo conditions. The therapeutic amount of the compound of formula I present in the microparticle formulation ranges from 1% to 5% (w / w).
</span>
    </p>
    <p num="0036" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  非侵襲的治療法：非侵襲的治療法とは、気管切開前の個体において行う噴霧や気管内注入のような方法である。その処置は無痛性で、痛みを緩和するための麻酔薬やその関連成分の投与を含む追加の医療行為を必要としない。
</span>
&nbsp;&nbsp;Non-invasive treatment: Non-invasive treatment is a method such as nebulization or intratracheal injection performed on an individual before tracheostomy. The procedure is painless and does not require additional medical practice, including the administration of anesthetics and related components to relieve pain.
</span>
    </p>
    <p num="0037" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、式Ｉの化合物と薬物送達用生分解性脂質とを含む微粒子製剤であって、脂質に対する薬物（式Ｉの化合物）の比が１：１５〜１：２５であり、生分解性で吸入可能である微粒子製剤に関する。
</span>
&nbsp;&nbsp;The present invention is a microparticle formulation comprising a compound of formula I and a biodegradable lipid for drug delivery, wherein the ratio of drug to lipid (compound of formula I) is from 1:15 to 1:25, biodegradable The present invention relates to a fine particle formulation that can be inhaled with a liquid.
</span>
    </p>
    <p num="0038" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の一局面によると、式Ｉの化合物は上記製剤の１％〜５％（ｗ／ｗ）を構成する。
</span>
&nbsp;&nbsp;According to one aspect of the invention, the compound of formula I constitutes 1% to 5% (w / w) of the formulation.
</span>
    </p>
    <p num="0039" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物は、構造的に以下の式によって表される。
</span>
&nbsp;&nbsp;The compound of formula I is structurally represented by the following formula:
</span>
    </p>
    <p num="0040" class="style-scope patent-text">
      <chemistry num="1" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></chemistry></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000002" he="108" wi="138" file="2013532722.tif" img-format="tif" img-content="drawing" width="552" height="432" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000002" he="108" wi="138" file="2013532722.tif" img-format="tif" img-content="drawing" width="552" height="432" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0041" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物の産生に用いられ得る微生物は、南極圏のシルマッハーオアシス（Schirmacher Oasis）から採取した土壌試料から分離したストレプトマイセス種（ＰＭ０６２６２７１／ＭＴＣＣ ５４４７）の菌株であり、以降本明細書においては、培養物番号ＰＭ０６２６２７１と呼ぶ。培養物番号ＰＭ０６２６２７１は、世界知的所有権機関（ＷＩＰＯ）が承認した国際寄託当局（ＩＤＡ）である微生物工学研究所（Institute of Microbial Technology）、セクター３９Ａ、チャンディーガル、インド、 郵便番号１６００３６の微生物系統保存機関(Microbial Type Culture Collection)（ＭＴＣＣ）に寄託され、受入番号ＭＴＣＣ５４４７が付与されている。
</span>
&nbsp;&nbsp;Microorganisms that can be used for the production of compounds of formula I are strains of Streptomyces sp. (PM06262271 / MTCC 5447) isolated from soil samples taken from the Antarctic Schirmacher Oasis, hereinafter referred to herein. Is called the culture number PM0626271. Culture number PM0626271 is an International Depository Authority (IDA) approved by the World Intellectual Property Organization (WIPO), Institute of Microbial Technology, Sector 39A, Chandigarh, India, ZIP Code 160036 It has been deposited with the Microbial Type Culture Collection (MTCC) and given the accession number MTCC5447.
</span>
    </p>
    <p num="0042" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  上記化合物は、浸水好気条件下で、１つまたは複数の炭素源および１つまたは複数の窒素源ならびに場合によっては栄養無機塩および／または微量元素を含む栄養培地において、培養物番号ＰＭ０６２６２７１を培養し、培養液から式Ｉの化合物を分離し、当該技術分野において一般的に用いられる精製方法を用いて、式Ｉの化合物を精製する工程などを経て、培養物番号ＰＭ０６２６２７１、その突然変異体（mutants）および変異形（variants）から産生することができる。
</span>
&nbsp;&nbsp;The compound is cultured in culture no. PM0626271 in a nutrient medium containing one or more carbon sources and one or more nitrogen sources and optionally nutrient mineral salts and / or trace elements under submerged aerobic conditions. Then, the compound of formula I is separated from the culture broth and purified using a purification method generally used in the art, and the like, and then the culture number PM0626271, a mutant thereof ( mutants) and variants.
</span>
    </p>
    <p num="0043" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  当然のことながら、本明細書中に記載の特定の微生物に加え、Ｘ線や紫外線などを含む化学的または物理的変異原の使用によって生産されるものおよび分子生物学的手法によってその遺伝子構造が組み換えられた生物などの微生物の突然変異体もまた上記化合物を産生するために培養されても良い。
</span>
&nbsp;&nbsp;Of course, in addition to the specific microorganisms described herein, those produced by the use of chemical or physical mutagens, including X-rays, ultraviolet light, etc., and their genetic structure can be determined by molecular biological techniques. Mutants of microorganisms such as recombinant organisms may also be cultured to produce the compound.
</span>
    </p>
    <p num="0044" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物を産生する培養物番号ＰＭ０６２６２７１の分離および培養に用いる培地および／または栄養培地は、好ましくは、炭素、窒素および栄養無機塩を含む。炭素源としては、例えば、デンプン、グルコース、スクロース、デキストリン、フルクトース、糖蜜、グリセロール、ラクトースまたはガラクトースのうちの１つまたは複数があげられる。好ましい炭素源は、可溶性デンプンとグルコースである。窒素源としては、例えば、大豆粉、ピーナッツ粉、酵母エキス、牛肉エキス、ペプトン、麦芽エキス、コーンスティープリカー、ゼラチンまたはカザミノ酸のうちの１つまたは複数があげられる。好ましい窒素源は、ペプトンと酵母エキスである。栄養無機塩としては、例えば、塩化ナトリウム、塩化カリウム、塩化カルシウム、塩化マグネシウム、塩化第二鉄、塩化ストロンチウム、塩化コバルト、臭化カリウム、フッ化ナトリウム、リン酸水素ナトリウム、リン酸水素カリウム、リン酸水素二カリウム、リン酸マグネシウム、炭酸カルシウム、重炭酸ナトリウム、ケイ酸ナトリウム、硝酸アンモニウム、硝酸カリウム、硫酸第一鉄、硫酸ナトリウム、硫酸アンモニウム、硫酸マグネシウム、クエン酸鉄、ホウ酸あるいは硫酸銅、塩化マンガンまたは硫酸亜鉛などの微量塩溶液のうちの１つまたは複数があげられる。炭酸カルシウム、塩化ナトリウムおよび塩化マグネシウムは、好ましい栄養無機塩である。
</span>
&nbsp;&nbsp;The medium and / or nutrient medium used for the separation and cultivation of culture number PM0626271 producing the compound of formula I preferably comprises carbon, nitrogen and nutrient mineral salts. Examples of the carbon source include one or more of starch, glucose, sucrose, dextrin, fructose, molasses, glycerol, lactose or galactose. Preferred carbon sources are soluble starch and glucose. Examples of the nitrogen source include one or more of soybean powder, peanut powder, yeast extract, beef extract, peptone, malt extract, corn steep liquor, gelatin, and casamino acid. Preferred nitrogen sources are peptone and yeast extract. Examples of nutrient inorganic salts include sodium chloride, potassium chloride, calcium chloride, magnesium chloride, ferric chloride, strontium chloride, cobalt chloride, potassium bromide, sodium fluoride, sodium hydrogen phosphate, potassium hydrogen phosphate, phosphorus Dipotassium hydrogen phosphate, magnesium phosphate, calcium carbonate, sodium bicarbonate, sodium silicate, ammonium nitrate, potassium nitrate, ferrous sulfate, sodium sulfate, ammonium sulfate, magnesium sulfate, iron citrate, boric acid or copper sulfate, manganese chloride or One or more of the trace salt solutions such as zinc sulfate may be mentioned. Calcium carbonate, sodium chloride and magnesium chloride are preferred nutrient mineral salts.
</span>
    </p>
    <p num="0045" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  培養物番号ＰＭ０６２６２７１の維持は、２２℃〜３６℃の範囲の温度およびｐＨ約７．５〜８．０で行なってもよい。典型的に、培養物番号ＰＭ０６２６２７１は、２５℃〜２７℃およびｐＨ約７．４〜７．８で維持される。十分増殖した培養物は、４℃〜８℃で冷蔵庫に保存しても良い。
</span>
&nbsp;&nbsp;Culture number PM0626271 may be maintained at a temperature in the range of 22 ° C to 36 ° C and at a pH of about 7.5 to 8.0. Typically, culture number PM0626271 is maintained at 25 ° C. to 27 ° C. and pH about 7.4 to 7.8. A sufficiently grown culture may be stored in a refrigerator at 4 ° C to 8 ° C.
</span>
    </p>
    <p num="0046" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  培養物番号ＰＭ０６２６２７１の種培養物培養は、２５℃〜３６℃の範囲の温度およびｐＨ約７．５〜８．０で６６時間〜７５時間２００ｒｐｍ（revolutions per minute）〜２８０ｒｐｍで行なってもよい。典型的に、培養物番号ＰＭ０６２６２７１種は、２９℃〜３１℃およびｐＨ約７．４〜７．８で７２時間２３０ｒｐｍ〜２５０ｒｐｍで培養される。
</span>
&nbsp;&nbsp;The seed culture culture of culture number PM0626271 may be performed at a temperature in the range of 25 ° C. to 36 ° C. and a pH of about 7.5 to 8.0 at a speed of 200 rpm (revolutions per minute) to 280 rpm for 66 hours to 75 hours. Typically, culture number PM0626271 species is cultured at 230 rpm to 250 rpm for 72 hours at 29 ° C. to 31 ° C. and a pH of about 7.4 to 7.8.
</span>
    </p>
    <p num="0047" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物の産生は、２６℃〜３６℃の範囲の温度およびｐＨ約６．５〜８．５で２４時間〜９６時間６０ｒｐｍ〜１４０ｒｐｍおよび１００ｌｐｍ（liter per minute）〜２００ｌｐｍの通気での発酵によって培養物番号ＰＭ０６２６２７１を培養することによって行なってもよい。典型的に、培養物番号ＰＭ０６２６２７１は、３０℃〜３２℃およびｐＨ７．４〜７．８で４０時間〜９６時間９０ｒｐｍ、１１０ｌｐｍの通気で培養される。
</span>
&nbsp;&nbsp;Production of the compound of Formula I is carried out by fermentation at temperatures ranging from 26 ° C. to 36 ° C. and pH of about 6.5 to 8.5 for 24 hours to 96 hours at 60 rpm to 140 rpm and 100 lpm (liter per minute) to 200 lpm aeration. May be performed by culturing culture number PM0626271. Typically, culture number PM0626271 is cultured at 30 ° C. to 32 ° C. and pH 7.4 to 7.8 for 40 hours to 96 hours at 90 rpm, 110 lpm aeration.
</span>
    </p>
    <p num="0048" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  発酵および化合物の産生の進行は、高速液体クロマトグラフィー（ＨＰＬＣ）や、公知の微生物寒天平板拡散試験法によってブドウ球菌（Staphylococci）および／または腸球菌（Enterococci）種に対する培養液の生物活性の測定とにより検出することができる。好ましい培養物は、文献において報告されているメチシリンとベータラクタム系抗生物質に耐性のある菌株である黄色ブドウ球菌（Staphylococcus aureus）Ｅ７１０およびバンコマイシンに耐性のあるエンテロコッカスフェシウム（Enterococcus faecium）Ｒ２（ＶＲＥ）である。得られた培養液において、化合物は培養ろ液中および細胞集団に存在し得、溶媒抽出やカラムクロマトグラフィーのような公知の分離法を用いて分離することができる。式Ｉの化合物は、石油エーテル、ジクロロメタン、クロロホルム、酢酸エチル、ジエチルエーテルまたはブタノールのような水不混和性溶媒でｐＨ約５〜９での抽出により、あるいは「ダイヤイオンＨＰ−２０（登録商標）」（三菱化成工業、日本）、「アンバーライトＸＡＤ（登録商標）」（ロームアンドハース工業 米国）などの高分子樹脂、活性炭を用いる疎水性相互作用クロマトグラフィーにより、あるいはｐＨ５〜９でイオン交換クロマトグラフィーにより培養ろ液から回収することができる。活性物質は、メタノール、アセトン、アセトニトリル、ｎ−プロパノールまたはイソプロパノールなどの水混和性溶媒あるいは石油エーテル、ジクロロメタン、クロロホルム、酢酸エチルまたはブタノールなどの水不混和性溶媒で抽出することによって、細胞集団から回収することができる。他の選択肢としては、石油エーテル、ジクロロメタン、クロロホルム、酢酸エチル、メタノール、アセトン、アセトニトリル、ｎ−プロパノール、イソプロパノールまたはブタノールから選択される溶媒で全液体培地を抽出することである。典型的には、活性物質は全液体培地から酢酸エチルで抽出される。
</span>
&nbsp;&nbsp;The progress of fermentation and the production of compounds can be determined by measuring the biological activity of the culture against Staphylococci and / or Enterococci species by high performance liquid chromatography (HPLC) or known microbial agar plate diffusion test methods. Can be detected. Preferred cultures are Staphylococcus aureus E710, a strain resistant to methicillin and beta-lactam antibiotics reported in the literature, and Enterococcus faecium R2 (VRE) resistant to vancomycin. It is. In the obtained culture broth, the compound can be present in the culture filtrate and in the cell population, and can be separated using a known separation method such as solvent extraction or column chromatography. The compounds of formula I can be obtained by extraction with water-immiscible solvents such as petroleum ether, dichloromethane, chloroform, ethyl acetate, diethyl ether or butanol at a pH of about 5-9 or by “Diaion HP-20®”. "Mitsubishi Kasei Kogyo, Japan", "Amberlite XAD (registered trademark)" (Rohm and Haas Industry USA), etc., by hydrophobic interaction chromatography using activated carbon, or ion exchange chromatography at pH 5-9 It can be recovered from the culture filtrate by chromatography. The active substance is recovered from the cell population by extraction with a water miscible solvent such as methanol, acetone, acetonitrile, n-propanol or isopropanol or a water immiscible solvent such as petroleum ether, dichloromethane, chloroform, ethyl acetate or butanol. can do. Another option is to extract the whole liquid medium with a solvent selected from petroleum ether, dichloromethane, chloroform, ethyl acetate, methanol, acetone, acetonitrile, n-propanol, isopropanol or butanol. Typically, the active substance is extracted with ethyl acetate from the whole liquid medium.
</span>
    </p>
    <p num="0049" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  抽出物を濃縮および凍結乾燥すると活性粗材料が得られる。式Ｉの化合物は、順相クロマトグラフィー（固定相としてアルミナまたはシリカゲル；および石油エーテル、酢酸エチル、ジクロロメタン、アセトン、クロロホルム、メタノールまたはそれらの組み合わせなどの溶離液を用いる）；逆相クロマトグラフィー（固定相としてジメチルオクタデシルシリルシリカゲル（ＲＰ−１８）またはジメチルオクチルシリルシリカゲル（ＲＰ−８）などの逆相シリカゲル；ならびに水、緩衝液（例えば、リン酸塩、酢酸塩、クエン酸塩（ｐＨ２〜８））および有機溶媒（例えば、メタノール、アセトニトリル、アセトン、テトラヒドロフランまたはこれらの溶媒の組み合わせ）などの溶離液を用いる）；ゲル浸透クロマトグラフィー（メタノール、クロロホルム、アセトン、酢酸エチルまたはそれらの組み合わせなどの溶媒中でセファデックスＬＨ−２０（登録商標）（ファルマシア化学工業，スウェーデン）、ＴＳＫゲル（登録商標）トヨパールＨＷ（トーソーハース、東ソー株式会社、日本）、あるいは水でセファデックス（登録商標）Ｇ−１０およびＧ−２５などの樹脂を用いる）；あるいは向流クロマトグラフィー（水、メタノール、エタノール、イソプロパノール、ｎ−プロパノール、テトラヒドロフラン、アセトン、アセトニトリル、塩化メチレン、クロロホルム、酢酸エチル、石油エーテル、ベンゼンおよびトルエンなどの溶媒２つ以上からなる二相溶離液系を用いる）のいずれかを用いて分画法によって粗材料から回収することができる。これらの手法を単独または組み合わせて繰り返して用いても良い。典型的な方法は、シリカゲルを用いた順相でのクロマトグラフィーである。
</span>
&nbsp;&nbsp;The extract is concentrated and lyophilized to give the active crude material. Compounds of formula I are normal phase chromatography (using alumina or silica gel as stationary phase; and eluents such as petroleum ether, ethyl acetate, dichloromethane, acetone, chloroform, methanol or combinations thereof); reverse phase chromatography (stationary Reversed phase silica gel such as dimethyloctadecylsilyl silica gel (RP-18) or dimethyloctylsilyl silica gel (RP-8) as a phase; and water, buffer (eg, phosphate, acetate, citrate (pH 2-8)) ) And organic solvents (eg, eluents such as methanol, acetonitrile, acetone, tetrahydrofuran or combinations of these)); gel permeation chromatography (methanol, chloroform, acetone, ethyl acetate or combinations thereof) Sephadex LH-20 (registered trademark) (Pharmacia Chemical Industries, Sweden), TSK Gel (registered trademark) Toyopearl HW (Tosoh Haas, Tosoh Corporation, Japan), or Sephadex (registered trademark) in water ) Using resins such as G-10 and G-25); or countercurrent chromatography (water, methanol, ethanol, isopropanol, n-propanol, tetrahydrofuran, acetone, acetonitrile, methylene chloride, chloroform, ethyl acetate, petroleum ether, Can be recovered from the crude material by fractionation using either a two-phase eluent system comprising two or more solvents such as benzene and toluene. These methods may be used alone or in combination to be used repeatedly. A typical method is normal phase chromatography using silica gel.
</span>
    </p>
    <p num="0050" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物およびその異性体は、エステルやエーテルのようなその薬学的に許容される塩および誘導体に変換することができ、それらは全て本発明の範囲内である。
</span>
&nbsp;&nbsp;Compounds of formula I and isomers thereof can be converted into their pharmaceutically acceptable salts and derivatives such as esters and ethers, all of which are within the scope of the invention.
</span>
    </p>
    <p num="0051" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  上記製剤中に用いられる生分解性脂質は、内因性肺サーファクタントシステムの自然発生のリン脂質であるジパルミトイルホスファチジルコリン（ＤＰＰＣ）である。ＤＰＰＣと組み合わせて用いることができる生分解性脂質の他の非限定例は、ＤＰＰＧ（ジパルミトイルホスファチジルグリセロール）、ＤＰＰＥ（ジパルミトイルホスファチジルエタノールアミン）、コレステロール、ホスファチジルイノシトールおよびホスファチジルセリンを含む。
</span>
&nbsp;&nbsp;The biodegradable lipid used in the formulation is dipalmitoyl phosphatidylcholine (DPPC), a naturally occurring phospholipid of the endogenous lung surfactant system. Other non-limiting examples of biodegradable lipids that can be used in combination with DPPC include DPPG (dipalmitoylphosphatidylglycerol), DPPE (dipalmitoylphosphatidylethanolamine), cholesterol, phosphatidylinositol and phosphatidylserine.
</span>
    </p>
    <p num="0052" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の他の局面において、上記製剤の微粒子のサイズは０．５〜１０ミクロンの範囲である。
</span>
&nbsp;&nbsp;In another aspect of the invention, the microparticle size of the formulation is in the range of 0.5 to 10 microns.
</span>
    </p>
    <p num="0053" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明のさらに他の局面において、上記製剤の微粒子の９０％は１０ミクロン未満のサイズである。
</span>
&nbsp;&nbsp;In yet another aspect of the invention, 90% of the microparticles in the formulation are less than 10 microns in size.
</span>
    </p>
    <p num="0054" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明のさらに他の局面において、上記製剤は水性リポソーム分散液である。
</span>
&nbsp;&nbsp;In yet another aspect of the present invention, the formulation is an aqueous liposome dispersion.
</span>
    </p>
    <p num="0055" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の１つの局面において、上記製剤のｐＨは６から７である。
</span>
&nbsp;&nbsp;In one aspect of the invention, the formulation has a pH of 6-7.
</span>
    </p>
    <p num="0056" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  他の局面において、上記製剤の重量モル浸透圧濃度は３００ｍＯｓｍｏｌ／ｋｇから４００ｍＯｓｍｏｌ／ｋｇである。本発明のさらに他の局面において、上記製剤の相転移温度は４１℃から４３℃である。本発明の他の局面において、上記製剤は、ネブライザーを用いることによって、空気力学的質量中位径１μｍ〜１０μｍにエアロゾル化することができる。
</span>
&nbsp;&nbsp;In another aspect, the osmolality of the formulation is from 300 mOsmol / kg to 400 mOsmol / kg. In yet another aspect of the present invention, the formulation has a phase transition temperature of 41 ° C to 43 ° C. In another aspect of the present invention, the preparation can be aerosolized to a median aerodynamic mass of 1 μm to 10 μm by using a nebulizer.
</span>
    </p>
    <p num="0057" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  用いることが可能なネブライザーの種類は、ジェットネブライザー、超音波ネブライザーおよび振動メッシュ式ネブライザーを含むが、これらに限定されない。
</span>
&nbsp;&nbsp;Types of nebulizers that can be used include, but are not limited to, jet nebulizers, ultrasonic nebulizers, and vibrating mesh nebulizers.
</span>
    </p>
    <p num="0058" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、微粒子製剤の調製のためのプロセスに関する。
</span>
&nbsp;&nbsp;The invention also relates to a process for the preparation of a microparticle formulation.
</span>
    </p>
    <p num="0059" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の１つ局面において、上記製剤の調製のためのプロセスは、以下の工程を含む「溶媒蒸発法」の使用を伴う。
</span>
&nbsp;&nbsp;In one aspect of the invention, the process for the preparation of the formulation involves the use of a “solvent evaporation method” comprising the following steps.
</span>
    </p>
    <p num="0060" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (a) 式Ｉの化合物とＤＰＰＣ（１：１５〜１：２５の比）を３ｍＬ〜１５ｍＬのクロロホルムに溶解し、溶液を得る。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Dissolve the compound of formula I and DPPC (ratio 1:15 to 1:25) in 3 mL to 15 mL of chloroform to obtain a solution.
</span>
    </p>
    <p num="0061" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (b) ２０ｍＬ〜４５ｍＬのメタノールを工程(a)の溶液に加え、十分混合し、均質溶液を得る。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Add 20 mL to 45 mL of methanol to the solution of step (a) and mix well to obtain a homogeneous solution.
</span>
    </p>
    <p num="0062" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (c) ２０ｍＬ〜５０ｍＬの模擬肺液(simulated lung fluid）（ＳＬＦ）を工程(b)の溶液に加える。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Add 20-50 mL of simulated lung fluid (SLF) to the solution of step (b).
</span>
    </p>
    <p num="0063" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (d) 溶媒を蒸発させる。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Evaporate the solvent.
</span>
    </p>
    <p num="0064" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (e) 工程(d)で得た量をＳＬＦで３０ｍＬにし、１５０００Ｇ〜３５０００Ｇ、４℃で１０分間遠心分離し、ペレットを得る。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The amount obtained in step (d) is made 30 mL with SLF, and centrifuged at 15000 G to 35000 G at 4 ° C. for 10 minutes to obtain a pellet.
</span>
    </p>
    <p num="0065" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (f) 工程(e)で得たペレットをＳＬＦ中に再懸濁し、濃度０．５ｍｇ／ｍＬ〜１０ｍｇ／ｍＬの懸濁液を得る。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) The pellet obtained in step (e) is resuspended in SLF to obtain a suspension having a concentration of 0.5 mg / mL to 10 mg / mL.
</span>
    </p>
    <p num="0066" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (g) 工程(f)で得た懸濁液を０．５μｍ〜５μｍのポリカーボネートフィルターを通してろ過し、形成された微粒子の粒径を均一にする。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) The suspension obtained in the step (f) is filtered through a polycarbonate filter of 0.5 μm to 5 μm so that the formed fine particles have a uniform particle size.
</span>
    </p>
    <p num="0067" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書において用いられる上記「溶媒蒸発法」は、米国特許第４８７７５６１号において報告されている方法の変形例である。
</span>
&nbsp;&nbsp;As used herein, the “solvent evaporation method” is a variation of the method reported in US Pat. No. 4,877,561.
</span>
    </p>
    <p num="0068" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の実施形態において、上記微粒子製剤の調製のためのプロセスの工程(a)において、式Ｉの化合物およびＤＰＰＣを１：２０の比で溶解する。
</span>
&nbsp;&nbsp;In an embodiment of the invention, in step (a) of the process for the preparation of the microparticle formulation, the compound of formula I and DPPC are dissolved in a ratio of 1:20.
</span>
    </p>
    <p num="0069" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の他の実施形態において、上記微粒子製剤の調製のためのプロセスの工程(a)において、式Ｉの化合物およびＤＰＰＣを５〜１０ｍＬのクロロホルムに溶解し溶液を得る。
</span>
&nbsp;&nbsp;In another embodiment of the invention, in step (a) of the process for the preparation of the microparticle formulation, the compound of formula I and DPPC are dissolved in 5-10 mL of chloroform to obtain a solution.
</span>
    </p>
    <p num="0070" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の実施形態において、上記微粒子製剤の調製のためのプロセスの工程(b)において、３０〜４０ｍＬのメタノールを加える。
</span>
&nbsp;&nbsp;In an embodiment of the invention, 30-40 mL of methanol is added in step (b) of the process for preparation of the microparticle formulation.
</span>
    </p>
    <p num="0071" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の他の実施形態において、上記微粒子製剤の調製のためのプロセスの工程(c)において、２５〜３５ｍＬのＳＬＦを加える。本発明の他の実施形態において、上記微粒子製剤の調製のためのプロセスの工程(e)において、遠心分離を２００００〜３００００Ｇで行う。
</span>
&nbsp;&nbsp;In another embodiment of the invention, 25-35 mL of SLF is added in step (c) of the process for preparation of the microparticle formulation. In another embodiment of the invention, in step (e) of the process for preparation of the microparticle formulation, centrifugation is performed at 20000-30000G.
</span>
    </p>
    <p num="0072" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の他の実施形態において、上記微粒子製剤の調製のためのプロセスの工程(f)において、ペレットをＳＬＦ中に再懸濁し、濃度１〜５ｍｇ／ｍＬの懸濁液を得る。
</span>
&nbsp;&nbsp;In another embodiment of the invention, in step (f) of the process for preparation of the microparticle formulation, the pellet is resuspended in SLF to obtain a suspension with a concentration of 1-5 mg / mL.
</span>
    </p>
    <p num="0073" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の他の実施形態において、上記微粒子製剤の調製のためのプロセスの工程(g)において、工程(f)で得られた懸濁液を、２μｍ〜５μｍポリカーボネートフィルターを通してろ過する。
</span>
&nbsp;&nbsp;In another embodiment of the invention, in step (g) of the process for the preparation of the microparticle formulation, the suspension obtained in step (f) is filtered through a 2 μm to 5 μm polycarbonate filter.
</span>
    </p>
    <p num="0074" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の他の局面において、上記製剤の調製のためのプロセスは、以下の工程を含む「無溶媒脂質自己組織化法（Solvent free lipid self assembly method）」である。
</span>
&nbsp;&nbsp;In another aspect of the invention, the process for preparation of the formulation is a “Solvent free lipid self assembly method” comprising the following steps.
</span>
    </p>
    <p num="0075" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (i)   ２０ｍＬ〜４５ｍＬのＳＬＦを、式Ｉの化合物とＤＰＰＣとの混合物（１：１５〜１：２５の比）に加える。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) 20 mL to 45 mL of SLF is added to a mixture of compound of formula I and DPPC (ratio 1:15 to 1:25).
</span>
    </p>
    <p num="0076" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (ii)  工程(i)の混合物を、４２℃〜４５℃で１時間、１００ｒｐｍ〜２００ｒｐｍで回転させ、懸濁液を得る。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) The mixture of step (i) is rotated at 100 rpm to 200 rpm for 1 hour at 42 ° C to 45 ° C to obtain a suspension.
</span>
    </p>
    <p num="0077" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (iii) 工程(ii)で得た懸濁液を、１５０００Ｇ〜３５０００Ｇ、４℃で１０分間遠心分離し、ペレットを得る。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) The suspension obtained in step (ii) is centrifuged at 15000G-35000G at 4 ° C. for 10 minutes to obtain a pellet.
</span>
    </p>
    <p num="0078" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (iv)  工程(iii)で得たペレットをＳＬＦ中に再懸濁し、濃度０．５ｍｇ／ｍＬ〜１０ｍｇ／ｍＬの懸濁液を得る。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) The pellet obtained in step (iii) is resuspended in SLF to obtain a suspension having a concentration of 0.5 mg / mL to 10 mg / mL.
</span>
    </p>
    <p num="0079" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (v)   工程(iv)で得た懸濁液を０．５μｍ〜５μｍのポリカーボネートフィルターを通してろ過し、形成された微粒子の粒径を均一にする。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) The suspension obtained in step (iv) is filtered through a polycarbonate filter of 0.5 μm to 5 μm to make the formed fine particles have a uniform particle size.
</span>
    </p>
    <p num="0080" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の実施形態において、上記微粒子製剤の調製のためのプロセスの工程(i)において、３０ｍＬ〜４０ｍＬのＳＬＦを、式Ｉの化合物とＤＰＰＣとの混合物に加える。
</span>
&nbsp;&nbsp;In an embodiment of the invention, in step (i) of the process for preparation of the microparticle formulation, 30 mL to 40 mL of SLF is added to the mixture of the compound of formula I and DPPC.
</span>
    </p>
    <p num="0081" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の他の実施形態において、上記微粒子製剤の調製のためのプロセスの工程(i)において、式Ｉの化合物およびＤＰＰＣを１：２０の比で溶解する。
</span>
&nbsp;&nbsp;In another embodiment of the invention, in step (i) of the process for the preparation of the microparticle formulation, the compound of formula I and DPPC are dissolved in a ratio of 1:20.
</span>
    </p>
    <p num="0082" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の実施形態において、上記微粒子製剤の調製のためのプロセスの工程(iii)において、工程(ii)で得られた懸濁液を、２００００Ｇ〜３５０００Ｇ、４℃で１０分間遠心分離しペレットを得る。
</span>
&nbsp;&nbsp;In an embodiment of the present invention, in step (iii) of the process for preparation of the microparticle preparation, the suspension obtained in step (ii) is centrifuged at 20000G-35000G for 10 minutes at 4 ° C. obtain.
</span>
    </p>
    <p num="0083" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の他の実施形態において、上記微粒子製剤の調製のためのプロセスの工程(iv)において、工程(iii)で得たペレットをＳＬＦ中に再懸濁し、濃度１ｍｇ／ｍＬ〜５ｍｇ／ｍＬの懸濁液を得る。
</span>
&nbsp;&nbsp;In another embodiment of the present invention, in step (iv) of the process for the preparation of the microparticle formulation, the pellet obtained in step (iii) is resuspended in SLF to a concentration of 1 mg / mL to 5 mg / mL. A suspension is obtained.
</span>
    </p>
    <p num="0084" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の他の実施形態において、上記微粒子製剤の調製のためのプロセスの工程(v)において、工程(iv)で得られた懸濁液を、２μｍ〜５μｍポリカーボネートフィルターを通してろ過する。
</span>
&nbsp;&nbsp;In another embodiment of the invention, in step (v) of the process for the preparation of the microparticle formulation, the suspension obtained in step (iv) is filtered through a 2 μm to 5 μm polycarbonate filter.
</span>
    </p>
    <p num="0085" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はさらに、治療上効果的な量の製剤をそれを必要とする哺乳類に投与することによる、肺結核、ＭＤＲＴＢ、ＭＲＳＡ肺炎およびＭＳＳＡ肺炎の治療法における製剤の使用に関する。
</span>
&nbsp;&nbsp;The invention further relates to the use of the formulations in the treatment of pulmonary tuberculosis, MDRTB, MRSA pneumonia and MSSA pneumonia by administering a therapeutically effective amount of the formulation to a mammal in need thereof.
</span>
    </p>
    <p num="0086" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はさらに、肺結核、ＭＤＲＴＢ、ＭＲＳＡ肺炎およびＭＳＳＡ肺炎の治療のための薬剤の製造のための、式Ｉの化合物と薬物送達用生分解性脂質とを含み、脂質に対する薬物（式Ｉの化合物）の比が１：１５〜１：２５である微粒子製剤の使用に関する。
</span>
&nbsp;&nbsp;The present invention further comprises a compound of formula I and a biodegradable lipid for drug delivery for the manufacture of a medicament for the treatment of pulmonary tuberculosis, MDRTB, MRSA pneumonia and MSSA pneumonia, wherein the drug against the lipid (compound of formula I ) Ratio of 1:15 to 1:25.
</span>
    </p>
    <p num="0087" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の１つの局面において、上記治療法は、結核菌ならびにメチシリン耐性黄色ブドウ球菌およびメチシリン感受性黄色ブドウ球菌を宿すことができる肺胞マクロファージを標的とする。
</span>
&nbsp;&nbsp;In one aspect of the invention, the method of treatment targets alveolar macrophages that can harbor M. tuberculosis and methicillin-resistant and methicillin-sensitive S. aureus.
</span>
    </p>
    <p num="0088" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、微粒子製剤をそれを必要とする哺乳類に送達する方法であって、上記製剤は肺送達のために吸入または気管内注入によって投与される送達方法に関する。
</span>
&nbsp;&nbsp;The invention also relates to a method of delivering a particulate formulation to a mammal in need thereof, wherein the formulation is administered by inhalation or intratracheal infusion for pulmonary delivery.
</span>
    </p>
    <p num="0089" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の１つの局面において、上記微粒子製剤の送達方法は吸入による。
</span>
&nbsp;&nbsp;In one aspect of the invention, the delivery method of the microparticle formulation is by inhalation.
</span>
    </p>
    <p num="0090" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の他の局面において、吸入方法は、式Ｉの化合物を上記微粒子中に封入した噴霧である。
</span>
&nbsp;&nbsp;In another aspect of the invention, the inhalation method is a spray in which the compound of formula I is encapsulated in the microparticles.
</span>
    </p>
    <p num="0091" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の微粒子製剤については、吸入によって投与された際、製剤に含まれた式Ｉの化合物のかなりの濃度がマウスの肺において検出されるということが観察されている。しかしながら、未製剤の式Ｉの化合物（unformulated compound of formula I）を投与したマウスの肺では、式Ｉの化合物はほとんど検出されない。これは、上記微粒子製剤における式Ｉの化合物の高生物学的利用能を示している。さらに、本発明の微粒子製剤が吸入によって投与された際、上記薬物（式Ｉの化合物）は、２４時間を超えて肺に保持されるということが観察されている。
</span>
&nbsp;&nbsp;For the microparticle formulations of the present invention, it has been observed that significant concentrations of the compound of formula I contained in the formulation are detected in the lungs of mice when administered by inhalation. However, almost no compound of formula I is detected in the lungs of mice administered an unformulated compound of formula I. This indicates the high bioavailability of the compound of formula I in the microparticle formulation. Furthermore, it has been observed that when the microparticle formulation of the present invention is administered by inhalation, the drug (formula I compound) is retained in the lungs for more than 24 hours.
</span>
    </p>
    <p num="0092" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の他の局面において、封入された式Ｉの化合物の保持率は、３０％以上である。特に、封入された式Ｉの化合物の保持率は、３０％〜７０％の範囲である。
</span>
&nbsp;&nbsp;In another aspect of the invention, the retention rate of the encapsulated compound of formula I is 30% or more. In particular, the retention of encapsulated compounds of formula I is in the range of 30% to 70%.
</span>
    </p>
    <p num="0093" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  吸入のための式Ｉの化合物の投与量は、０．０５〜１０ｍｇ／ｋｇ体重／日の範囲である。
</span>
&nbsp;&nbsp;The dosage of the compound of formula I for inhalation ranges from 0.05 to 10 mg / kg body weight / day.
</span>
    </p>
    <p num="0094" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の他の局面において、上記微粒子製剤の送達方法は、呼吸補助システムに依存している患者における気管内注入である。
</span>
&nbsp;&nbsp;In another aspect of the invention, the delivery method of the microparticle formulation is intratracheal infusion in a patient who is dependent on a respiratory assistance system.
</span>
    </p>
    <p num="0095" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の他の局面において、噴霧による投与は、肺結核、ＭＤＲＴＢ、ＭＲＳＡ肺炎およびＭＳＳＡ肺炎の治療に必要とされる式Ｉの化合物量を減らすのに役立つ。
</span>
&nbsp;&nbsp;In other aspects of the invention, administration by nebulization helps to reduce the amount of compound of formula I required for the treatment of pulmonary tuberculosis, MDRTB, MRSA pneumonia and MSSA pneumonia.
</span>
    </p>
    <p num="0096" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明のさらに他の局面において、上記方法は、式Ｉの化合物が肺に到達するのを助ける。
</span>
&nbsp;&nbsp;In yet another aspect of the invention, the method helps the compound of Formula I reach the lung.
</span>
    </p>
    <p num="0097" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  上記微粒子製剤の有効性は、次の実施例において詳細に記載される生物学的試験によって確立されている。これらの実施例は、本明細書において例示されているにすぎず、本発明の範囲を限定するものではない。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例<br class="style-scope patent-text">
<br class="style-scope patent-text">
  以下の用語／略語／化学式は実施例において用いられる：<br class="style-scope patent-text">
ＮａＣｌ          :塩化ナトリウム<br class="style-scope patent-text">
ＣａＣｌ<sub class="style-scope patent-text">2 </sub>        :塩化カルシウム<br class="style-scope patent-text">
ＮａＯＨ          :水酸化ナトリウム<br class="style-scope patent-text">
ＳＬＦ            :模擬肺液<br class="style-scope patent-text">
ＨＰＬＣ          :高速液体クロマトグラフィー<br class="style-scope patent-text">
ＤＰＰＣ          :１，２−ジパルミトイル−ｓｎ−グリセロ−３−ホスフォコリン<br class="style-scope patent-text">
ＤＭＳＯ          :ジメチルスルホキシド<br class="style-scope patent-text">
ＲＢフラスコ      :丸底フラスコ<br class="style-scope patent-text">
ｒｐｍ            :毎分回転数<br class="style-scope patent-text">
ＤＳＣ            :示差走査熱量計<br class="style-scope patent-text">
ＴＳＩ            :ツインステージインピンジャー<br class="style-scope patent-text">
ＭＳＳＡ          :メチシリン感受性黄色ブドウ球菌<br class="style-scope patent-text">
ＭＲＳＡ          :メチシリン耐性黄色ブドウ球菌<br class="style-scope patent-text">
ＶＲＥ            :バンコマイシン耐性腸球菌<br class="style-scope patent-text">
ＴＳＡ            :トリプトースソイ寒天<br class="style-scope patent-text">
ＣＦＵ            :コロニー形成単位<br class="style-scope patent-text">
ＨＢＳＳ          :ハンクス緩衝塩溶液<br class="style-scope patent-text">
ＭＴＳ            :（３−（４，５−ジメチルシアゾール−２−イル）−５−（３−カルボキシメトキシフェニル）−２−（４−スルホフェニル）−２Ｈ−テトラゾリウム）<br class="style-scope patent-text">
ＧＣ−ＨＳ        :ヘッドスペースアッタチメントでのガスクロマトグラフ<br class="style-scope patent-text">
ＣＰＣＳＥＡ      :動物実験管理監督委員会（Committee for the Purpose of Control and Supervision of Experiments on Animals）<br class="style-scope patent-text">
ＩＡＥＣ          :動物倫理委員会（Institutional Animal Ethics Committee）<br class="style-scope patent-text">
ＡＰＩ            :医薬有効成分<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例１<br class="style-scope patent-text">
南極圏から採取した土壌からの培養物番号ＰＭ０６２６２７１の分離<br class="style-scope patent-text">
ａ）分離培地の組成：<br class="style-scope patent-text">
  改変人工海水寒天：ペプトン１．５ｇ、酵母エキス０．５ｇ、塩化第二鉄０．００７ｇ、水１．０Ｌ（７５０ｍＬの人工海水 ＋ ２５０ｍＬの脱塩水）、寒天末１５．０ｇ、最終ｐＨ（２５℃で）７．４〜７．８．<br class="style-scope patent-text">
  人工海水の組成：塩化ナトリウム２４．６ｇ、塩化カリウム０．６７ｇ、塩化カルシウム２水和物１．３６ｇ、硫酸マグネシウム７水和物６．２９ｇ、塩化マグネシウム６水和物４．６６ｇ、重炭酸ナトリウム０．１８ｇ、脱塩水１．０Ｌ、最終ｐＨ（２５℃で）７．８〜８．２．<br class="style-scope patent-text">
ｂ）手順：<br class="style-scope patent-text">
  南極圏のシルマッハーオアシスから、表層土壌を採取し、ピラマル・ライフ・サイエンス・リミテッド（Piramal Life Sciences Limited）、ゴレガオン（Goregaon）、ムンバイ、インドへの旅程の間、−２０℃で保管した。試料を−２０℃〜２２℃で保管し、後に微生物の分離のために室温（２５℃±２℃）に解凍した。土壌試料（〜１ｇ）を、１００ｍＬの殺菌されたフラスコ中で無菌１％ペプトン水２５ｍＬに懸濁した。フラスコを３０秒間ボルテックスした。１０<sup class="style-scope patent-text">-5</sup>までの段階希釈物を無菌１％ペプトン水で調製した。１０<sup class="style-scope patent-text">-5</sup>希釈物の１００μＬを、改変人工海水寒天の表面に塗布した。プレートを、コロニーが観察されるまで室温（２５±２℃）で培養した。１か月半の培養後、この培地に現れたコロニーを、７５％人工海水［Ａｃｃｕｍｉｘ（商標）］（ＡＳ−ＡＩＡ）中に調製された放線菌アイソレーション寒天［高濃度培地］を含むシャーレ上に画線した。分離株を精製し、培養物ＩＤ番号ＰＭ０６２６２７１とした。培養物番号ＰＭ０６２６２７１をこのようにして、増殖中の微生物の中から単一の分離株として分離した<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例２<br class="style-scope patent-text">
培養物番号ＰＭ０６２６２７１の精製<br class="style-scope patent-text">
ａ）精製培地（放線菌アイソレーション寒天、１．５％寒天により寒天化）の組成：<br class="style-scope patent-text">
  グリセロール５．０ｍＬ、カゼインナトリウム２．０ｇ、Ｌ−アスパラギン０．１ｇ、プロピオン酸ナトリウム４．０ｇ、リン酸二カリウム０．５ｇ、硫酸マグネシウム０．１ｇ、硫酸第一鉄０．００１ｇ、１．０Ｌの水（７５０ｍＬの人工海水 ＋ ２５０ｍＬの脱塩水）、寒天末１５．０ｇ、最終ｐＨ（２５℃で）７．４〜７．８．<br class="style-scope patent-text">
  人工海水の組成：塩化ナトリウム２４．６ｇ、塩化カリウム０・６７ｇ、塩化カルシウム２水和物１．３６ｇ、硫酸マグネシウム７水和物６．２９ｇ、塩化マグネシウム６水和物４．６６ｇ、重炭酸ナトリウム０．１８ｇ、脱塩水１．０Ｌ、最終ｐＨ（２５℃で）７．８〜８．２．<br class="style-scope patent-text">
ｂ）手順：<br class="style-scope patent-text">
  培養物番号ＰＭ０６２６２７１を、（７５％人工海水塩を含む）放線菌アイソレーション寒天シャーレ上に画線した。シャーレを２５℃で１０日間培養した。シャーレから分離されたコロニーのうち１つのコロニーを、７５％人工海水で調製された放線菌アイソレーション寒天の新しい斜面培地に移した。斜面培地を２５℃で１０日間培養した。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例３<br class="style-scope patent-text">
産生株−培養物番号ＰＭ０６２６２７１の維持<br class="style-scope patent-text">
ａ）培地（放線菌アイソレーション寒天）の組成：<br class="style-scope patent-text">
  グリセロール５．０ｍＬ、カゼインナトリウム２．０ｇ、Ｌ−アスパラギン０．１ｇ、プロピオン酸ナトリウム４．０ｇ、リン酸二カリウム０．５ｇ、硫酸マグネシウム０．１ｇ、硫酸第一鉄０．００１ｇ、１．０Ｌの水（７５０ｍＬの人工海水 ＋ ２５０ｍＬの脱塩水）、寒天末１５．０ｇ、最終ｐＨ（２５℃で）７．４〜７．８。
</span>The effectiveness of the microparticle formulation is established by biological tests described in detail in the following examples. These examples are merely illustrative herein and are not intended to limit the scope of the invention. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example <br class="style-scope patent-text"> <br class="style-scope patent-text"> The following terms / abbreviations / chemical formulas are used in the examples: <br class="style-scope patent-text"> NaCl: sodium chloride CaCl <sub class="style-scope patent-text">2</sub> : calcium chloride NaOH: sodium hydroxide SLF: simulated lung fluid HPLC: high performance liquid chromatography DPPC: 1,2-dipalmitoyl-sn-glycero-3-phosphocholine DMSO: dimethyl sulfoxide RB flask: round bottom Flask rpm: Number of revolutions per minute DSC: Differential scanning calorimeter TSI: Twin stage impinger MSSA: Methicillin-sensitive Staphylococcus aureus MRSA: Methicillin-resistant Staphylococcus aureus VRE: Vancomycin-resistant enterococcus TSA: Tryptose soy agar CFU: Colony forming unit HBSS: Hanks buffered salt solution MTS: (3- (4,5-dimethylciazol-2-yl) -5- (3-carboxymethoxyphenyl) -2- (4-sulfophenyl) -2H-tetrazolium) <br class="style-scope patent-text"> GC-HS: Gas chromatograph CPCSEA at Headspace Attachment: Committee for the Purpose of Control and Supervision of Experiments on Animals <br class="style-scope patent-text"> IAEC: Institutional Animal Ethics Committee <br class="style-scope patent-text"> API: Active pharmaceutical ingredients <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 1 <br class="style-scope patent-text"> Separation of culture number PM0626271 from soil collected from the Antarctic Circle a) Composition of the separation medium: <br class="style-scope patent-text"> Modified artificial seawater agar: peptone 1.5 g, yeast extract 0.5 g, ferric chloride 0.007 g, water 1.0 L (750 mL artificial seawater + 250 mL demineralized water), agar powder 15.0 g, final pH (25 7.4-7.8. <br class="style-scope patent-text"> Composition of artificial seawater: sodium chloride 24.6g, potassium chloride 0.67g, calcium chloride dihydrate 1.36g, magnesium sulfate heptahydrate 6.29g, magnesium chloride hexahydrate 4.66g, sodium bicarbonate 0.18 g, deionized water 1.0 L, final pH (at 25 ° C.) 7.8-8.2. <br class="style-scope patent-text"> b) Procedure: <br class="style-scope patent-text"> Surface soil was collected from Sirmahar Oasis in Antarctica and stored at −20 ° C. during the itinerary to Piramal Life Sciences Limited, Goregaon, Mumbai, India. Samples were stored at −20 ° C. to 22 ° C. and later thawed to room temperature (25 ° C. ± 2 ° C.) for microbial separation. A soil sample (˜1 g) was suspended in 25 mL of sterile 1% peptone water in a 100 mL sterilized flask. The flask was vortexed for 30 seconds. <sup class="style-scope patent-text">Serial</sup> dilutions up to 10 <sup class="style-scope patent-text">-5</sup> were prepared with sterile 1% peptone water. 100 μL of the 10 <sup class="style-scope patent-text">−5</sup> dilution was applied to the surface of the modified artificial seawater agar. Plates were incubated at room temperature (25 ± 2 ° C.) until colonies were observed. After culturing for one and a half months, colonies appearing on this medium were collected on a petri dish containing actinomycete isolation agar [high concentration medium] prepared in 75% artificial seawater [Accumix ™] (AS-AIA). Streaked. The isolate was purified and designated culture ID number PM06626271. Culture number PM0626271 was thus isolated as a single isolate from the growing microorganisms. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 2 <br class="style-scope patent-text"> Purification of culture number PM0626271 a) Composition of purified medium (Actinic Isolation Agar, agarized with 1.5% agar): <br class="style-scope patent-text"> Glycerol 5.0 mL, sodium caseinate 2.0 g, L-asparagine 0.1 g, sodium propionate 4.0 g, dipotassium phosphate 0.5 g, magnesium sulfate 0.1 g, ferrous sulfate 0.001 g, 1.0 L Water (750 mL artificial seawater + 250 mL demineralized water), agar powder 15.0 g, final pH (at 25 ° C.) 7.4-7.8. <br class="style-scope patent-text"> Composition of artificial seawater: sodium chloride 24.6g, potassium chloride 0.67g, calcium chloride dihydrate 1.36g, magnesium sulfate heptahydrate 6.29g, magnesium chloride hexahydrate 4.66g, sodium bicarbonate 0.18 g, deionized water 1.0 L, final pH (at 25 ° C.) 7.8-8.2. <br class="style-scope patent-text"> b) Procedure: <br class="style-scope patent-text"> Culture number PM0626271 was streaked on actinomycete isolation agar dishes (containing 75% artificial sea salt). The petri dish was cultured at 25 ° C. for 10 days. One of the colonies isolated from the petri dish was transferred to a fresh slant medium of actinomycete isolation agar prepared with 75% artificial seawater. The slant medium was cultured at 25 ° C. for 10 days. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 3 <br class="style-scope patent-text"> Production strain-maintenance of culture number PM0626271 a) Composition of medium (actinomycete isolation agar): <br class="style-scope patent-text"> Glycerol 5.0 mL, sodium caseinate 2.0 g, L-asparagine 0.1 g, sodium propionate 4.0 g, dipotassium phosphate 0.5 g, magnesium sulfate 0.1 g, ferrous sulfate 0.001 g, 1.0 L Of water (750 mL artificial seawater + 250 mL demineralized water), agar powder 15.0 g, final pH (at 25 ° C.) 7.4-7.8.</span>
    </p>
    <p num="0098" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  人工海水の組成：塩化ナトリウム２４．６ｇ、塩化カリウム０．６７ｇ、塩化カルシウム２水和物１．３６ｇ、硫酸マグネシウム７水和物６．２９ｇ、塩化マグネシウム６水和物４．６６ｇ、重炭酸ナトリウム０．１８ｇ、脱塩水１．０Ｌ、最終ｐＨ（２５℃で）７．８〜８．２．<br class="style-scope patent-text">
ｂ）加熱により材料をよく溶かした後、得られた溶液を試験管に分配し、１２１℃で３０分間殺菌した。試験管を冷却し、斜位にて凝固した。寒天斜面培地を、培養物番号ＰＭ０６２６２７１の増殖物でワイヤループにより画線し、良好な増殖物が観察されるまで２７℃〜２９℃で培養した。十分増殖した培養物を、４℃〜８℃で冷蔵庫に保管した。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例４<br class="style-scope patent-text">
振とうフラスコ中の培養物番号ＰＭ０６２６２７１の発酵<br class="style-scope patent-text">
ａ）種培地［ＡＳ−２７４（１）］の組成：<br class="style-scope patent-text">
  グルコース１５ｇ、コーンスティープリカー５ｇ、ペプトン７．５ｇ、酵母エキス７．５ｇ、炭酸カルシウム２．０ｇ、塩化ナトリウム５．０ｇ、７５０ｍＬの人工海水と２５０ｍＬの脱塩水とからなる量。<br class="style-scope patent-text">
ｂ）上記の培地を５００ｍＬ容量のエルレンマイヤーフラスコに４０ｍＬの分量で分配し、１２１℃で３０分間加圧滅菌した。フラスコを室温（２５℃ ± ２℃）に冷却され、斜面培地上に十分増殖した産生性株（培養物番号ＰＭ０６２６２７１）の１白金耳量を各フラスコに播種し、７２時間、２３０ｒｐｍ〜２５０ｒｐｍ、３０℃ ± ℃で振とうし、種培養物を得た。<br class="style-scope patent-text">
ｃ）産生培地［ＡＳ ３６Ｐ（１）］の組成：<br class="style-scope patent-text">
  可溶性デンプン２０ｇ、グルコース１５ｇ、酵母エキス２ｇ、ペプトン３ｇ、炭酸カルシウム２ｇ、硫酸アンモニウム０．５ｇ、コーンスティープリカー２ｇ、塩化ナトリウム２ｇ、リン酸マグネシウム５ｇ、１ｇ／Ｌの貯蔵液から塩化コバルト１ｍＬ／Ｌ、微量塩溶液１ｍＬ／Ｌ、７５％人工海水と２５％脱塩水を使い、量を１Ｌに調製した。<br class="style-scope patent-text">
ｄ）５００ｍＬ容量のエルレンマイヤーフラスコ中の産生培地４０ｍＬを１２１℃で３０分間加圧滅菌し、２９℃〜３０℃に冷却し、実施例４ｂで記載された種培養物を５％（ｖ／ｖ）で播種した。<br class="style-scope patent-text">
ｅ）発酵パラメーター：<br class="style-scope patent-text">
  産生フラスコを、２９℃、２２０ｒｐｍで９６時間、振とう機で培養した。産生フラスコを集菌し、各培地フラスコから収集した全液体培地を２９℃で１時間、振とう条件化で同量のメタノールで抽出し、３５００ｒｐｍで３０分間遠心分離した。上清を活性の監視のために抗菌寒天ウェル拡散アッセイに用いた。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例５<br class="style-scope patent-text">
発酵用振とうフラスコでの種培養物の調製<br class="style-scope patent-text">
ａ）培地［ＡＳ−２７４（１）］の組成：<br class="style-scope patent-text">
  グルコース１５ｇ、コーンスティープリカー５ｇ、ペプトン７．５ｇ、酵母エキス７．５ｇ、炭酸カルシウム２．０ｇ、塩化ナトリウム５．０ｇ、７５０ｍＬの人工海水と２５０ｍＬの脱塩水とからなる量。<br class="style-scope patent-text">
ｂ）上記の培地を１０００ｍＬのエルレンマイヤーフラスコに２００ｍＬの分量で分配し、１２１℃で３０分間加圧滅菌した。フラスコを室温（２５℃ ± ２℃）に冷却し、斜面培地上に十分増殖した産生性株（培養物番号ＰＭ０６２６２７１）の１白金耳量を各フラスコに播種し、７０時間〜７４時間、２３０ｒｐｍ〜２５０ｒｐｍ、２９℃〜３０℃で振とうし、種培養物を得た。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例６<br class="style-scope patent-text">
発酵槽での培養物番号ＰＭ０６２６２７１の培養<br class="style-scope patent-text">
ａ）産生培地の組成：<br class="style-scope patent-text">
  人工海水（人工海水塩２８．３２ｇ）（７５％）、可溶性デンプン２０ｇ、グルコース１５ｇ、酵母エキス２ｇ、ペプトン３ｇ、炭酸カルシウム２ｇ、硫酸アンモニウム０．０５ｇ、コーンスティープリカー２ｇ、塩化ナトリウム２ｇ、リン酸マグネシウム５ｇ、塩化コバルト（塩化コバルト１ｇ、脱塩水１．０Ｌ）１ｍＬ／Ｌ、微量塩溶液（硫酸銅７ｇ、硫酸第一鉄１ｇ、塩化マンガン８ｇ、硫酸亜鉛２ｇ、脱塩水１．０Ｌ）１ｍＬ／Ｌ、脱塩水１．０Ｌ、ｐＨ６．５〜７．５（殺菌前）。<br class="style-scope patent-text">
ｂ）１５０Ｌの発酵槽中で産生培地１００Ｌを消泡剤としてのデスモフェン３０ｍＬとともに３０分間１２１℃でその場で殺菌し、２９℃〜３０℃に冷却し、上記実施例５で得られた種培養物２．５Ｌ〜３．５Ｌを播種した。<br class="style-scope patent-text">
ｃ）発酵パラメーター：発酵を温度２９℃〜３０℃、攪拌１００ｒｐｍ、通気６０ｌｐｍで行い、７０時間〜７４時間で集菌した。発酵液体培地における式Ｉの化合物の産生を、寒天ウェル拡散法を用いて黄色ブドウ球菌（S. aureus）Ｅ７１０（ＭＲＳＡ株）および／またはエンテロコッカスフェシウム（Enterococcus faecium）Ｒ２（ＶＲＥ）に対する生物活性を試験することにより定性的に検出した。培養液の集菌ｐＨは７．５〜８．０であった。集菌後、全液体培地を溶媒抽出した。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例７<br class="style-scope patent-text">
化合物の分離および精製<br class="style-scope patent-text">
  全液体培地（１０Ｌのバッチ量）を酢酸エチルを用い（１：１）抽出した。有機層と水層を分離した。溶媒を蒸発させるよう有機層を処理し、粗酢酸エチル抽出物を得た（１．５ｇ）。粗抽出物をフラッシュクロマトグラフィーによりさらに処理した（シリカゲル３０ｇ、溶媒：メタノール／クロロホルム 段階勾配、流量：１５ｍＬ／分）。活性化合物はクロロホルム中１％〜５％のメタノールで溶出し、溶出物を濃縮し半純粋化合物（２５０ｍｇ）を得た。その後の精製は順相分取ＨＰＬＣを繰り返して行った。<br class="style-scope patent-text">
分取ＨＰＬＣ条件：<br class="style-scope patent-text">
カラム            :Ｅｕｒｏｓｐｈｅｒシリカ（１０μ、２０×２５０ｍｍ）<br class="style-scope patent-text">
溶離液            :メタノール:クロロホルム（５：９５）<br class="style-scope patent-text">
流速              :２０ｍＬ／分<br class="style-scope patent-text">
検出（ＵＶ）      :２４５ｎｍ<br class="style-scope patent-text">
保持時間          :（５〜６分）<br class="style-scope patent-text">
  画分の純度をエンテロコッカスフェシウム（E. faecium）Ｒ２および／または黄色ブドウ球菌（S. aureus）３０６６に対するバイオアッセイならびに／あるいは分析ＨＰＬＣにより調べた。溶出物を貯留し減圧下で濃縮して溶媒を取り除き、化合物を得た。<br class="style-scope patent-text">
分析ＨＰＬＣ条件：<br class="style-scope patent-text">
カラム            :Ｅｕｒｏｓｐｈｅｒ ＲＰ−１８（３μ、４．６×１２５ｍｍ）<br class="style-scope patent-text">
溶媒系            :勾配（１５分間で水に対して０％〜１００％のアセトニトリル、その後５分間１００％のアセトニトリル）<br class="style-scope patent-text">
流速              :１ｍＬ／分<br class="style-scope patent-text">
検出（ＵＶ）      :２４５ｎｍ<br class="style-scope patent-text">
保持時間          :式Ｉの化合物（１２〜１３分）<br class="style-scope patent-text">
式Ｉの化合物の物理特性および分光特性：<br class="style-scope patent-text">
外観                  :白色粉末<br class="style-scope patent-text">
融点                  :２４０℃（分解）<br class="style-scope patent-text">
溶解度                :クロロホルム、酢酸エチル、メタノールに可溶かつ水に不溶<br class="style-scope patent-text">
ＨＲ−ＥＳＩ          :１６５０．４８５８（Ｍ＋Ｈ）<br class="style-scope patent-text">
分子量（ＥＳＩ）      :１６５０．５（Ｍ＋Ｈ）<br class="style-scope patent-text">
分子式                :Ｃ<sub class="style-scope patent-text">71</sub>Ｈ<sub class="style-scope patent-text">83</sub>Ｎ<sub class="style-scope patent-text">19</sub>Ｏ<sub class="style-scope patent-text">18</sub>Ｓ<sub class="style-scope patent-text">5</sub> <br class="style-scope patent-text">
ＩＲ（ＫＢｒ          :３３８６、２９２７、１６４８、１５０７、１２０６、７５６、６６６ｃｍ<sup class="style-scope patent-text">-1</sup> <br class="style-scope patent-text">
<sup class="style-scope patent-text">1</sup>Ｈ ＮＭＲ            :表１参照<br class="style-scope patent-text">
<sup class="style-scope patent-text">13</sup>Ｃ ＮＭＲ           :表２参照
</span>Composition of artificial seawater: sodium chloride 24.6g, potassium chloride 0.67g, calcium chloride dihydrate 1.36g, magnesium sulfate heptahydrate 6.29g, magnesium chloride hexahydrate 4.66g, sodium bicarbonate 0.18 g, deionized water 1.0 L, final pH (at 25 ° C.) 7.8-8.2. <br class="style-scope patent-text"> b) After thoroughly dissolving the material by heating, the resulting solution was dispensed into test tubes and sterilized at 121 ° C. for 30 minutes. The test tube was cooled and solidified in the oblique position. The agar slant medium was streaked with a growth of culture number PM0626271 with a wire loop and cultured at 27-29 ° C. until good growth was observed. Fully grown cultures were stored in a refrigerator at 4-8 ° C. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 4 <br class="style-scope patent-text"> Composition of fermentation a) seed medium [AS-274 (1)] with culture number PM0626271 in shake flask: <br class="style-scope patent-text"> An amount consisting of 15 g of glucose, 5 g of corn steep liquor, 7.5 g of peptone, 7.5 g of yeast extract, 2.0 g of calcium carbonate, 5.0 g of sodium chloride, 750 mL of artificial seawater and 250 mL of demineralized water. <br class="style-scope patent-text"> b) The above medium was distributed in a volume of 40 mL to a 500 mL Erlenmeyer flask and autoclaved at 121 ° C. for 30 minutes. The flasks were cooled to room temperature (25 ° C. ± 2 ° C.), and one platinum loop of a productive strain (culture number PM0626271) sufficiently grown on the slant medium was inoculated into each flask, and for 72 hours, 230 rpm to 250 rpm, 30 The seed culture was obtained by shaking at ° C ± ° C. <br class="style-scope patent-text"> c) Composition of production medium [AS 36P (1)]: <br class="style-scope patent-text"> Soluble starch 20g, glucose 15g, yeast extract 2g, peptone 3g, calcium carbonate 2g, ammonium sulfate 0.5g, corn steep liquor 2g, sodium chloride 2g, magnesium phosphate 5g, 1g / L cobalt chloride 1mL / L, Using 1 mL / L of trace salt solution, 75% artificial seawater and 25% demineralized water, the amount was adjusted to 1 L. <br class="style-scope patent-text"> d) Autoclaving 40 mL of production medium in a 500 mL Erlenmeyer flask at 121 ° C. for 30 minutes, cooling to 29 ° C.-30 ° C., and 5% (v / v) of the seed culture described in Example 4b Seeding in v). <br class="style-scope patent-text"> e) Fermentation parameters: <br class="style-scope patent-text"> The production flask was incubated on a shaker at 29 ° C. and 220 rpm for 96 hours. The production flask was collected, and the whole liquid medium collected from each medium flask was extracted with the same amount of methanol at 29 ° C. for 1 hour under shaking conditions, and centrifuged at 3500 rpm for 30 minutes. The supernatant was used in an antibacterial agar well diffusion assay for activity monitoring. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 5 <br class="style-scope patent-text"> Preparation of seed culture in shake flask for fermentation a) Composition of medium [AS-274 (1)]: <br class="style-scope patent-text"> An amount consisting of 15 g of glucose, 5 g of corn steep liquor, 7.5 g of peptone, 7.5 g of yeast extract, 2.0 g of calcium carbonate, 5.0 g of sodium chloride, 750 mL of artificial seawater and 250 mL of demineralized water. <br class="style-scope patent-text"> b) The above medium was distributed in a volume of 200 mL into a 1000 mL Erlenmeyer flask and autoclaved at 121 ° C. for 30 minutes. The flask was cooled to room temperature (25 ° C. ± 2 ° C.), and 1 platinum loop of a productive strain (culture No. PM0626271) sufficiently grown on the slant medium was inoculated on each flask, and 70 to 74 hours, 230 rpm to The seed culture was obtained by shaking at 250 rpm and 29 ° C. to 30 ° C. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 6 <br class="style-scope patent-text"> Culture of fermentation number PM0626271 in fermentor a) Composition of production medium: <br class="style-scope patent-text"> Artificial sea water (artificial sea salt 28.32 g) (75%), soluble starch 20 g, glucose 15 g, yeast extract 2 g, peptone 3 g, calcium carbonate 2 g, ammonium sulfate 0.05 g, corn steep liquor 2 g, sodium chloride 2 g, magnesium phosphate 5 g, Cobalt chloride (Cobalt chloride 1 g, demineralized water 1.0 L) 1 mL / L, Trace salt solution (Copper sulfate 7 g, Ferrous sulfate 1 g, Manganese chloride 8 g, Zinc sulfate 2 g, Demineralized water 1.0 L) 1 mL / L , 1.0 L of demineralized water, pH 6.5-7.5 (before sterilization). <br class="style-scope patent-text"> b) In a 150 L fermenter, 100 L of production medium was sterilized on-site at 121 ° C. for 30 minutes with 30 mL of desmophene as an antifoam, cooled to 29 ° C. to 30 ° C., and seed culture obtained in Example 5 above 2.5L-3.5L of the product was seeded. <br class="style-scope patent-text"> c) Fermentation parameters: Fermentation was performed at a temperature of 29 ° C. to 30 ° C., agitation of 100 rpm, and aeration of 60 lpm, and collected in 70 to 74 hours. Production of the compound of formula I in the fermentation liquid medium can be performed using agar well diffusion method to increase biological activity against S. aureus E710 (MRSA strain) and / or Enterococcus faecium R2 (VRE). Qualitatively detected by testing. The collection pH of the culture solution was 7.5 to 8.0. After collection, the whole liquid medium was solvent extracted. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 7 <br class="style-scope patent-text"> Compound Separation and Purification Whole liquid medium (10 L batch volume) was extracted with ethyl acetate (1: 1). The organic and aqueous layers were separated. The organic layer was treated to evaporate the solvent to give a crude ethyl acetate extract (1.5 g). The crude extract was further processed by flash chromatography (silica gel 30 g, solvent: methanol / chloroform step gradient, flow rate: 15 mL / min). The active compound was eluted with 1% to 5% methanol in chloroform and the eluate was concentrated to give a semi-pure compound (250 mg). Subsequent purification was performed by repeating normal phase preparative HPLC. <br class="style-scope patent-text"> Preparative HPLC conditions: <br class="style-scope patent-text"> Column: Eurosphere silica (10μ, 20 × 250mm) <br class="style-scope patent-text"> Eluent: Methanol: Chloroform (5:95) <br class="style-scope patent-text"> Flow rate: 20 mL / min detection (UV): 245 nm <br class="style-scope patent-text"> Retention time: (5-6 minutes) <br class="style-scope patent-text"> The purity of the fractions was checked by bioassay and / or analytical HPLC against E. faecium R2 and / or S. aureus 3066. The eluate was stored and concentrated under reduced pressure to remove the solvent to obtain the compound. <br class="style-scope patent-text"> Analytical HPLC conditions: <br class="style-scope patent-text"> Column: Eurosphere RP-18 (3μ, 4.6 × 125mm) <br class="style-scope patent-text"> Solvent system: Gradient (0% to 100% acetonitrile over water in 15 minutes, then 100% acetonitrile in 5 minutes) <br class="style-scope patent-text"> Flow rate: 1 mL / min detection (UV): 245 nm <br class="style-scope patent-text"> Retention time: compound of formula I (12-13 minutes) <br class="style-scope patent-text"> Physical and spectral properties of compounds of formula I: <br class="style-scope patent-text"> Appearance: White powder Melting point: 240 ° C (decomposition) <br class="style-scope patent-text"> Solubility: Soluble in chloroform, ethyl acetate, methanol and insoluble in water HR-ESI: 16500.4858 (M + H) <br class="style-scope patent-text"> Molecular weight (ESI): 1650.5 (M + H) <br class="style-scope patent-text"> Molecular <sub class="style-scope patent-text"> <sub class="style-scope patent-text"> <sub class="style-scope patent-text">formula: C 71 H 83 N 19 O</sub> </sub> </sub> 18 S 5 <br class="style-scope patent-text"> IR (KBr: 3386, 2927, 1648, 1507, 1206, 756, 666 cm <sup class="style-scope patent-text">−1</sup> <br class="style-scope patent-text"> <sup class="style-scope patent-text">1</sup> H NMR: See Table 1 <br class="style-scope patent-text"> <sup class="style-scope patent-text">13</sup> C NMR: See Table 2</span>
    </p>
    <p num="0099" class="style-scope patent-text">
      <tables num="1" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000003" he="184" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="736" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000003" he="184" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="736" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0100" class="style-scope patent-text">
      <tables num="2" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000004" he="178" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="712" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000004" he="178" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="712" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0101" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
実施例８<br class="style-scope patent-text">
ＳＬＦ（ｐＨ７．４）中における式Ｉの化合物の溶解度の測定<br class="style-scope patent-text">
用いた物質：<br class="style-scope patent-text">
ＮａＣｌ        :ＲＦＣＬ社、インド<br class="style-scope patent-text">
ＣａＣｌ<sub class="style-scope patent-text">2</sub>       :ＲＦＣＬ社、インド<br class="style-scope patent-text">
ＮａＯＨ        :ＲＦＣＬ社、インド<br class="style-scope patent-text">
手順：<br class="style-scope patent-text">
  ＳＬＦを「呼吸生理学＆神経生物学（Respiratory Physiology &amp; Neurobiology）」、２００８年、１６２、ｐ．７３−７９に基づく方法によって調製した。<br class="style-scope patent-text">
ＳＬＦの調製<br class="style-scope patent-text">
  塩化ナトリウム９ｇ、塩化カルシウム０．２２０ｇおよびラクトース６．５ｇを水１０００ｍＬに溶解した。得られた溶液のｐＨを７．４に調整した。ＳＬＦ中における式Ｉの化合物の溶解度を２つの温度、４５℃および６０℃で測定した。このために、式Ｉの化合物１ｍｇをＳＬＦ３ｍＬ（２つ）に加え、数秒ボルテックスした後に必要とされる温度に設定された水浴で培養した。溶解度を３時間にわたって１時間間隔で測定した。溶液を０．２２μｍフィルターを通してろ過し、ろ液をＨＰＬＣに注入した。溶解度を適切な較正曲線について計算した。
</span>Example 8 <br class="style-scope patent-text"> Determination of the solubility of the compound of formula I in SLF (pH 7.4) Substances used: <br class="style-scope patent-text"> NaCl: RFCL, India CaCl <sub class="style-scope patent-text">2</sub> : RFCL, India NaOH: RFCL, India Procedure: <br class="style-scope patent-text"> SLF is described in “Respiratory Physiology &amp; Neurobiology”, 2008, 162, p. Prepared by a method based on 73-79. <br class="style-scope patent-text"> Preparation of SLF Sodium chloride 9g, calcium chloride 0.220g and lactose 6.5g were dissolved in water 1000mL. The pH of the resulting solution was adjusted to 7.4. The solubility of the compound of formula I in SLF was measured at two temperatures, 45 ° C and 60 ° C. For this, 1 mg of the compound of formula I was added to 3 mL of SLF (2) and vortexed for a few seconds and then cultured in a water bath set to the required temperature. Solubility was measured at 1 hour intervals over 3 hours. The solution was filtered through a 0.22 μm filter and the filtrate was injected into the HPLC. Solubility was calculated for the appropriate calibration curve.</span>
    </p>
    <p num="0102" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  得られた結果を表３に示す。
</span>
&nbsp;&nbsp;The obtained results are shown in Table 3.
</span>
    </p>
    <p num="0103" class="style-scope patent-text">
      <tables num="3" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000005" he="43" wi="138" file="2013532722.tif" img-format="tif" img-content="drawing" width="552" height="172" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000005" he="43" wi="138" file="2013532722.tif" img-format="tif" img-content="drawing" width="552" height="172" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0104" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
結論：<br class="style-scope patent-text">
  式Ｉの化合物は４５℃および６０℃でＳＬＦ中において難溶性を示す。溶解度はまた時間に依存しない。式Ｉの化合物は水不溶性化合物であり、したがって溶解度は緩衝ＳＬＦにおいて測定した。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例９<br class="style-scope patent-text">
式Ｉの化合物の微粒子製剤の調製<br class="style-scope patent-text">
用いた物質：<br class="style-scope patent-text">
ＤＰＰＣ                            :アバンティポーラーリピッド、カナダ<br class="style-scope patent-text">
メタノール                          :ＲＦＣＬ社、インド<br class="style-scope patent-text">
クロロホルム                        :ＲＦＣＬ社、インド<br class="style-scope patent-text">
ＤＭＳＯ                            :ＲＦＣＬ社、インド<br class="style-scope patent-text">
ＮａＣｌ                            :ＲＦＣＬ社、インド<br class="style-scope patent-text">
ＣａＣｌ<sub class="style-scope patent-text">2</sub>                           :ＲＦＣＬ社、インド<br class="style-scope patent-text">
ＮａＯＨ                            :ＲＦＣＬ社、インド<br class="style-scope patent-text">
ラクトース１水和物                 :シグネット化学（Signet Chemical Corporation Private Ltd.）、米国<br class="style-scope patent-text">
ガラス器具                          :メルク、インド<br class="style-scope patent-text">
ガラスビーズ                        :Ｎ．Ｍ．エンタープライズ、インド<br class="style-scope patent-text">
ポリカーボネート膜フィルター        :ＩＳＯＰＯＲＥ（商標）、ミリポア、米国<br class="style-scope patent-text">
ポリポロピレンフィルターホルダー    :ＳＷＩＮＮＥＸ（登録商標）、ミリポア、米国<br class="style-scope patent-text">
金属ルアーロック式気密ガラス注射器  :ハミルトン社、米国<br class="style-scope patent-text">
ｐＨメーター                        :ユーテック社（Eutech instruments）、米国<br class="style-scope patent-text">
手順：<br class="style-scope patent-text">
方法Ａ<br class="style-scope patent-text">
溶媒蒸発法<br class="style-scope patent-text">
  アッセイを文献ＵＳ４８７７５６１に基づいて行った。
</span>Conclusion: <br class="style-scope patent-text"> Compounds of formula I are sparingly soluble in SLF at 45 ° C and 60 ° C. Solubility is also independent of time. The compound of formula I is a water insoluble compound and so solubility was measured in buffered SLF. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 9 <br class="style-scope patent-text"> Preparation of microparticle formulations of compounds of formula I Substances used: <br class="style-scope patent-text"> DPPC: Avanti Polar Lipids, Canada methanol: RFCL Co., India chloroform: RFCL Co., India DMSO: RFCL Co., India NaCl: RFCL Co., India CaCl <sub class="style-scope patent-text">2:</sub> RFCL Co., India NaOH: RFCL Co., India lactose monohydrate: Signet Chemical Corporation Private Ltd., US glassware: Merck, Indian glass beads: N.C. M.M. Enterprise, Indian Polycarbonate Membrane Filter: ISOPORE ™, Millipore, US Polypropylene Filter Holder: SWINNEX®, Millipore, US Metal Luer Lock Airtight Glass Syringe: Hamilton, USA pH Meter: Eutech instruments ) US procedure: <br class="style-scope patent-text"> Method A <br class="style-scope patent-text"> Solvent evaporation method The assay was carried out according to document US 4877561.</span>
    </p>
    <p num="0105" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物およびＤＰＰＣを、１：１、１：１０および１：２０ｗ／ｗの比でガラスビーカー中の５ｍＬのクロロホルムに溶解した。３０ｍＬのメタノールを加え、混合物を２５０ｍＬの丸底フラスコに移した。ＳＬＦ３０ｍＬを混合物にゆっくりと注いだ。溶媒をロータリーエバポレーター（ビュッヒ（Buchi）社、スイス）を用いて蒸発させた。水浴を４５℃に設定し、１００ｒｐｍに設定して回転させた。真空制御器を４００ｍＢａｒの圧力に設定した。蒸発した溶媒をガラス製の溶媒回収器に回収した。ＲＢフラスコに残っている溶液はリポソームの形成を示す乳白色になった。ＲＢフラスコからの懸濁液の量をＳＬＦで３０ｍＬに調整し、２５０００Ｇ、４℃で１０分間遠心分離した。得られたペレットをＳＬＦに再懸濁、ボルテックスし、１．２μｍのポリカーボネートフィルターでのろ過を１１回行い、確実に均一粒径にした。微粒子製剤を光学顕微鏡検査および電子顕微鏡検査によって分析した。<br class="style-scope patent-text">
<br class="style-scope patent-text">
方法Ｂ<br class="style-scope patent-text">
無溶媒脂質自己組織化法<br class="style-scope patent-text">
  目的は製剤のための無溶媒製造プロセスを開発することである。
</span>The compound of formula I and DPPC were dissolved in 5 mL of chloroform in a glass beaker at a ratio of 1: 1, 1:10 and 1:20 w / w. 30 mL of methanol was added and the mixture was transferred to a 250 mL round bottom flask. 30 mL of SLF was slowly poured into the mixture. The solvent was evaporated using a rotary evaporator (Buchi, Switzerland). The water bath was set at 45 ° C. and rotated at 100 rpm. The vacuum controller was set to a pressure of 400 mBar. The evaporated solvent was collected in a glass solvent collector. The solution remaining in the RB flask became milky white indicating the formation of liposomes. The amount of suspension from the RB flask was adjusted to 30 mL with SLF and centrifuged at 25000 G, 4 ° C. for 10 minutes. The obtained pellet was resuspended in SLF, vortexed, and filtered through a 1.2 μm polycarbonate filter 11 times to ensure a uniform particle size. The microparticle formulation was analyzed by light microscopy and electron microscopy. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Method B <br class="style-scope patent-text"> Solvent-free lipid self-assembly method The aim is to develop a solvent-free manufacturing process for formulations.</span>
    </p>
    <p num="0106" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物２０ｍｇおよびＤＰＰＣ２０ｍｇ（１：２０ｗ／ｗ）を２０〜３０のガラスビーズおよびＳＬＦ３０ｍＬを含むＲＢフラスコに加えた。混合物を４５℃の温度で１時間、１００ｒｐｍで回転させた。得られた製剤を方法Ａに記載のように遠心分離しろ過した。 製剤を光学顕微鏡検査によって分析した。<br class="style-scope patent-text">
観察：<br class="style-scope patent-text">
方法Ａによって調製された製剤における微粒子では、<br class="style-scope patent-text">
      (i)   光学顕微鏡で観察した際、１：１ｗ／ｗの比および１：１０ｗ／ｗの比で式Ｉの化合物およびＤＰＰＣを含む微粒子の製剤は不均一で不安定な懸濁液を示し薬物凝集体が存在した。微粒子は試験管の底に沈降した。
</span>20 mg of the compound of formula I and 20 mg DPPC (1:20 w / w) were added to an RB flask containing 20-30 glass beads and 30 mL SLF. The mixture was rotated at 100 rpm for 1 hour at a temperature of 45 ° C. The resulting formulation was centrifuged and filtered as described in Method A. The formulation was analyzed by light microscopy. <br class="style-scope patent-text"> Observation: <br class="style-scope patent-text"> In the microparticles in the formulation prepared by Method A: <br class="style-scope patent-text"> (i) When observed with an optical microscope, the formulation of microparticles containing the compound of formula I and DPPC in a ratio of 1: 1 w / w and 1:10 w / w showed a heterogeneous and unstable suspension Aggregates were present. The fine particles settled to the bottom of the test tube.</span>
    </p>
    <p num="0107" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (ii)  光学顕微鏡で観察した際、１：２０ｗ／ｗの比で式Ｉの化合物およびＤＰＰＣを含む微粒子の製剤は均一な懸濁液を示し薬物凝集体が存在しなかった。微粒子は試験管に沈降しなかった。
</span>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) When observed with an optical microscope, the microparticle formulation containing the compound of formula I and DPPC at a ratio of 1:20 w / w showed a uniform suspension and no drug aggregates were present. The fine particles did not settle into the test tube.
</span>
    </p>
    <p num="0108" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      (iii) 電子顕微鏡で観察した際、１：２０ｗ／ｗの比で式Ｉの化合物およびＤＰＰＣを含む微粒子の製剤はサイズ２μｍ〜３μｍの微粒子を示した。<br class="style-scope patent-text">
結果：<br class="style-scope patent-text">
  式Ｉの化合物およびＤＰＰＣを含む微粒子の製剤は、薬物：脂質比１：２０ｗ／ｗを用いると最適に形成された。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例１０<br class="style-scope patent-text">
  実施例９方法Ａの製剤および実施例９方法Ｂの製剤における式Ｉの化合物の封入効率およびマスバランスの測定。<br class="style-scope patent-text">
用いた物質：<br class="style-scope patent-text">
メタノール      :ＲＦＣＬ社、インド<br class="style-scope patent-text">
ＤＭＳＯ        :ＲＦＣＬ社、インド<br class="style-scope patent-text">
ガラス器具      :メルク、インド<br class="style-scope patent-text">
自動ピペット    :エッペンドルフ、ドイツ<br class="style-scope patent-text">
手順：<br class="style-scope patent-text">
実施例９方法Ａおよび実施例９方法Ｂの製剤における式Ｉの化合物の封入効率は、ＨＰＬＣ（アジレント、米国）によって分析された。ＨＰＬＣ条件は以下のとおりである。<br class="style-scope patent-text">
カラム          :Ｌｉｃｈｒｏｓｐｈｅｒｅ（登録商標）１００、ＲＰ−１８ｅ、１５０×４．６ｍｍ、５μｍ<br class="style-scope patent-text">
移動相          :（ａ）１０００ｍＬの水に０．０１Ｍの酢酸アンモニウム＋０．５％のトリエチルアミン、氷酢酸でｐＨを６．５に調整<br class="style-scope patent-text">
                 （ｂ）アセトニトリル<br class="style-scope patent-text">
組成            :（ａ）：（ｂ）：：５０：５０<br class="style-scope patent-text">
実行時間        :５分<br class="style-scope patent-text">
カラム温度      :２５℃<br class="style-scope patent-text">
注入量          :２０μＬ<br class="style-scope patent-text">
保持時間        :〜３．５分<br class="style-scope patent-text">
溶媒            :メタノール中に２０％のＤＭＳＯ<br class="style-scope patent-text">
  式Ｉの化合物を２０％ＤＭＳＯに溶解し、２００μｇ／ｍＬの濃縮物を得て参照標準物質として用いた。実施例９方法Ａの製剤１００μＬおよび実施例９方法Ｂの製剤１００μＬを２ｍＬの遠心管に別々にピペットで移し、２０％のＤＭＳＯ９００μＬを各遠心管に加えた。各遠心管はボルテックスされ、微粒子マトリックスが破裂しマトリックスに封入された式Ｉの化合物の全内容物が放出した。ＨＰＬＣに別々に注入された試料は、参照標準物質、実施例９方法Ａの製剤（微粒子マトリックスの破裂後）および実施例９方法Ｂの製剤（微粒子マトリックスの破裂後）である。ピーク面積の平均値を加味して計算した。
</span>(iii) When observed with an electron microscope, the preparation of microparticles containing the compound of formula I and DPPC at a ratio of 1:20 w / w showed microparticles of size 2 μm to 3 μm. <br class="style-scope patent-text"> result: <br class="style-scope patent-text"> A microparticulate formulation comprising a compound of formula I and DPPC was optimally formed using a drug: lipid ratio of 1:20 w / w. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 10 <br class="style-scope patent-text"> Example 9 Determination of encapsulation efficiency and mass balance of the compound of formula I in the formulation of Method A and the formulation of Example 9 Method B. <br class="style-scope patent-text"> Substances used: <br class="style-scope patent-text"> Methanol: RFCL, India DMSO: RFCL, India glassware: Merck, Indian automatic pipette: Eppendorf, Germany Procedure: <br class="style-scope patent-text"> Example 9 The encapsulation efficiency of the compound of formula I in the formulation of Method A and Example 9 Method B was analyzed by HPLC (Agilent, USA). The HPLC conditions are as follows. <br class="style-scope patent-text"> Column: Lichlorosphere (registered trademark) 100, RP-18e, 150 × 4.6 mm, 5 μm <br class="style-scope patent-text"> Mobile phase: (a) 0.01 mL ammonium acetate + 0.5% triethylamine in 1000 mL water, pH adjusted to 6.5 with glacial acetic acid <br class="style-scope patent-text"> (B) Acetonitrile composition: (a) :( b) :: 50:50 <br class="style-scope patent-text"> Run time: 5 minutes Column temperature: 25 ° C <br class="style-scope patent-text"> Injection volume: 20 μL <br class="style-scope patent-text"> Retention time: ~ 3.5 minutes Solvent: 20% DMSO in methanol <br class="style-scope patent-text"> The compound of formula I was dissolved in 20% DMSO to obtain a 200 μg / mL concentrate and used as a reference standard. Example 9 100 μL of Method A formulation and 100 μL of Example 9 Method B formulation were pipetted separately into a 2 mL centrifuge tube and 900 μL of 20% DMSO was added to each centrifuge tube. Each centrifuge tube was vortexed to rupture the particulate matrix and release the entire contents of the compound of Formula I encapsulated in the matrix. Samples injected separately on the HPLC are the reference standard, the formulation of Example 9 Method A (after rupture of the particulate matrix) and the formulation of Example 9 Method B (after rupture of the particulate matrix). Calculations were made taking into account the average peak area.</span>
    </p>
    <p num="0109" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  封入効率を、下記の式により求めた。
</span>
&nbsp;&nbsp;Encapsulation efficiency was determined by the following formula.
</span>
    </p>
    <p num="0110" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
      ％封入＝（Ｗ／ｗ）×１００<br class="style-scope patent-text">
（Ｗ＝微粒子内に結合／封入された薬物（式Ｉの化合物）量、ｗ＝式Ｉの化合物の初期量とする）<br class="style-scope patent-text">
  マスバランス計算のため、式Ｉの化合物をガラス器具、フィルターおよび製剤調製プロセス（実施例９方法Ａおよび実施例９方法Ｂ）において用いた他の全ての実験器具から回収し、その量を測定した。ポリカーボネートフィルター（実施例９方法Ａおよび実施例９方法Ｂ）をメタノール中の２０％のＤＭＳＯ５ｍＬで洗浄した。この試料を「膜残渣」としてＨＰＬＣに注入した。
</span>% Encapsulation = (W / w) x 100 <br class="style-scope patent-text"> (W = the amount of drug (compound of formula I) bound / encapsulated in microparticles, w = initial amount of compound of formula I) <br class="style-scope patent-text"> For mass balance calculations, the compound of Formula I was recovered from the glassware, filters and all other laboratory equipment used in the formulation preparation process (Example 9 Method A and Example 9 Method B) and the amount measured. . The polycarbonate filters (Example 9 Method A and Example 9 Method B) were washed with 5 mL of 20% DMSO in methanol. This sample was injected into the HPLC as a “membrane residue”.</span>
    </p>
    <p num="0111" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  製剤を調製するために用いたＲＢフラスコをメタノール中の２０％のＤＭＳＯ１０ｍＬで洗浄した。この試料を「フラスコ残渣」としてＨＰＬＣに注入した。
</span>
&nbsp;&nbsp;The RB flask used to prepare the formulation was washed with 10 mL of 20% DMSO in methanol. This sample was injected into the HPLC as a “flask residue”.
</span>
    </p>
    <p num="0112" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  参照標準物質をＨＰＬＣに６回注入し、ピーク面積を記した。標準物質の６回の注入の相対標準偏差は２．０％未満であった。試料をＨＰＬＣに２回注入し、ピーク面積の平均値を加味して計算した。
</span>
&nbsp;&nbsp;The reference standard was injected 6 times into the HPLC and the peak area was noted. The relative standard deviation of 6 injections of standard was less than 2.0%. The sample was injected twice into the HPLC and calculated by taking into account the average peak area.
</span>
    </p>
    <p num="0113" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  得られた結果を表４に示す。
</span>
&nbsp;&nbsp;Table 4 shows the obtained results.
</span>
    </p>
    <p num="0114" class="style-scope patent-text">
      <tables num="4" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000006" he="38" wi="148" file="2013532722.tif" img-format="tif" img-content="drawing" width="592" height="152" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000006" he="38" wi="148" file="2013532722.tif" img-format="tif" img-content="drawing" width="592" height="152" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0115" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
結論：<br class="style-scope patent-text">
  製剤の封入効率は、実施例９の方法Ｂで調製したときよりも実施例９の方法Ａで調製した方が比較的良好である。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例１１<br class="style-scope patent-text">
実施例９方法Ａの製剤の微粒子の粒径の測定<br class="style-scope patent-text">
手順：<br class="style-scope patent-text">
  実施例９方法Ａの製剤の微粒子の流体力学的径およびサイズ分布を光子相関分光法（ＤＥＬＳＡ Ｎａｎｏ、ベックマンコールター、米国）を用いて測定した。製剤１ｍＬをＳＬＦ１０ｍＬで希釈した。この溶液１ｍＬを粒径測定に用いた。<br class="style-scope patent-text">
結果：<br class="style-scope patent-text">
  実施例９方法Ａの製剤の微粒子の平均粒径は２μｍ〜３μｍである。それぞれの個体集団に関して、平均値からの粒径の分散度は約０．４５〜０．４７である。
</span>Conclusion: <br class="style-scope patent-text"> The encapsulation efficiency of the formulation is relatively better when prepared by Method A of Example 9 than when prepared by Method B of Example 9. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 11 <br class="style-scope patent-text"> Example 9 Procedure for Measuring Particle Size of Method A Formulation: <br class="style-scope patent-text"> Example 9 The hydrodynamic diameter and size distribution of the microparticles of Method A formulation were measured using photon correlation spectroscopy (DELSA Nano, Beckman Coulter, USA). 1 mL of the formulation was diluted with 10 mL of SLF. 1 mL of this solution was used for particle size measurement. <br class="style-scope patent-text"> result: <br class="style-scope patent-text"> Example 9 The average particle size of the fine particles of the preparation of Method A is 2 μm to 3 μm. For each individual population, the dispersion of the particle size from the mean value is about 0.45 to 0.47.</span>
    </p>
    <p num="0116" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  表５に３つのカットオフ直径を示す。Ｄ<sub class="style-scope patent-text">10</sub>、Ｄ<sub class="style-scope patent-text">50</sub>およびＤ<sub class="style-scope patent-text">90</sub>はそれぞれ粒子集団の１０％、５０％および９０％の平均直径を示す。
</span>Table 5 shows the three cutoff diameters. D <sub class="style-scope patent-text">10</sub> , D <sub class="style-scope patent-text">50</sub> and D <sub class="style-scope patent-text">90</sub> indicate the average diameter of 10%, 50% and 90% of the particle population, respectively.</span>
    </p>
    <p num="0117" class="style-scope patent-text">
      <tables num="5" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000007" he="30" wi="141" file="2013532722.tif" img-format="tif" img-content="drawing" width="564" height="120" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000007" he="30" wi="141" file="2013532722.tif" img-format="tif" img-content="drawing" width="564" height="120" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0118" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
結論：<br class="style-scope patent-text">
  式Ｉの化合物脂質系微粒子を得るための溶媒蒸発法（実施例９方法Ａ）により１μｍ〜１０μｍ（表５に示されるように）の範囲のミクロンサイズ粒子が生成され、９９％を超える粒子の粒径は１０μｍ未満であった（表６に示す）。
</span>Conclusion: <br class="style-scope patent-text"> The solvent evaporation method (Example 9 Method A) to obtain compound lipid-based microparticles of formula I produced micron-sized particles in the range of 1 μm to 10 μm (as shown in Table 5), with over 99% of the particles The particle size was less than 10 μm (shown in Table 6).</span>
    </p>
    <p num="0119" class="style-scope patent-text">
      <tables num="6" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000008" he="34" wi="145" file="2013532722.tif" img-format="tif" img-content="drawing" width="580" height="136" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000008" he="34" wi="145" file="2013532722.tif" img-format="tif" img-content="drawing" width="580" height="136" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0120" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
実施例１２<br class="style-scope patent-text">
実施例９方法Ａの製剤のｐＨの測定<br class="style-scope patent-text">
手順：<br class="style-scope patent-text">
  ｐＨメーター（ユーテック、米国）を、ｐＨ４、７および９の標準ｐＨ緩衝液に対して電子的に標準化した。実施例９方法Ａの製剤のｐＨを同じｐＨメーターを用いて測定した。<br class="style-scope patent-text">
結果：<br class="style-scope patent-text">
  実施例９方法Ａの製剤のｐＨは６．１４である。<br class="style-scope patent-text">
結論：<br class="style-scope patent-text">
  実施例９方法Ａの製剤のｐＨは、１度の噴霧または気管内注入による３０分以内の短期間の薬物（式Ｉの化合物）の投与と生理的に適合する。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例１３<br class="style-scope patent-text">
実施例９方法Ａの製剤の重量モル浸透圧濃度の測定<br class="style-scope patent-text">
物質：<br class="style-scope patent-text">
標準溶液    :ウィーコン社（Wheecon Instruments Privates Limited）<br class="style-scope patent-text">
浸透圧計    :ウィーコン社<br class="style-scope patent-text">
手順：<br class="style-scope patent-text">
  実施例９方法Ａの製剤の重量モル浸透圧濃度を浸透圧計を用いて測定した。浸透圧計を２９０ｍＯｓｍｏｌ／ｋｇの標準溶液を用いて標準化した。<br class="style-scope patent-text">
結果：<br class="style-scope patent-text">
  実施例９方法Ａの製剤の重量モル浸透圧濃度は３４０ｍＯｓｍｏｌ／ｋｇである。<br class="style-scope patent-text">
結論：<br class="style-scope patent-text">
  体液の生理的重量モル浸透圧濃度は、３００ｍＯｓｍｏｌ／ｋｇである。この重量モル浸透圧濃度における著しい変化は病理学的意味を持つ。高張溶液（非常に高い重量モル浸透圧濃度）または低張溶液（非常に低い重量モル浸透圧濃度）の大量投与は、液体の過剰損失／獲得のいずれかを引き起こし、肺水腫および組織浮腫あるいは脱水につながる。通常の重量モル浸透圧濃度のエアロゾル形態で液体を少量投与することは前述の症状の発生を防ぐ。実施例９方法Ａの製剤は、重量モル浸透圧濃度３４０ｍＯｓｍｏｌ／ｋｇであり、したがって安全限度内である。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例１４<br class="style-scope patent-text">
実施例９方法Ａの製剤における式Ｉの化合物の賦形剤相溶性の評価<br class="style-scope patent-text">
物質：<br class="style-scope patent-text">
Ｏ−リング付気密容器    :パーキンエルマーインドリミテッド（Perkin Elmer India Limited）<br class="style-scope patent-text">
ＤＳＣ                   :パーキンエルマー、米国<br class="style-scope patent-text">
手順：<br class="style-scope patent-text">
  実施例９方法Ａの製剤５０μＬをＤＳＣ容器にピペットで移す。試料および空の標準容器（参照標準）を密閉し、高速ＤＳＣに設置し温度プログラムを以下のように実行した。<br class="style-scope patent-text">
温度プログラム    :０℃〜５０℃<br class="style-scope patent-text">
加熱速度          :５℃／分<br class="style-scope patent-text">
パージガス        :窒素<br class="style-scope patent-text">
流速              :３０ｍＬ／分<br class="style-scope patent-text">
結果：<br class="style-scope patent-text">
  式Ｉの化合物なしで調製されたリポソームは４１．１℃になると吸熱した。この吸熱はリップルゲルから液体結晶相への転移に起因し得る。微粒子製剤はおよそ４２．５℃で吸熱した。吸熱が始まる温度におけるこのズレは、ＤＰＰＣリポソームと式Ｉの化合物の物理的相互作用によるかもしれない。この主な転移におけるズレは、立体障害が大きくよく組織化された炭化水素鎖が詰め込まれた状態から一部のアシル鎖がねじれの存在を示す状態へのリン脂質二重層の転移を示す。<br class="style-scope patent-text">
結論：<br class="style-scope patent-text">
  結果は式Ｉの化合物およびＤＰＰＣ間の薬物−賦形剤相溶性を示す。吸熱発生温度において過剰なズレはなく、ピークの消滅もない。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例１５<br class="style-scope patent-text">
実施例９方法Ａの製剤における溶媒含有量の測定<br class="style-scope patent-text">
物質：<br class="style-scope patent-text">
メタノール（ＨＰＬＣグレード）      :ＲＦＣＬ社、インド<br class="style-scope patent-text">
クロロホルム（ＨＰＬＣグレード）    :ＲＦＣＬ社、インド<br class="style-scope patent-text">
ＤＭＳＯ（ＨＰＬＣグレード）        :ＲＦＣＬ社、インド<br class="style-scope patent-text">
ガラスＧＣ−ＨＳバイアル          :パーキンエルマーインドリミテッド （Perkin Elmer India Limited）<br class="style-scope patent-text">
ガラス器具                          :メルク、インド<br class="style-scope patent-text">
手順：<br class="style-scope patent-text">
  ＧＣ−ＨＳを用いて実施例９方法Ａの製剤における残留溶媒含有量を試験するために実験を行った。この実験は、実施例９方法Ａの製剤の大規模な商業生産に用いられる溶媒蒸発法（実施例９方法Ａ）を用いることの実現可能性を評価する。<br class="style-scope patent-text">
ブランクの調製：ＤＭＳＯ５ｍＬを２０ｍＬのＧＣ−ＨＳガラスバイアルに加えた。バイアルをテフロン（登録商標）ストッパーおよびアルミキャップでかしめた。２つのそのようなバイアルをブランク注入のために調製した。<br class="style-scope patent-text">
標準物質の調製：クロロホルム１０ｍｇおよびメタノール１００ｍｇを１００ｍＬの標準メスフラスコで正確に秤量した。溶媒を溶かし、量をＤＭＳＯで１００ｍＬにした。貯蔵液５ｍＬを２０ｍＬのＧＣ−ＨＳガラスバイアルにピペットで移した。バイアルをテフロン（登録商標）ストッパーおよびアルミキャップでかしめた。６つのそのようなバイアルを標準物質注入のために調製した。<br class="style-scope patent-text">
試料の調製：ＤＭＳＯ５ｍＬを２０ｍＬＧＣ−ＨＳガラスバイアルに加えた。バイアルを電子秤にのせ、その重量を風袋引きした。実施例９方法Ａの製剤５００μＬをガラスバイアルに加え、その重量を正確に記した。バイアルをテフロン（登録商標）ストッパーおよびアルミキャップでかしめた。３つのそのようなバイアルを試料注入のために調製した。
</span>Example 12 <br class="style-scope patent-text"> Example 9 Procedure for Measuring pH of Method A Formulation: <br class="style-scope patent-text"> The pH meter (Utec, USA) was electronically standardized against pH 4, 7 and 9 standard pH buffers. Example 9 The pH of the formulation of Method A was measured using the same pH meter. <br class="style-scope patent-text"> result: <br class="style-scope patent-text"> Example 9 The pH of the formulation of Method A is 6.14. <br class="style-scope patent-text"> Conclusion: <br class="style-scope patent-text"> Example 9 The pH of the formulation of Method A is physiologically compatible with administration of the drug (compound of formula I) for a short period of time within 30 minutes by a single spray or intratracheal infusion. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 13 <br class="style-scope patent-text"> Example 9 Substance for measuring the osmolality of the preparation of Method A: <br class="style-scope patent-text"> Standard solution: Weecon Instruments Privates Limited <br class="style-scope patent-text"> Osmometer: Wicon procedure: <br class="style-scope patent-text"> Example 9 The osmolality of Method A formulation was measured using an osmometer. The osmometer was standardized using a standard solution of 290 mOsmol / kg. <br class="style-scope patent-text"> result: <br class="style-scope patent-text"> Example 9 The osmolality of Method A formulation is 340 mOsmol / kg. <br class="style-scope patent-text"> Conclusion: <br class="style-scope patent-text"> The physiological osmolality of the body fluid is 300 mOsmol / kg. This significant change in osmolality has pathological implications. Large doses of hypertonic solution (very high osmolality) or hypotonic solution (very low osmolality) cause either excessive loss / acquisition of fluid, pulmonary edema and tissue edema or dehydration Leads to. Administering a small amount of liquid in aerosol form of normal osmolality prevents the occurrence of the aforementioned symptoms. Example 9 The formulation of Method A has a osmolality of 340 mOsmol / kg and is therefore within safe limits. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 14 <br class="style-scope patent-text"> Example 9 Evaluation of excipient compatibility of compound of formula I in formulation of method A: <br class="style-scope patent-text"> Airtight container with O-ring: Perkin Elmer India Limited <br class="style-scope patent-text"> DSC: Perkin Elmer, US Procedure: <br class="style-scope patent-text"> Example 9 Pipette 50 μL of Method A formulation into a DSC container. The sample and an empty standard container (reference standard) were sealed, installed in a high-speed DSC, and the temperature program was executed as follows. <br class="style-scope patent-text"> Temperature program: 0 ℃ ~ 50 ℃ <br class="style-scope patent-text"> Heating rate: 5 ° C./min Purge gas: Nitrogen flow rate: 30 mL / min Result: <br class="style-scope patent-text"> Liposomes prepared without the compound of Formula I endothermed at 41.1 ° C. This endotherm can be attributed to the transition from ripple gel to liquid crystalline phase. The microparticle formulation absorbed heat at approximately 42.5 ° C. This deviation in the temperature at which the endotherm begins may be due to the physical interaction between the DPPC liposome and the compound of formula I. This misalignment in the main transition indicates a transition of the phospholipid bilayer from a state where a highly organized hydrocarbon chain with large steric hindrance is packed to a state where some acyl chains show the presence of twist. <br class="style-scope patent-text"> Conclusion: <br class="style-scope patent-text"> The results show drug-excipient compatibility between the compound of formula I and DPPC. There is no excessive shift in the endothermic generation temperature, and no peaks disappear. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 15 <br class="style-scope patent-text"> Example 9 Substance for Measuring Solvent Content in Formulation of Method A: <br class="style-scope patent-text"> Methanol (HPLC grade): RFCL, India chloroform (HPLC grade): RFCL, India DMSO (HPLC grade): RFCL, India glass GC-HS vial: Perkin Elmer India Limited (Perkin Elmer India Limited) <br class="style-scope patent-text"> Glassware: Merck, India Procedure: <br class="style-scope patent-text"> An experiment was conducted to test the residual solvent content in the formulation of Example 9 Method A using GC-HS. This experiment evaluates the feasibility of using the solvent evaporation method (Example 9 Method A) used for large scale commercial production of Example 9 Method A formulations. <br class="style-scope patent-text"> Blank preparation: 5 mL of DMSO was added to a 20 mL GC-HS glass vial. The vial was crimped with a Teflon stopper and an aluminum cap. Two such vials were prepared for blank injection. <br class="style-scope patent-text"> Preparation of standard substance: 10 mg of chloroform and 100 mg of methanol were accurately weighed in a 100 mL standard volumetric flask. The solvent was dissolved and the volume was made up to 100 mL with DMSO. 5 mL of stock solution was pipetted into a 20 mL GC-HS glass vial. The vial was crimped with a Teflon stopper and an aluminum cap. Six such vials were prepared for standard injection. <br class="style-scope patent-text"> Sample preparation: 5 mL of DMSO was added to a 20 mL GC-HS glass vial. The vial was placed on an electronic balance and its weight was tared. Example 9 500 μL of Method A formulation was added to a glass vial and the weight accurately noted. The vial was crimped with a Teflon stopper and an aluminum cap. Three such vials were prepared for sample injection.</span>
    </p>
    <p num="0121" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  表７はクロマトグラフィーの条件および実施例９方法Ａの製剤における溶媒含有量の測定方法である。
</span>
&nbsp;&nbsp;Table 7 shows the chromatographic conditions and methods for measuring the solvent content in the formulation of Example 9 Method A.
</span>
    </p>
    <p num="0122" class="style-scope patent-text">
      <tables num="7" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000009" he="206" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="824" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000009" he="206" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="824" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0123" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
結果：<br class="style-scope patent-text">
  表８は実施例９方法Ａの製剤の溶媒含有量および封入効率への蒸発時間の影響を別々に示す。
</span>result: <br class="style-scope patent-text"> Table 8 separately shows the effect of evaporation time on the solvent content and encapsulation efficiency of the Example 9 Method A formulation.</span>
    </p>
    <p num="0124" class="style-scope patent-text">
      <tables num="8" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000010" he="44" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="176" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000010" he="44" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="176" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0125" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
観察：<br class="style-scope patent-text">
  ２時間の蒸発時間により実施例９方法Ａの製剤の溶媒含有量は低下し、望ましい封入効率およびマスバランス特性が得られることが観察された。また、ＧＣ−ＨＳにより検出されたような残留溶媒含有量は、ＡＰＩ溶媒含有量の各溶媒の許容限度（クロロホルムの１日あたりの許容濃度は６０ｐｐｍで、メタノールの１日あたりの許容濃度は３０００ｐｐｍ（「ＩＣＨ品質ガイドライン、不純物：残留溶媒のガイドライン」（ICH Quality Guidelines, Impurities: Guidelines for Residual Solvents）、Ｑ３Ｃ（Ｒ５）、２０１１年２月）および医薬品の１日当たりの許容濃度を下まわる。<br class="style-scope patent-text">
結論：<br class="style-scope patent-text">
  溶媒蒸発法（実施例９方法Ａ）はこの製剤を開発するのに適した方法として考えることができる。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例１６<br class="style-scope patent-text">
実施例９方法Ａの製剤の噴霧<br class="style-scope patent-text">
物質：<br class="style-scope patent-text">
ツインステージインピンジャー  :コプリーサイエンティフィック（Copley Scientific）、英国<br class="style-scope patent-text">
ネブライザー                  : DeVILBISS（登録商標）、サンライズメディカル、米国<br class="style-scope patent-text">
メタノール                    :ＲＦＣＬ社、インド<br class="style-scope patent-text">
ＤＭＳＯ                      :ＲＦＣＬ社、インド<br class="style-scope patent-text">
ＨＰＬＣ                      :アジレント、米国<br class="style-scope patent-text">
電子秤                        :デンバー社（Denver Instruments）、米国<br class="style-scope patent-text">
手順：<br class="style-scope patent-text">
  ＴＳＩユニットをこの試験のために用い、取扱説明書に従って組み立てた。ＴＳＩはヒト肺気道のインビトロガラスモデルであり、インビトロ肺薬物沈着能を定量化するために用いる。
</span>Observation: <br class="style-scope patent-text"> It was observed that an evaporation time of 2 hours reduced the solvent content of the formulation of Example 9 Method A, resulting in desirable encapsulation efficiency and mass balance characteristics. In addition, the residual solvent content as detected by GC-HS is the permissible limit of each solvent of API solvent content (permissible concentration of chloroform is 60 ppm per day, and permissible concentration of methanol is 3000 ppm per day) ("ICH Quality Guidelines, Impurities: Guidelines for Residual Solvents", Q3C (R5), February 2011) and acceptable daily concentrations of pharmaceuticals. <br class="style-scope patent-text"> Conclusion: <br class="style-scope patent-text"> The solvent evaporation method (Example 9 Method A) can be considered as a suitable method for developing this formulation. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 16 <br class="style-scope patent-text"> Example 9 Spray Material of Method A Formulation: <br class="style-scope patent-text"> Twin stage impinger: Copley Scientific (Copley Scientific), UK nebulizer: DeVILBISS (registered trademark), Sunrise Medical, US methanol: RFCL, India DMSO: RFCL, India HPLC: Agilent, American electronic scale: Denver ( Denver Instruments), US procedure: <br class="style-scope patent-text"> A TSI unit was used for this test and was assembled according to the instructions. TSI is an in vitro glass model of human lung airways and is used to quantify in vitro pulmonary drug deposition ability.</span>
    </p>
    <p num="0126" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＴＳＩの真空ポンプのスイッチをいれ、系の流量を正確に調べるために流量計を用いた。正確な流量指定条件（２８．３Ｌ／分）を確保するために真空ポンプの流量バルブを調整した。気流の較正後、全ユニットを解体した。メタノール７ｍＬを上部インピンジャーに加え、メタノール２０ｍＬを下部インピンジャーに加えた。取り扱い説明書に従ってＴＳＩユニットを再び組み立てた。
</span>
&nbsp;&nbsp;A TSI vacuum pump was turned on and a flow meter was used to accurately check the system flow rate. The flow rate valve of the vacuum pump was adjusted to ensure accurate flow rate specification conditions (28.3 L / min). After airflow calibration, all units were dismantled. 7 mL of methanol was added to the upper impinger and 20 mL of methanol was added to the lower impinger. The TSI unit was reassembled according to the instruction manual.
</span>
    </p>
    <p num="0127" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  実施例９方法Ａの製剤５ｍＬをネブライザーの薬剤カップに加えた。ネブライザーのマウスピースをＴＳＩの口部に取り付けた。真空ではなくなることを防ぐために全部品を確実に密着させた。
</span>
&nbsp;&nbsp;EXAMPLE 9 5 mL of Method A formulation was added to a nebulizer drug cup. A nebulizer mouthpiece was attached to the mouth of the TSI. In order to prevent the vacuum from disappearing, all parts were firmly brought into close contact.
</span>
    </p>
    <p num="0128" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＴＳＩの真空ポンプを起動し、均一な気流を確保した。３０秒後、ネブライザーを起動し、開始時間を記した。正確に５分後、ネブライザーを止めた。ポンプをさらに３０秒動かし、その後ポンプのスイッチを止めた。上部インピンジメントチャンバは咽頭および上気道を模し、下部インピンジメントチャンバは肺胞を模している。
</span>
&nbsp;&nbsp;A TSI vacuum pump was activated to ensure a uniform airflow. After 30 seconds, the nebulizer was activated and the start time was noted. After exactly 5 minutes, the nebulizer was turned off. The pump was run for another 30 seconds, after which the pump was switched off. The upper impingement chamber mimics the pharynx and upper airway, and the lower impingement chamber mimics the alveoli.
</span>
    </p>
    <p num="0129" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  メタノールを洗浄溶媒として用い、上部および下部インピンジメントチャンバの内容物を適切な標準メスフラスコに回収した。２０％のＤＭＳＯを加え、式Ｉの化合物を確実に溶解した。メスフラスコの最終容積をメタノールによって調整した。上記実験を６つの製剤バッチおよび２つの未製剤の式Ｉの化合物バッチで繰り返した。
</span>
&nbsp;&nbsp;Using methanol as the wash solvent, the contents of the upper and lower impingement chambers were collected in appropriate standard volumetric flasks. 20% DMSO was added to ensure dissolution of the compound of formula I. The final volume of the volumetric flask was adjusted with methanol. The above experiment was repeated with 6 formulation batches and 2 unformulated Formula I compound batches.
</span>
    </p>
    <p num="0130" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  試料を下記のいくつかの濃度で評価した。<br class="style-scope patent-text">
実施例９方法Ａの製剤５ｍＬ中に式Ｉの化合物０．５ｍｇ−試料１、<br class="style-scope patent-text">
実施例９方法Ａの製剤５ｍＬ中に式Ｉの化合物１ｍｇ−試料２、<br class="style-scope patent-text">
実施例９方法Ａの製剤５ｍＬ中に式Ｉの化合物２．５ｍｇ−試料３、<br class="style-scope patent-text">
実施例９方法Ａの製剤５ｍＬ中に式Ｉの化合物５ｍｇ−試料４、<br class="style-scope patent-text">
未製剤の式Ｉの化合物１００μｇ／ｍＬ（式Ｉの化合物のみ）−試料５。
</span>Samples were evaluated at several concentrations: <br class="style-scope patent-text"> Example 9 0.5 mg of the compound of formula I in 5 mL of the formulation of Method A-Sample 1, <br class="style-scope patent-text"> Example 9 1 mg of a compound of formula I-sample 2 in 5 mL of method A formulation, <br class="style-scope patent-text"> Example 9 Compound 2.5 mg of Formula I in Sample 5 of Method A-Sample 3, <br class="style-scope patent-text"> Example 9 Compound 5 mg of Formula I in 5 mL of Formulation of Method A-Sample 4, <br class="style-scope patent-text"> Unformulated compound of formula I 100 μg / mL (compound of formula I only) —Sample 5.</span>
    </p>
    <p num="0131" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  インビトロ薬物沈着への濃度の影響を知るためにこの試験を行った。この試験をさらに続け、噴霧プロセスで失われ、したがってネブライザーカップに残った薬物（式Ｉの化合物）の量を測定した。
</span>
&nbsp;&nbsp;This study was conducted to determine the effect of concentration on in vitro drug deposition. This test was continued further to determine the amount of drug (compound of formula I) that was lost in the nebulization process and therefore remained in the nebulizer cup.
</span>
    </p>
    <p num="0132" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＴＳＩの上部および下部インピンジメントチャンバに沈着した式Ｉの化合物を、勾配ポンプおよび自動サンプラー付ＨＰＬＣにより分析した。ＨＰＣＬ分析に用いられたクロマトグラフィーの条件を表９に示す。
</span>
&nbsp;&nbsp;Compounds of Formula I deposited in the upper and lower impingement chambers of TSI were analyzed by HPLC with a gradient pump and an autosampler. Table 9 shows the chromatographic conditions used for the HPCL analysis.
</span>
    </p>
    <p num="0133" class="style-scope patent-text">
      <tables num="9" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000011" he="98" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="392" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000011" he="98" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="392" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0134" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物１００μｇ／ｍＬ（式Ｉの化合物２．５ｍｇをメタノール中２０％のＤＭＳＯに溶解した）を参照標準物質として用いた。
</span>
&nbsp;&nbsp;100 μg / mL of the compound of formula I (2.5 mg of the compound of formula I dissolved in 20% DMSO in methanol) was used as a reference standard.
</span>
    </p>
    <p num="0135" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  参照標準物質をＨＰＬＣに６回注入し、ピーク面積を記した。標準物質の６回の注入の相対標準偏差は２．０％未満であった。試料をＨＰＬＣに２回注入し、ピーク面積の平均値を加味して計算した。<br class="style-scope patent-text">
結果：<br class="style-scope patent-text">
  ＴＳＩの上部および下部インピンジャーにさまざまな試料（試料１〜６）によって沈着した式Ｉの化合物の％を表１０に示す。
</span>The reference standard was injected 6 times into the HPLC and the peak area was noted. The relative standard deviation of 6 injections of standard was less than 2.0%. The sample was injected twice into the HPLC and calculated by taking into account the average peak area. <br class="style-scope patent-text"> result: <br class="style-scope patent-text"> The percent of compound of Formula I deposited by the various samples (Samples 1-6) on the upper and lower impingers of TSI is shown in Table 10.</span>
    </p>
    <p num="0136" class="style-scope patent-text">
      <tables num="10" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000012" he="62" wi="161" file="2013532722.tif" img-format="tif" img-content="drawing" width="644" height="248" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000012" he="62" wi="161" file="2013532722.tif" img-format="tif" img-content="drawing" width="644" height="248" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0137" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
（Ｂ）噴霧カップ中の失われた（噴霧プロセス中）式Ｉの化合物量（μｇ）を表１１に示す。
</span>
(B) The amount of compound of formula I (μg) lost in the spray cup (during the spray process) is shown in Table 11.
</span>
    </p>
    <p num="0138" class="style-scope patent-text">
      <tables num="11" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000013" he="62" wi="161" file="2013532722.tif" img-format="tif" img-content="drawing" width="644" height="248" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000013" he="62" wi="161" file="2013532722.tif" img-format="tif" img-content="drawing" width="644" height="248" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0139" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
観察：<br class="style-scope patent-text">
  １ｍｇ／ｍＬの濃度および２．５ｍｇ／ｍＬの濃度で噴霧された際の製剤は、噴霧カップに投入された式Ｉの化合物の初期量の約１６％および１０％が沈着した。式Ｉの化合物の最小抑制濃度は０．１２５μｇ／ｍＬ〜５μｇ／ｍＬの範囲である（国際公開ＷＯ２０１１−０２７２９０号公報）。沈着した式Ｉの化合物量は、インビトロモデルにおいて十分であり上記最小抑制濃度より多い。この結果は、１ｍｇ／ｍＬおよび２．５ｍｇ／ｍＬの式Ｉの化合物製剤の濃度がインビボ試験において評価に必要とされる濃度であり得るということを示唆する。１ｍｇ／ｍＬ未満の濃度では、沈着した式Ｉの化合物のパーセントは高くなるがその量は十分ではない。一方、５ｍｇ／ｍＬの濃度では、式Ｉの化合物の十分な量がネブライザーカップに保持され、式Ｉの化合物が無駄になる。<br class="style-scope patent-text">
結論：<br class="style-scope patent-text">
  結果は、実施例９方法Ａの製剤は、ＴＳＩインビトロ肺モデルにおいて十分な量の式Ｉの化合物を沈着させることが可能だが、未製剤の式Ｉの化合物はＴＳＩに噴霧では沈着しない。従って、実施例９方法Ａの製剤を式Ｉの化合物の吸入送達のために用いることができる。<br class="style-scope patent-text">
〔微粒子製剤の生物学的評価〕<br class="style-scope patent-text">
インビトロアッセイ<br class="style-scope patent-text">
実施例１７<br class="style-scope patent-text">
微生物アッセイ<br class="style-scope patent-text">
  アッセイを文献（ネーサン（Nathan P.）他、１９７８年、「感染した熱傷を治療する局所抗菌剤選択のための実験方法」（Laboratory Methods for Selection of Topical antimicrobial Agents to treat infected Burn Wounds）、バーンズ４：ｐ．１７７−１８７）に基づいて行った。<br class="style-scope patent-text">
（Ａ）本アッセイに用いた細菌供試モデル：<br class="style-scope patent-text">
黄色ブドウ球菌（Staphylococcus aureus）２０９Ｐ（ＭＳＳＡ）<br class="style-scope patent-text">
黄色ブドウ球菌ＡＴＣＣ３３５９１（ＭＲＳＡ）<br class="style-scope patent-text">
エンテロコッカスフェシウム（Enterococcus faecium）Ｒ−２（ＶＲＥ）<br class="style-scope patent-text">
（Ｂ）接種物の調製<br class="style-scope patent-text">
  クライオバイアルから培養物をＴＳＡ斜面培地に画線し、３７℃で１８〜２４時間培養した。斜面培地上の増殖物を用い、懸濁液を調製し、５６０ｎｍでの光学濃度を０．３ユニット（〜１０<sup class="style-scope patent-text">8</sup>ＣＦＵ／ｍＬ）に調整した。<br class="style-scope patent-text">
（Ｃ）試料の調製<br class="style-scope patent-text">
  アッセイで検査された試料は下記である。<br class="style-scope patent-text">
試料１：実施例９方法Ｂの製剤の未ろ過懸濁液。<br class="style-scope patent-text">
試料２：実施例９方法Ｂの製剤のろ過懸濁液（０．２２μｍフィルターでろ過後）。<br class="style-scope patent-text">
試料３：メタノール崩壊法によって調整された試料。試料２を同量のメタノールと混ぜ、１時間培養した。この溶液の希釈物をメタノールで調製し、放出した式Ｉの化合物の有効性を評価するために用いた。<br class="style-scope patent-text">
試料４：未製剤の式Ｉの化合物（１：８０（メタノール：クロロホルム）の比に溶かした式Ｉの化合物）。
</span>Observation: <br class="style-scope patent-text"> Formulations when sprayed at concentrations of 1 mg / mL and 2.5 mg / mL deposited approximately 16% and 10% of the initial amount of compound of formula I charged into the spray cup. The minimum inhibitory concentration of the compound of formula I is in the range of 0.125 μg / mL to 5 μg / mL (International Publication No. WO2011-027290). The amount of deposited Formula I compound is sufficient in the in vitro model and is above the minimum inhibitory concentration. This result suggests that the concentrations of 1 mg / mL and 2.5 mg / mL compound formulations of Formula I may be the concentrations required for evaluation in in vivo studies. At concentrations below 1 mg / mL, the percentage of Formula I compound deposited is high but the amount is not sufficient. On the other hand, at a concentration of 5 mg / mL, a sufficient amount of the compound of formula I is retained in the nebulizer cup and the compound of formula I is wasted. <br class="style-scope patent-text"> Conclusion: <br class="style-scope patent-text"> The results show that the formulation of Example 9 Method A can deposit a sufficient amount of the compound of formula I in the TSI in vitro lung model, while the unformulated compound of formula I does not deposit on TSI upon spraying. Thus, the formulation of Example 9 Method A can be used for inhalation delivery of a compound of Formula I. <br class="style-scope patent-text"> [Biological evaluation of microparticle preparations] <br class="style-scope patent-text"> In Vitro Assay Example 17 <br class="style-scope patent-text"> Microbial assay The assay is described in the literature (Nathan P. et al., 1978, “Laboratory Methods for Selection of Topical antimicrobial Agents to treat infected Burn Wounds”, Burns 4: p. 177-187). <br class="style-scope patent-text"> (A) Bacteria test model used in this assay: <br class="style-scope patent-text"> Staphylococcus aureus 209P (MSSA) <br class="style-scope patent-text"> Staphylococcus aureus ATCC 33591 (MRSA) <br class="style-scope patent-text"> Enterococcus faecium R-2 (VRE) <br class="style-scope patent-text"> (B) Preparation of inoculum The culture was streaked on a TSA slant medium from a cryovial and cultured at 37 ° C for 18-24 hours. Suspensions were prepared using the growth on the slant medium and the optical density at 560 nm was adjusted to 0.3 units (−10 <sup class="style-scope patent-text">8</sup> CFU / mL). <br class="style-scope patent-text"> (C) Sample preparation The samples examined in the assay are as follows. <br class="style-scope patent-text"> Sample 1: Unfiltered suspension of the formulation of Example 9 Method B. <br class="style-scope patent-text"> Sample 2: Filtration suspension of formulation of Example 9 method B (after filtration through 0.22 μm filter). <br class="style-scope patent-text"> Sample 3: A sample prepared by the methanol disintegration method. Sample 2 was mixed with the same amount of methanol and incubated for 1 hour. Dilutions of this solution were prepared with methanol and used to evaluate the effectiveness of the released Formula I compound. <br class="style-scope patent-text"> Sample 4: Unformulated compound of formula I (compound of formula I dissolved in a ratio of 1:80 (methanol: chloroform)).</span>
    </p>
    <p num="0140" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本アッセイで評価された試料１、２、３および４の濃度は、１００、５０、２５、１２．５、６．２５、３．１２５、１．５６、０．７８、０．３９および０．１９５μｇ／ｍＬである。<br class="style-scope patent-text">
（Ｄ）アッセイ手順：<br class="style-scope patent-text">
  （Ｂ）から得た供試培養物の接種物懸濁液４０μＬを、１００ｍＬ容量の無菌三角フラスコ内の４０ｍＬの解けたＴＳＡ残片（３８℃〜３９℃に維持）のそれぞれに注入し、均一に混ぜるために回転させた。播種された残片をシャーレ（１５０ｍｍの外径）に注ぎ、約３０分間固化させた。完全に固化させるためシャーレを４℃〜８℃に保った。ウェル（直径６ｍｍ）の必要数を固化した培地から打ち抜いた。試料１、試料２および試料３を５０μＬずつシャーレの対応するウェルに加えた。シャーレを低温（２℃〜８℃）で約３０分間プレインキュベートし、拡散させた。そしてシャーレを３７℃で１８〜２４時間培養した。２０μｇ／ｍＬのバンコマイシンを標準抗生物質として用いた。さまざまな試料の活性結果は阻止円のサイズ（ｍｍ）で解釈した。<br class="style-scope patent-text">
結果：<br class="style-scope patent-text">
  試料３は１００μｇ／ｍＬ〜０．７８μｇ／ｍＬで透明帯を示したが、試料４は１００μｇ／ｍＬ〜０．３９μｇ／ｍＬで透明帯を示した。
</span>The concentrations of samples 1, 2, 3 and 4 evaluated in this assay are 100, 50, 25, 12.5, 6.25, 3.125, 1.56, 0.78, 0.39 and 0. 195 μg / mL. <br class="style-scope patent-text"> (D) Assay procedure: <br class="style-scope patent-text"> Inject 40 μL of the inoculum suspension of the test culture obtained from (B) into each 40 mL of undissolved TSA residue (maintained at 38 ° C. to 39 ° C.) in a 100 mL sterile Erlenmeyer flask. Rotated to mix. The seeded residue was poured into a petri dish (150 mm outer diameter) and allowed to solidify for about 30 minutes. The petri dish was kept at 4 ° C to 8 ° C for complete solidification. The required number of wells (diameter 6 mm) was punched from the solidified medium. Sample 1, sample 2 and sample 3 were added in 50 μL each to the corresponding well of the petri dish. The petri dish was preincubated at low temperature (2 ° C. to 8 ° C.) for about 30 minutes to diffuse. The petri dish was cultured at 37 ° C. for 18 to 24 hours. 20 μg / mL vancomycin was used as a standard antibiotic. The activity results for the various samples were interpreted as the size of the inhibition circle (mm). <br class="style-scope patent-text"> result: <br class="style-scope patent-text"> Sample 3 exhibited a zona pellucida at 100 μg / mL to 0.78 μg / mL, while sample 4 exhibited a zona pellucida at 100 μg / mL to 0.39 μg / mL.</span>
    </p>
    <p num="0141" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  試料２は１２．５μｇ／ｍＬで透明な阻止円を示したが、試料１は２５μｇ／ｍＬで透明帯を示したので、試料２の活性（円サイズに関して）は試料１よりもよい。
</span>
&nbsp;&nbsp;Sample 2 showed a clear blocking circle at 12.5 μg / mL, but sample 1 showed a zona pellucida at 25 μg / mL, so the activity of sample 2 (in terms of circle size) is better than sample 1.
</span>
    </p>
    <p num="0142" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  試料３の場合、式Ｉの化合物の円サイズは未製剤の式Ｉの化合物（試料４）よりも小さい。これは脂質製剤からの式Ｉの化合物の遅放性によるのかもしれない。<br class="style-scope patent-text">
結論：<br class="style-scope patent-text">
  実施例９方法Ｂの製剤（試料３）から放出された式Ｉの化合物の活性は、未製剤の式Ｉの化合物（試料４）に匹敵するので、インビボ試験および評価を進めることができる。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例１８<br class="style-scope patent-text">
インビトロ細胞適合性アッセイ<br class="style-scope patent-text">
  文献「医用材料研究の学術雑誌」（Journal of Biomedical Materials Research、２００９年、８９Ａ、ｐ．２８１−２９２）に基づいてアッセイを行った。
</span>In the case of sample 3, the circle size of the compound of formula I is smaller than the unformulated compound of formula I (sample 4). This may be due to the delayed release of the compound of formula I from the lipid formulation. <br class="style-scope patent-text"> Conclusion: <br class="style-scope patent-text"> Example 9 Since the activity of the compound of formula I released from the formulation of Method B (sample 3) is comparable to the unformulated compound of formula I (sample 4), in vivo testing and evaluation can proceed. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 18 <br class="style-scope patent-text"> In vitro cytocompatibility assay The assay was performed based on the document "Academic Journal of Biomedical Materials Research" (Journal of Biomedical Materials Research, 2009, 89A, p.281-292).</span>
    </p>
    <p num="0143" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  規制当局により指定された関連細胞株および標準細胞を用いて実施例９方法Ａの製剤の細胞適合性を評価するためにこのアッセイを行った。<br class="style-scope patent-text">
評価した細胞株：<br class="style-scope patent-text">
ＭＲＣ５（肺線維芽細胞株）<br class="style-scope patent-text">
Ａ５４９（悪性腫瘍から分離したタイプＩＩ肺胞細胞株）<br class="style-scope patent-text">
Ｌ９２９（マウス線維芽細胞株、ＡＳＴＭ規格）<br class="style-scope patent-text">
実験の詳細：<br class="style-scope patent-text">
細胞濃度：ＭＲＣ５およびＬ２９２には１００００／ウェル、Ａ５４９には３０００／ウェル<br class="style-scope patent-text">
時点：２４時間および４８時間<br class="style-scope patent-text">
評価した濃度：<br class="style-scope patent-text">
実施例９方法Ｂの製剤の微粒子に対して、１、０．７、０．３、０．１ｍｇ／ｍＬ−試料１<br class="style-scope patent-text">
式Ｉの化合物およびＤＰＰＣなしの微粒子に対して、０．３、０．１ｍｇ／ｍＬ−試料２<br class="style-scope patent-text">
式Ｉの化合物のみに対して、０．１、０．０１ｍｇ／ｍＬ―試料３。<br class="style-scope patent-text">
手順：<br class="style-scope patent-text">
  毒性評価をプロメガのセルタイター９６エイクイアス・ワンソルーション・アッセイ（The CellTiter 96 Aqueous One Solution Assay）（カタログ番号：Ｇ３５８２）を用いて行った。アッセイは細胞増殖アッセイまたは細胞毒性アッセイにおける生存細胞数を測定するための標準比色法である。本アッセイに用いられるＭＴＳは細胞培養培地において可溶性の着色ホルマザン生成物に細胞によって生物学的に還元される。４９０ｎｍ吸光度量で測定されたようにホルマザン生成物量は培養物における生細胞数に正比例する。
</span>This assay was performed to assess the cytocompatibility of the formulation of Example 9 Method A using relevant cell lines and standard cells designated by regulatory authorities. <br class="style-scope patent-text"> Cell lines evaluated: <br class="style-scope patent-text"> MRC5 (lung fibroblast cell line) <br class="style-scope patent-text"> A549 (type II alveolar cell line isolated from malignant tumor) <br class="style-scope patent-text"> L929 (mouse fibroblast cell line, ASTM standard) <br class="style-scope patent-text"> Experimental details: <br class="style-scope patent-text"> Cell concentration: 10,000 / well for MRC5 and L292, 3000 / well for A549 Time point: Concentration evaluated at 24 and 48 hours: <br class="style-scope patent-text"> Example 9 1, 0.7, 0.3, 0.1 mg / mL-Sample 1 for the microparticles of Method B formulation <br class="style-scope patent-text"> 0.3, 0.1 mg / mL for sample I and microparticles without DPPC-Sample 2 <br class="style-scope patent-text"> 0.1, 0.01 mg / mL-sample 3 for compounds of formula I only. <br class="style-scope patent-text"> procedure: <br class="style-scope patent-text"> Toxicity evaluation was performed using the Promega CellTiter 96 Aqueous One Solution Assay (Cat. No. G3582). The assay is a standard colorimetric method for determining the number of viable cells in a cell proliferation assay or cytotoxicity assay. The MTS used in this assay is biologically reduced by the cells to a soluble colored formazan product in the cell culture medium. The amount of formazan product is directly proportional to the number of living cells in the culture as measured by the amount of absorbance at 490 nm.</span>
    </p>
    <p num="0144" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  手短に言えば、細胞株を３つの９６ウェルプレートに蒔いて培養し、２４時間付着および増殖させた。細胞付着後２４時間して、化合物を加えた。４８時間のポスト細胞プレーティングし、１００μＬの新しい培地で培地を取り替えることによりアッセイを終え、セルタイター９６エイクイアス・ワンソルーション（プロメガ、カタログ番号：Ｇ３５８２）２０μＬを加えた。また、培養培地１００μＬおよび「ワンソルーション」２０μＬを含む「無細胞」コントロールを３つセットアップし、それらを本アッセイにおけるコントロールとして維持した。プレート３０分〜４時間培養し、発色させた。そして、エサイザ（ELISA）９６ウェルプレートを９６ウェルプレートリーダを用い４９０ｎｍ（４５０〜５４０ｎｍ）で吸光度測定した。「無細胞」コントロールからの平均４９０ｎｍ吸光度を全てのほかの吸光度値から引き、修正した吸光度をさらなる計算のために利用した。（「無細胞」コントロールからの背景吸光度は典型的に培養４時間後の０．２〜０．３吸光度ユニットである）。<br class="style-scope patent-text">
結果：<br class="style-scope patent-text">
  試料１の存在下で評価した全細胞株の生存率は９８％より高かった。その細胞株のモルフォロジーは変化せず、単層集密（monolayer confluence）が存在した。これは評価された濃度において、試料１は体細胞由来アッセイにおいて毒性を示さなかったことをあらわす。しかしながら、未製剤形態の式Ｉの化合物は評価された異なる細胞株全てにおいて細胞毒性を示した。したがって、製剤は式Ｉの化合物によって現れる毒性を制限するという別の利点を有する。その結果を表１２にまとめる。
</span>Briefly, cell lines were cultured in three 96 well plates and allowed to attach and grow for 24 hours. Compounds were added 24 hours after cell attachment. The assay was terminated by 48 hour post-cell plating and medium replacement with 100 μL fresh medium, and 20 μL of CellTiter 96 Aequius One Solution (Promega, Catalog No. G3582) was added. In addition, three “cell-free” controls containing 100 μL of culture medium and 20 μL of “One Solution” were set up and maintained as controls in this assay. The plate was incubated for 30 minutes to 4 hours to develop color. The absorbance of the ELISA 96 well plate was measured at 490 nm (450 to 540 nm) using a 96 well plate reader. The average 490 nm absorbance from the “cell free” control was subtracted from all other absorbance values and the corrected absorbance was used for further calculations. (The background absorbance from the “cell-free” control is typically 0.2-0.3 absorbance units after 4 hours of culture). <br class="style-scope patent-text"> result: <br class="style-scope patent-text"> The viability of all cell lines evaluated in the presence of sample 1 was higher than 98%. The cell line morphology did not change and there was a monolayer confluence. This indicates that at the concentration evaluated, Sample 1 was not toxic in the somatic cell-derived assay. However, the unformulated compound of formula I showed cytotoxicity in all the different cell lines evaluated. Thus, the formulation has another advantage of limiting the toxicity exhibited by the compounds of formula I. The results are summarized in Table 12.</span>
    </p>
    <p num="0145" class="style-scope patent-text">
      <tables num="12" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000014" he="51" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="204" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000014" he="51" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="204" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0146" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
結論：<br class="style-scope patent-text">
  試料３はインビボで副作用および毒性に結びつくまたは発現する可能性を有する。しかしながら、ＤＰＰＣを含む試料１では、式Ｉの化合物の毒性が隠され、毒性がなく生物学的有効性が観察される。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例１９<br class="style-scope patent-text">
インビトロマクロファージ取り込みアッセイ（uptake assay）<br class="style-scope patent-text">
  アッセイを文献「呼吸器研究」（Respiratory Research、２００９年、１０、ｐ.４４）に基づいて行った。<br class="style-scope patent-text">
ラット肺胞マクロファージ分離および培養<br class="style-scope patent-text">
  ラットからの気管支肺胞洗浄洗液を適切な倫理承認後取った。無菌の温めた生理食塩水を肺に導入し、吸入により除去した。気管支肺胞洗浄液を積氷に移した（通常、ドナーあたり気管支肺胞洗浄液１００〜２００ｍＬが望ましい）。液体を２５０Ｇで１０分間遠心分離し、細胞を採取した。細胞を総量１０ｍＬのＨＢＳＳに再懸濁することにより細胞ペレットを貯留した。１００μＬのアリコットを取り、ライト・ギムザ染色により染色し示差的細胞計数（differential cell count）を行った。細胞計数は調整され、細胞をマクロファージ培養培地（ＨＡＭ Ｆ１２培地、Ａｍｉｍｅｄ、スイス）に蒔いた。細胞懸濁液０．５ｍＬをマクロファージ培養培地とともに各６ウェル組織培養プレートに加えた。細胞を２４時間３７℃、５％ＣＯ<sub class="style-scope patent-text">2</sub>で培養した。細胞付着および細胞増殖物を評価し、スルホローダミン染料でタグ付けされた実施例９方法Ａの製剤で処理した。ポスト処理において、細胞を蛍光評価した。この蛍光は肺胞マクロファージによる製剤の選択的取り込みを意味する。<br class="style-scope patent-text">
結果：<br class="style-scope patent-text">
  実施例９方法Ａの製剤の微粒子は、肺胞マクロファージによって選択的に取り込まれ、取り込みは１時間のポスト処理から始まる。染料は３時間で強度のゆっくりとした飽和を示す。これは活発な取り込みおよびその取り込みの飽和点を示す。結核菌は肺胞マクロファージに住みおよび生存するので、薬物がマクロファージに確実に到達することが非常に重大な意味を持つ。実施例９方法Ａの設計された微粒子製剤により、式Ｉの化合物がマクロファージに到達するだけでなく、マクロファージによって活発に取り込まれるが、これはインビボで成功すべき療法のために望ましい。
</span>Conclusion: <br class="style-scope patent-text"> Sample 3 has the potential to lead to or develop side effects and toxicity in vivo. However, in Sample 1 containing DPPC, the toxicity of the compound of Formula I is hidden, and there is no toxicity and biological effectiveness is observed. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 19 <br class="style-scope patent-text"> In vitro macrophage uptake assay <br class="style-scope patent-text"> The assay was performed based on the literature “Respiratory Research” (2009, 10, p. 44). <br class="style-scope patent-text"> Rat Alveolar Macrophage Isolation and Culture Bronchoalveolar lavage fluid from rats was taken after appropriate ethical approval. Sterile warm saline was introduced into the lung and removed by inhalation. Bronchoalveolar lavage fluid was transferred to ice (usually 100-200 mL bronchoalveolar lavage fluid per donor is desirable). The liquid was centrifuged at 250 G for 10 minutes, and the cells were collected. The cell pellet was pooled by resuspending the cells in a total volume of 10 mL HBSS. A 100 μL aliquot was taken, stained with Wright-Giemsa staining, and subjected to differential cell count. Cell counts were adjusted and cells were seeded in macrophage culture medium (HAM F12 medium, Aimed, Switzerland). 0.5 mL of cell suspension was added to each 6-well tissue culture plate along with macrophage culture medium. Cells were cultured for 24 hours at 37 ° C., 5% CO <sub class="style-scope patent-text">2</sub> . Cell attachment and cell growth were assessed and treated with the formulation of Example 9 Method A tagged with sulforhodamine dye. Cells were evaluated for fluorescence in the post treatment. This fluorescence implies selective uptake of the formulation by alveolar macrophages. <br class="style-scope patent-text"> result: <br class="style-scope patent-text"> Example 9 Microparticles of the formulation of Method A are selectively taken up by alveolar macrophages, and uptake begins with a 1 hour post-treatment. The dye exhibits a slow saturation of intensity in 3 hours. This indicates active uptake and the saturation point of that uptake. Since Mycobacterium tuberculosis lives and survives in alveolar macrophages, it is very important that the drug reaches the macrophages reliably. Example 9 The designed microparticle formulation of Method A not only allows the compound of Formula I to reach macrophages, but is also actively taken up by macrophages, which is desirable for successful therapy in vivo.</span>
    </p>
    <p num="0147" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  表１２における値から明白なように、実施例９方法Ａの製剤は活発に取り込まれ（化合物濃度においてゆっくりと増加する）、マクロファージによって代謝される（化合物濃度において減少する）。遊離薬物（式Ｉの化合物）は活発な取り込みを示さない（遊離薬物の飽和濃度から明白である）。
</span>
&nbsp;&nbsp;As is evident from the values in Table 12, the formulation of Example 9 Method A is actively taken up (slowly increasing at compound concentration) and metabolized by macrophages (decreasing at compound concentration). The free drug (compound of formula I) does not show active uptake (apparent from the saturating concentration of free drug).
</span>
    </p>
    <p num="0148" class="style-scope patent-text">
      <tables num="13" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000015" he="45" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="180" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000015" he="45" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="180" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0149" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
結論：<br class="style-scope patent-text">
  脂質系微粒子製剤として開発された式Ｉの化合物は治療の標的である肺胞マクロファージによる活発に取り込まれる。この療法は活発に標的や関連する細胞に到達する可能性を有する。<br class="style-scope patent-text">
<br class="style-scope patent-text">
インビボアッセイ<br class="style-scope patent-text">
  実験に用いられた動物はＣＰＣＳＥＡ,タミル・ナードゥ、インドによって出版されたガイドラインに従って収容され世話された。実験動物を用いる手順はピラマル・ライフ・サイエンス・リミテッド（Piramal Life Sciences Limited）、ゴレアゴン、ムンバイ、インドのＩＡＥＣによって承認された。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例２０<br class="style-scope patent-text">
肺沈着試験<br class="style-scope patent-text">
  ＡＡＰＳ学術雑誌（The AAPS Journal）、２００５年、７（１）、Ｅ２０−Ｅ４１によって報告されたようにアッセイを行った。
</span>Conclusion: <br class="style-scope patent-text"> The compound of formula I developed as a lipid-based microparticle formulation is actively taken up by alveolar macrophages, which are therapeutic targets. This therapy has the potential to actively reach the target and associated cells. <br class="style-scope patent-text"> <br class="style-scope patent-text"> In Vivo Assays The animals used in the experiments were housed and cared for according to guidelines published by CPCSEA, Tamil Nadu, India. Procedures using laboratory animals were approved by IAEC of Piramal Life Sciences Limited, Goreagon, Mumbai, India. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 20 <br class="style-scope patent-text"> Lung deposition test The assay was performed as reported by The AAPS Journal, 2005, 7 (1), E20-E41.</span>
    </p>
    <p num="0150" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  パイロットインビボ肺沈着試験（pilot in vivo lung deposition study）を上記文献に従って行った。モルモットを３つの群に分けた。群１には実施例９方法Ａの製剤を投与し、群２には未製剤の式Ｉの化合物を投与し、群３は処置しなかった（未処置群）。製剤１０ｍｇ／ｋｇをエアロゾル化し、上記動物を受動的に呼吸させた。実施例９方法Ａの製剤の投与に続いて、３０分の時点で動物を屠殺した。肺を採取し、ＨＰＬＣによって分析した。ＨＰＬＣ条件を表１３に示す。
</span>
&nbsp;&nbsp;A pilot in vivo lung deposition study was performed according to the above literature. Guinea pigs were divided into three groups. Group 1 was administered the formulation of Example 9 Method A, Group 2 was administered an unformulated compound of Formula I, and Group 3 was not treated (untreated group). The formulation 10 mg / kg was aerosolized and the animals were passively breathed. Example 9 Following administration of Method A formulation, animals were sacrificed at 30 minutes. Lungs were collected and analyzed by HPLC. The HPLC conditions are shown in Table 13.
</span>
    </p>
    <p num="0151" class="style-scope patent-text">
      <tables num="14" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000016" he="113" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="452" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000016" he="113" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="452" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0152" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  得られた結果を表１４にまとめる。
</span>
&nbsp;&nbsp;The results obtained are summarized in Table 14.
</span>
    </p>
    <p num="0153" class="style-scope patent-text">
      <tables num="15" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000017" he="41" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="164" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000017" he="41" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="164" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0154" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
観察：<br class="style-scope patent-text">
  噴霧では、未製剤の式Ｉの化合物は肺に到達することができない。実施例９方法Ａの製剤は受動呼吸において肺に到達できた。動物をさらに製剤に曝露すると、肺における式Ｉの化合物量が増加する。<br class="style-scope patent-text">
結論：<br class="style-scope patent-text">
  実施例９方法Ａの製剤は肺に到達できる。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例２１<br class="style-scope patent-text">
  実施例９方法Ａの製剤の肺生物学的利用能の測定。
</span>Observation: <br class="style-scope patent-text"> By nebulization, unformulated compounds of formula I cannot reach the lungs. Example 9 Method A formulation was able to reach the lungs in passive breathing. Further exposure of the animal to the formulation increases the amount of compound of formula I in the lung. <br class="style-scope patent-text"> Conclusion: <br class="style-scope patent-text"> Example 9 Method A formulation can reach the lungs. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 21 <br class="style-scope patent-text"> Example 9 Determination of Lung Bioavailability of Method A Formulation.</span>
    </p>
    <p num="0155" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＡＡＰＳ学術雑誌（The AAPS Journal、２００５年、７（１）、Ｅ２０−Ｅ４１）によって報告されたようにアッセイを行った。
</span>
&nbsp;&nbsp;The assay was performed as reported by the AAPS journal (The AAPS Journal, 2005, 7 (1), E20-E41).
</span>
    </p>
    <p num="0156" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  鼻のみ曝露インビボ肺沈着試験（nose-only exposure in vivo lung deposition study）を上記文献に従って行った。モルモットを２つの群に分けた。群１には未製剤の式Ｉの化合物を投与し（３ｍｇ／ｋｇ）、群２には実施例９方法Ａの製剤を投与した（３ｍｇ／ｋｇ）。未製剤の式Ｉの化合物および実施例９方法Ａの製剤をエアロゾル化し、噴霧期間を１時間としてジェットネブライザーを用い鼻のみ曝露を行った。噴霧投与に続き、１時間、２時間、６時間、１２時間および２４時間のポスト噴霧曝露で動物を屠殺し、肺を採取して分析し、ＬＣ−ＭＳによって肺に沈着した式Ｉの化合物量（ｎｇ／ｇ）を定量化した。ＬＣ−ＭＳ条件を以下に明記する。
</span>
&nbsp;&nbsp;A nose-only exposure in vivo lung deposition study was performed according to the above literature. Guinea pigs were divided into two groups. Group 1 received an unformulated compound of Formula I (3 mg / kg) and Group 2 received the formulation of Example 9 Method A (3 mg / kg). The unformulated compound of Formula I and the formulation of Example 9 Method A were aerosolized and exposed only to the nose using a jet nebulizer with a nebulization period of 1 hour. Following spray administration, animals were sacrificed at 1 hour, 2 hours, 6 hours, 12 hours and 24 hours post spray exposure, lungs collected and analyzed, and the amount of compound of Formula I deposited in the lungs by LC-MS (Ng / g) was quantified. The LC-MS conditions are specified below.
</span>
    </p>
    <p num="0157" class="style-scope patent-text">
      <tables num="16" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000018" he="92" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="368" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000018" he="92" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="368" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0158" class="style-scope patent-text">
      <tables num="17" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000019" he="89" wi="162" file="2013532722.tif" img-format="tif" img-content="drawing" width="648" height="356" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000019" he="89" wi="162" file="2013532722.tif" img-format="tif" img-content="drawing" width="648" height="356" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0159" class="style-scope patent-text">
      <tables num="18" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000020" he="55" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="220" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000020" he="55" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="220" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0160" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  得られた結果を表１８にまとめる。
</span>
&nbsp;&nbsp;The results obtained are summarized in Table 18.
</span>
    </p>
    <p num="0161" class="style-scope patent-text">
      <tables num="19" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000021" he="54" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="216" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000021" he="54" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="216" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0162" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
観察<br class="style-scope patent-text">
  噴霧では、未製剤の式Ｉの化合物は肺に到達することができない。実施例９方法Ａの製剤は肺に到達でき、２４時間保持された。<br class="style-scope patent-text">
結論<br class="style-scope patent-text">
  実施例９方法Ａの製剤は、未製剤の式Ｉの化合物の生物学的利用能特性不良を克服することができた。さらに、実施例９方法Ａの製剤の肺保持特性は１日に一度の吸入に適している。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例２２<br class="style-scope patent-text">
１時間／日の噴霧曝露を５日間１日に一度投与を行った後の実施例９方法Ａの製剤の累積蓄積物の評価<br class="style-scope patent-text">
  ＡＡＰＳ学術雑誌（The AAPS Journal、２００５年、７（１）、Ｅ２０−Ｅ４１）によって報告されたようにアッセイを行った。
</span>Observation With nebulization, unformulated compounds of formula I cannot reach the lungs. Example 9 Method A formulation was able to reach the lungs and was held for 24 hours. <br class="style-scope patent-text"> Conclusion The formulation of Example 9 Method A was able to overcome the poor bioavailability properties of the unformulated compound of Formula I. Furthermore, the lung retention properties of the formulation of Example 9 Method A are suitable for inhalation once a day. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 22 <br class="style-scope patent-text"> Evaluation of Cumulative Accumulation of Example 9 Method A Formulation After 1 Hour / Day Spray Exposure Once Daily for 5 Days AAPS Journal (The AAPS Journal, 2005, 7 (1), E20 -The assay was performed as reported by E41).</span>
    </p>
    <p num="0163" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  鼻のみ曝露インビボ肺沈着試験を上記文献に従って行った。モルモットを２つの群に分けた。群１には未製剤の式Ｉの化合物を投与し（３ｍｇ／ｋｇ）、群２には実施例９方法Ａの製剤を投与した（３ｍｇ／ｋｇ）。未製剤の式Ｉの化合物および実施例９方法Ａの製剤をエアロゾル化し、噴霧期間を連続した５日間毎日１時間としジェットネブライザーを用い鼻のみ曝露を行い、動物を６日目に屠殺した。肺を採取、分析し、ＬＣ−ＭＳによって肺中に沈着した式Ｉの化合物量（ｎｇ／ｇ）を定量化した。ＬＣ−ＭＳ条件は実施例２１の表１５、１６および１７に示したような条件である。
</span>
&nbsp;&nbsp;A nose-only in vivo lung deposition test was performed according to the above literature. Guinea pigs were divided into two groups. Group 1 received an unformulated compound of Formula I (3 mg / kg) and Group 2 received the formulation of Example 9 Method A (3 mg / kg). The unformulated compound of Formula I and the formulation of Example 9 Method A were aerosolized and exposed to the nose only using a jet nebulizer with a nebulization period of 1 hour daily for 5 consecutive days, and the animals were sacrificed on day 6. Lungs were collected and analyzed, and the amount of compound of formula I (ng / g) deposited in the lungs by LC-MS was quantified. The LC-MS conditions are as shown in Tables 15, 16 and 17 of Example 21.
</span>
    </p>
    <p num="0164" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  得られた結果を表１９にまとめる。
</span>
&nbsp;&nbsp;The results obtained are summarized in Table 19.
</span>
    </p>
    <p num="0165" class="style-scope patent-text">
      <tables num="20" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000022" he="35" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="140" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000022" he="35" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="140" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0166" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
観察：<br class="style-scope patent-text">
  噴霧では、未製剤の式Ｉの化合物は肺に到達することができない。実施例９方法Ａの製剤は肺に到達でき２４時間保持され、また５日間の慢性的な毎日の曝露後に式Ｉの化合物を示した。<br class="style-scope patent-text">
結論：<br class="style-scope patent-text">
  ５日間製剤（実施例９方法Ａの製剤）として式Ｉの化合物を保持するための肺の能力を、治療レジメンとして５日間の噴霧として用いることができる。<br class="style-scope patent-text">
<br class="style-scope patent-text">
実施例２３<br class="style-scope patent-text">
  実施例９方法Ａの製剤の投与量スケジュールを評価する。
</span>Observation: <br class="style-scope patent-text"> By nebulization, unformulated compounds of formula I cannot reach the lungs. Example 9 Method A formulation reached the lungs and was maintained for 24 hours, and showed a compound of formula I after 5 days of chronic daily exposure. <br class="style-scope patent-text"> Conclusion: <br class="style-scope patent-text"> The ability of the lungs to retain a compound of formula I as a 5-day formulation (Example 9 Method A formulation) can be used as a 5-day nebulization as a treatment regimen. <br class="style-scope patent-text"> <br class="style-scope patent-text"> Example 23 <br class="style-scope patent-text"> Example 9 Evaluate the dosage schedule of Method A formulations.</span>
    </p>
    <p num="0167" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＡＡＰＳ学術雑誌（The AAPS Journal、２００５年、７（１）、Ｅ２０−Ｅ４１）によって報告されたようにアッセイを行った。
</span>
&nbsp;&nbsp;The assay was performed as reported by the AAPS journal (The AAPS Journal, 2005, 7 (1), E20-E41).
</span>
    </p>
    <p num="0168" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  鼻のみ曝露インビボ肺沈着試験を上記文献に従って行った。モルモットを３つの群に分けた。群１には未製剤の式Ｉの化合物（３ｍｇ／ｋｇ）を投与し、群２には１日間１日に一度実施例９方法Ａの製剤（３ｍｇ／ｋｇ）を投与し、群３には１日間１日に二度実施例９方法Ａの製剤（３ｍｇ／ｍＬ）を投与した。未製剤の式Ｉの化合物および実施例９方法Ａの製剤をエアロゾル化し、ジェットネブライザーを用い鼻のみ曝露を行った。動物を屠殺し、肺を採取および分析し、ＬＣ−ＭＳによって肺中に沈着した式Ｉの化合物量（ｎｇ／ｇ）を定量化した。ＬＣ−ＭＳ条件は実施例２１の表１５、１６および１７に示したような条件である。
</span>
&nbsp;&nbsp;A nose-only in vivo lung deposition test was performed according to the above literature. Guinea pigs were divided into three groups. Group 1 is administered an unformulated compound of Formula I (3 mg / kg), Group 2 is administered the formulation of Example 9 Method A (3 mg / kg) once a day, The formulation of Example 9 Method A (3 mg / mL) was administered twice daily for 1 day. The unformulated compound of Formula I and the formulation of Example 9 Method A were aerosolized and exposed only to the nose using a jet nebulizer. Animals were sacrificed, lungs collected and analyzed, and the amount of compound of formula I (ng / g) deposited in the lungs by LC-MS was quantified. The LC-MS conditions are as shown in Tables 15, 16 and 17 of Example 21.
</span>
    </p>
    <p num="0169" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  得られた結果を表２０にまとめる。
</span>
&nbsp;&nbsp;The results obtained are summarized in Table 20.
</span>
    </p>
    <p num="0170" class="style-scope patent-text">
      <tables num="21" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            </span></span></tables></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000023" he="39" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="156" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000023" he="39" wi="170" file="2013532722.tif" img-format="tif" img-content="drawing" width="680" height="156" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div>
        
      
    <p class="style-scope patent-text"></p>
    <p num="0171" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
観察：<br class="style-scope patent-text">
  噴霧では、未製剤の式Ｉの化合物は肺に到達することができない。実施例９方法Ａの製剤は肺に到達でき、肺によって吸収された式Ｉの化合物量は投与量が１日に２倍になると増加する。
</span>Observation: <br class="style-scope patent-text"> By nebulization, unformulated compounds of formula I cannot reach the lungs. Example 9 The formulation of Method A can reach the lungs, and the amount of compound of formula I absorbed by the lungs increases as the dosage is doubled per day.</span>
    </p>
  </summary-of-invention>
  
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(24)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Japanese</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM54450544" lang="EN" load-source="google" class="style-scope patent-text">
  <claim num="1" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  以下の式Ｉの化合物と薬物送達用生分解性脂質とを含み、脂質に対する薬物（式Ｉの化合物）の比が１：１５〜１：２５であり、生分解性であり吸入可能である製剤である微粒子製剤。<br class="style-scope patent-text">
<chemistry id="" num="1" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000024" he="108" wi="151" file="2013532722.tif" img-format="tif" img-content="drawing" width="604" height="432" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div> </chemistry>
</span>Formulation comprising a compound of formula I below and a biodegradable lipid for drug delivery, wherein the ratio of drug to lipid (compound of formula I) is from 1:15 to 1:25, biodegradable and inhalable A fine particle formulation. <br class="style-scope patent-text"> <chemistry id="" num="1" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png" class="style-scope patent-text"><img id="000024" he="108" wi="151" file="2013532722.tif" img-format="tif" img-content="drawing" width="604" height="432" alt="Figure 2013532722" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/48/b3/95bbc193b259cd/2013532722-9.png"></a></div> </chemistry> </span>
    </claim-text>
  </claim>
  <claim num="2" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式Ｉの化合物は、前記製剤の１％〜５％（ｗ／ｗ）を構成する、請求項１に記載の微粒子製剤。
</span>
&nbsp;&nbsp;2. A microparticulate formulation according to claim 1, wherein the compound of formula I constitutes 1% to 5% (w / w) of the formulation.
</span>
    </claim-text>
  </claim>
  <claim num="3" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記生分解性脂質は、ジパルミトイルホスファチジルコリン（ＤＰＰＣ）である、請求項１または２に記載の微粒子製剤。
</span>
&nbsp;&nbsp;The fine particle formulation according to claim 1 or 2, wherein the biodegradable lipid is dipalmitoylphosphatidylcholine (DPPC).
</span>
    </claim-text>
  </claim>
  <claim num="4" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記微粒子の粒径は、０．５ミクロンと１０ミクロンとの間の範囲である、請求項１から３のいずれか１項に記載の微粒子製剤。
</span>
&nbsp;&nbsp;The particulate formulation according to any one of claims 1 to 3, wherein the particle size of the microparticles is in the range between 0.5 microns and 10 microns.
</span>
    </claim-text>
  </claim>
  <claim num="5" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記微粒子の少なくとも９０％は、１０ミクロン未満の粒径である、請求項４に記載の微粒子製剤。
</span>
&nbsp;&nbsp;The microparticle formulation of claim 4, wherein at least 90% of the microparticles have a particle size of less than 10 microns.
</span>
    </claim-text>
  </claim>
  <claim num="6" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記製剤は水性リポソーム分散液である、請求項１から５のいずれか１項に記載の微粒子製剤。
</span>
&nbsp;&nbsp;The fine particle preparation according to any one of claims 1 to 5, wherein the preparation is an aqueous liposome dispersion.
</span>
    </claim-text>
  </claim>
  <claim num="7" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記製剤のｐＨは６から７の範囲である、請求項１から５のいずれか１項に記載の微粒子製剤。
</span>
&nbsp;&nbsp;The fine particle formulation according to any one of claims 1 to 5, wherein the pH of the formulation is in the range of 6 to 7.
</span>
    </claim-text>
  </claim>
  <claim num="8" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記製剤の相転移温度は４１℃から４３℃の範囲である、請求項１から５のいずれか１項に記載の微粒子製剤。
</span>
&nbsp;&nbsp;The fine particle formulation according to any one of claims 1 to 5, wherein a phase transition temperature of the formulation is in the range of 41 ° C to 43 ° C.
</span>
    </claim-text>
  </claim>
  <claim num="9" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  請求項１で定義されるような式Ｉの化合物とジパルミトイルホスファチジルコリン（ＤＰＰＣ）とを含み、ＤＰＰＣに対する薬物（式Ｉの化合物）の比が１：１〜１：２０である微粒子製剤の調製のためのプロセスであって、<br class="style-scope patent-text">
（ａ）  式Ｉの化合物およびＤＰＰＣ（１：１〜１：２０の比）を３ｍＬ〜１５ｍＬのクロロホルムに溶解し、溶液を得る工程と、<br class="style-scope patent-text">
（ｂ）  ２０ｍＬ〜４５ｍＬのメタノールを工程（ａ）の溶液に加え、十分混合し、確実に均質性を得る工程と、<br class="style-scope patent-text">
（ｃ）  ２０ｍＬ〜５０ｍＬの模擬肺液（ＳＬＦ）を工程（ｂ）の溶液に加える工程と、<br class="style-scope patent-text">
（ｄ）  溶媒を蒸発させる工程と、<br class="style-scope patent-text">
（ｅ）  工程（ｄ）で得た量をＳＬＦで３０ｍＬにし、１５０００Ｇ〜３５０００Ｇ、４℃で１０分間遠心分離しペレットを得る工程と、<br class="style-scope patent-text">
（ｆ）  工程（ｅ）で得たペレットをＳＬＦ中に再懸濁し、濃度０．５ｍｇ／ｍＬ〜１０ｍｇ／ｍＬの懸濁液を得る工程と、<br class="style-scope patent-text">
（ｇ）  工程（ｆ）で得た懸濁液を０．５μｍ〜５μｍのポリカーボネートフィルターを通してろ過し、形成された微粒子の粒径を均一にする工程と、を含むプロセス。
</span>A preparation of a microparticle formulation comprising a compound of formula I as defined in claim 1 and dipalmitoylphosphatidylcholine (DPPC), wherein the ratio of drug to DPPC (compound of formula I) is 1: 1 to 1:20. Process for <br class="style-scope patent-text"> (A) dissolving a compound of formula I and DPPC (ratio 1: 1-1: 20) in 3-15 mL of chloroform to obtain a solution; <br class="style-scope patent-text"> (B) adding 20 mL to 45 mL of methanol to the solution of step (a) and mixing well to ensure homogeneity; <br class="style-scope patent-text"> (C) adding 20 to 50 mL of simulated lung fluid (SLF) to the solution of step (b); <br class="style-scope patent-text"> (D) evaporating the solvent; <br class="style-scope patent-text"> (E) making the amount obtained in step (d) 30 mL with SLF and centrifuging at 15000G-35000G for 10 minutes at 4 ° C. to obtain pellets; <br class="style-scope patent-text"> (F) resuspending the pellet obtained in step (e) in SLF to obtain a suspension with a concentration of 0.5 mg / mL to 10 mg / mL; <br class="style-scope patent-text"> (G) A process comprising: filtering the suspension obtained in the step (f) through a polycarbonate filter of 0.5 μm to 5 μm to make the formed fine particles have a uniform particle size.</span>
    </claim-text>
  </claim>
  <claim num="10" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記微粒子の粒径は０．５ミクロンと１０ミクロンとの間の範囲である、請求項９に記載のプロセス。
</span>
&nbsp;&nbsp;The process of claim 9, wherein the particle size of the microparticles is in the range between 0.5 microns and 10 microns.
</span>
    </claim-text>
  </claim>
  <claim num="11" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記微粒子の少なくとも９０％が１０ミクロン未満のサイズである、請求項１０に記載のプロセス。
</span>
&nbsp;&nbsp;The process of claim 10, wherein at least 90% of the microparticles are less than 10 microns in size.
</span>
    </claim-text>
  </claim>
  <claim num="12" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  請求項１で定義されるような式Ｉの化合物とジパルミトイルホスファチジルコリン（ＤＰＰＣ）とを含み、ＤＰＰＣに対する薬物（式Ｉの化合物）の比が１：１〜１：２０である微粒子製剤の調製のためのプロセスであって、<br class="style-scope patent-text">
(ｉ)  ２０ｍＬ〜４５ｍＬの模擬肺液（ＳＬＦ）を、式Ｉの化合物とＤＰＰＣとの混合物（１：１〜１：２０の比）に加える工程と、<br class="style-scope patent-text">
(ｉｉ)  工程（ｉ）の混合物を、４５℃で１時間、１００ｒｐｍ〜２００ｒｐｍで回転させ、懸濁液を得る工程と、<br class="style-scope patent-text">
(ｉｉｉ)  工程（ｉｉ）で得た懸濁液を、１５０００Ｇ〜３５０００Ｇ、４℃で１０分間遠心分離し、ペレットを得る工程と、<br class="style-scope patent-text">
(ｉｖ)  工程（ｉｉｉ）で得たペレットをＳＬＦ中に再懸濁し、濃度０．５ｍｇ／ｍＬ〜１０ｍｇ／ｍＬの懸濁液を得る工程と、<br class="style-scope patent-text">
(ｖ)  工程（ｉｖ）で得た懸濁液を０．５μｍ〜５μｍのポリカーボネートフィルターを通してろ過し、形成された微粒子の粒径を均一にする工程と、を含むプロセス。
</span>A preparation of a microparticle formulation comprising a compound of formula I as defined in claim 1 and dipalmitoylphosphatidylcholine (DPPC), wherein the ratio of drug to DPPC (compound of formula I) is 1: 1 to 1:20. Process for <br class="style-scope patent-text"> (i) adding 20 mL to 45 mL of simulated lung fluid (SLF) to a mixture of compound of formula I and DPPC (ratio 1: 1 to 1:20); <br class="style-scope patent-text"> (ii) rotating the mixture of step (i) at 100 rpm to 200 rpm for 1 hour at 45 ° C. to obtain a suspension; <br class="style-scope patent-text"> (iii) centrifuging the suspension obtained in step (ii) at 15000G-35000G for 10 minutes at 4 ° C. to obtain a pellet; <br class="style-scope patent-text"> (iv) resuspending the pellet obtained in step (iii) in SLF to obtain a suspension with a concentration of 0.5 mg / mL to 10 mg / mL; <br class="style-scope patent-text"> (v) filtering the suspension obtained in the step (iv) through a polycarbonate filter of 0.5 μm to 5 μm to uniform the particle size of the formed fine particles.</span>
    </claim-text>
  </claim>
  <claim num="13" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  請求項１に記載の微粒子製剤をそれを必要とする哺乳類に吸入によって投与することを含む、肺結核、多剤耐性結核、メチシリン耐性黄色ブドウ球菌（Staphylococcus aureus）肺炎またはメチシリン感受性黄色ブドウ球菌肺炎の治療のための方法。
</span>
&nbsp;&nbsp;Treatment of pulmonary tuberculosis, multidrug-resistant tuberculosis, methicillin-resistant Staphylococcus aureus pneumonia or methicillin-sensitive Staphylococcus aureus pneumonia, comprising administering the particulate formulation of claim 1 to a mammal in need thereof by inhalation Way for.
</span>
    </claim-text>
  </claim>
  <claim num="14" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記方法は肺胞マクロファージを標的とする、請求項１３に記載の方法。
</span>
&nbsp;&nbsp;14. The method of claim 13, wherein the method targets alveolar macrophages.
</span>
    </claim-text>
  </claim>
  <claim num="15" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記製剤は肺送達のために吸入または気管内注入によってそれを必要とする哺乳類に投与される、請求項１に記載の微粒子製剤を該哺乳類に送達する方法。
</span>
&nbsp;&nbsp;2. The method of delivering a microparticle formulation of claim 1 to a mammal in need thereof by inhalation or intratracheal infusion for pulmonary delivery to a mammal in need thereof.
</span>
    </claim-text>
  </claim>
  <claim num="16" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記製剤は吸入によって投与される、請求項１５に記載の方法。
</span>
&nbsp;&nbsp;16. The method of claim 15, wherein the formulation is administered by inhalation.
</span>
    </claim-text>
  </claim>
  <claim num="17" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記吸入による製剤の投与は、前記薬物（式Ｉの化合物）を微粒子に封入した噴霧により行われる、請求項１６に記載の方法。
</span>
&nbsp;&nbsp;17. The method of claim 16, wherein the administration of the formulation by inhalation is performed by spraying the drug (compound of formula I) encapsulated in microparticles.
</span>
    </claim-text>
  </claim>
  <claim num="18" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記封入された式Ｉの化合物の保持率は、３０％から７０％の範囲である、請求項１７に記載の方法。
</span>
&nbsp;&nbsp;18. A method according to claim 17, wherein the retention of the encapsulated compound of formula I ranges from 30% to 70%.
</span>
    </claim-text>
  </claim>
  <claim num="19" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記吸入によって投与された製剤に含まれる薬物（式Ｉの化合物）は、肺に２４時間を超えて保持される、請求項１６に記載の方法。
</span>
&nbsp;&nbsp;17. The method of claim 16, wherein the drug (compound of formula I) contained in the formulation administered by inhalation is retained in the lungs for more than 24 hours.
</span>
    </claim-text>
  </claim>
  <claim num="20" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  吸入のための投与量は、０．０５と１０ｍｇ／ｋｇ体重／日との間の範囲である、請求項１６に記載の方法。
</span>
&nbsp;&nbsp;17. A method according to claim 16 wherein the dose for inhalation ranges between 0.05 and 10 mg / kg body weight / day.
</span>
    </claim-text>
  </claim>
  <claim num="21" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記方法は非侵襲である、請求項１３に記載の方法。
</span>
&nbsp;&nbsp;The method of claim 13, wherein the method is non-invasive.
</span>
    </claim-text>
  </claim>
  <claim num="22" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  肺結核、多剤耐性結核、メチシリン耐性黄色ブドウ球菌肺炎またはメチシリン感受性黄色ブドウ球菌肺炎の治療のための、式Ｉの化合物と薬物送達用生分解性脂質とを含み、脂質に対する薬物（式Ｉの化合物）の比が１：１５〜１：２５である、微粒子製剤の使用。
</span>
&nbsp;&nbsp;A compound for formula (compound of formula I) comprising a compound of formula I and a biodegradable lipid for drug delivery for the treatment of pulmonary tuberculosis, multidrug-resistant tuberculosis, methicillin-resistant Staphylococcus aureus pneumonia or methicillin-sensitive Staphylococcus aureus pneumonia ) Ratio of 1:15 to 1:25.
</span>
    </claim-text>
  </claim>
  <claim num="23" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  肺結核、多剤耐性結核、メチシリン耐性黄色ブドウ球菌肺炎およびメチシリン感受性黄色ブドウ球菌肺炎の治療のための薬剤の製造のための、式Ｉの化合物と薬物送達用生分解性脂質とを含み、脂質に対する薬物（式Ｉの化合物）の比が１：１５〜１：２５である、微粒子製剤の使用。
</span>
&nbsp;&nbsp;Comprising a compound of formula I and a biodegradable lipid for drug delivery for the manufacture of a medicament for the treatment of pulmonary tuberculosis, multidrug resistant tuberculosis, methicillin resistant S. aureus pneumonia and methicillin sensitive S. aureus pneumonia Use of a microparticle formulation wherein the ratio of drug (compound of formula I) is from 1:15 to 1:25.
</span>
    </claim-text>
  </claim>
  <claim num="24" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  肺結核、多剤耐性結核、メチシリン耐性黄色ブドウ球菌肺炎またはメチシリン感受性黄色ブドウ球菌肺炎の治療のための、式Ｉの化合物と薬物送達用生分解性脂質とを含み、脂質に対する薬物（式Ｉの化合物）の比が１：１５〜１：２５である、微粒子製剤。
</span>
&nbsp;&nbsp;A compound for formula (compound of formula I) comprising a compound of formula I and a biodegradable lipid for drug delivery for the treatment of pulmonary tuberculosis, multidrug-resistant tuberculosis, methicillin-resistant Staphylococcus aureus pneumonia or methicillin-sensitive Staphylococcus aureus pneumonia ) Ratio of 1:15 to 1:25.
</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (8)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS63502899A/en"><a id="link" href="#" class="style-scope state-modifier">JPS63502899A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1986-04-01</span>
                    <span class="td style-scope patent-result">1988-10-27</span>
                    <span class="td style-scope patent-result">アクチエボラゲツト・ドラコ</span>
                    <span class="td style-scope patent-result">
  Compositions of liposomes and β↓2-receptor active substances
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2001524930A/en"><a id="link" href="#" class="style-scope state-modifier">JP2001524930A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-07-03</span>
                    <span class="td style-scope patent-result">2001-12-04</span>
                    <span class="td style-scope patent-result">リサーチ  ディベロップメント  ファンデーション</span>
                    <span class="td style-scope patent-result">
  High dose liposome aerosol formulation
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2002529393A/en"><a id="link" href="#" class="style-scope state-modifier">JP2002529393A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-11-12</span>
                    <span class="td style-scope patent-result">2002-09-10</span>
                    <span class="td style-scope patent-result">フランク  ジー． ピルキーウィッツ，</span>
                    <span class="td style-scope patent-result">
  Inhalation system
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2003520815A/en"><a id="link" href="#" class="style-scope state-modifier">JP2003520815A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-01-31</span>
                    <span class="td style-scope patent-result">2003-07-08</span>
                    <span class="td style-scope patent-result">エーザイ株式会社</span>
                    <span class="td style-scope patent-result">
  Use of thiostrepton as an antibacterial agent
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2005530704A/en"><a id="link" href="#" class="style-scope state-modifier">JP2005530704A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-05</span>
                    <span class="td style-scope patent-result">2005-10-13</span>
                    <span class="td style-scope patent-result">トランセイブ， インク．</span>
                    <span class="td style-scope patent-result">
  Inhalation system for preventing and treating intracellular infections
 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH0751496B2/en"><a id="link" href="#" class="style-scope state-modifier">JPH0751496B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1986-04-02</span>
                    <span class="td style-scope patent-result">1995-06-05</span>
                    <span class="td style-scope patent-result">武田薬品工業株式会社</span>
                    <span class="td style-scope patent-result">
  Manufacturing method of liposome
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2435197T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2435197T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-01-10</span>
                    <span class="td style-scope patent-result">2013-12-16</span>
                    <span class="td style-scope patent-result">Board Of Regents, The University Of Texas System</span>
                    <span class="td style-scope patent-result">
  Improved administration of immunosuppressive drug compositions for pulmonary administration
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2772742A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2772742A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-09-02</span>
                    <span class="td style-scope patent-result">2011-03-10</span>
                    <span class="td style-scope patent-result">Piramal Life Sciences Limited</span>
                    <span class="td style-scope patent-result">Antibiotic compounds 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (3)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015107482A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015107482A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-01-17</span>
                    <span class="td style-scope patent-result">2015-07-23</span>
                    <span class="td style-scope patent-result">Piramal Enterprises Limited</span>
                    <span class="td style-scope patent-result">Pharmaceutical combination for treatment of tuberculosis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10335374B2/en"><a id="link" href="#" class="style-scope state-modifier">US10335374B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-12-04</span>
                    <span class="td style-scope patent-result">2019-07-02</span>
                    <span class="td style-scope patent-result">University System of Georgia, Valdosta State University</span>
                    <span class="td style-scope patent-result">Tablet composition for anti-tuberculosis antibiotics 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN109827875A/en"><a id="link" href="#" class="style-scope state-modifier">CN109827875A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-04-10</span>
                    <span class="td style-scope patent-result">2019-05-31</span>
                    <span class="td style-scope patent-result">上海市食品药品检验所</span>
                    <span class="td style-scope patent-result">A kind of device and method for measuring sucking preparation dissolution rate 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN102099009B/en"><a id="link" href="#" class="style-scope state-modifier">CN102099009B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-07-02</span>
                    <span class="td style-scope patent-result">Pulmonary delivery of a fluoroquinolone 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/2250928207759374273"><a id="link" href="#" class="style-scope state-modifier">Wang et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018</span>
                    <span class="td style-scope patent-result">Azithromycin-loaded respirable microparticles for targeted pulmonary delivery for the treatment of pneumonia</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN103717231B/en"><a id="link" href="#" class="style-scope state-modifier">CN103717231B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-08-17</span>
                    <span class="td style-scope patent-result">Dry powder vancomycin composition and associated method 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN104870438A/en"><a id="link" href="#" class="style-scope state-modifier">CN104870438A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-08-26</span>
                    <span class="td style-scope patent-result">Seca inhibitors and methods of making and using thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1011638A1/en"><a id="link" href="#" class="style-scope state-modifier">EP1011638A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-28</span>
                    <span class="td style-scope patent-result">Small particle liposome aerosols for delivery of anti-cancer drugs 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN101442989A/en"><a id="link" href="#" class="style-scope state-modifier">CN101442989A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-05-27</span>
                    <span class="td style-scope patent-result">Compositions comprising amphotericin B 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/PT2079443E/en"><a id="link" href="#" class="style-scope state-modifier">PT2079443E</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-11-26</span>
                    <span class="td style-scope patent-result">Dual action, inhaled formulations providing both an immediate and sustained release profile 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/11554762148479718084"><a id="link" href="#" class="style-scope state-modifier">Pilcer et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013</span>
                    <span class="td style-scope patent-result">Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001283491B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2001283491B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-02-15</span>
                    <span class="td style-scope patent-result">Macrolide formulations for inhalation and methods of treatment of endobronchial infections 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2024012393A/en"><a id="link" href="#" class="style-scope state-modifier">JP2024012393A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2024-01-30</span>
                    <span class="td style-scope patent-result">Composition of clofazimine, combination containing the same, process for preparing the same, and use and method including the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015107482A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015107482A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-07-23</span>
                    <span class="td style-scope patent-result">Pharmaceutical combination for treatment of tuberculosis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001283491A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2001283491A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-18</span>
                    <span class="td style-scope patent-result">Macrolide formulations for inhalation and methods of treatment of endobronchial infections 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2001505557A/en"><a id="link" href="#" class="style-scope state-modifier">JP2001505557A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-24</span>
                    <span class="td style-scope patent-result">
  Pure biologically active colistin, its components, and colistin formulations for treating pulmonary infections
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/4017968093445016733"><a id="link" href="#" class="style-scope state-modifier">Douafer et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020</span>
                    <span class="td style-scope patent-result">Characterization of a new aerosol antibiotic/adjuvant combination for the treatment of P. aeruginosa lung infections</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2013532722A/en"><a id="link" href="#" class="style-scope state-modifier">JP2013532722A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-08-19</span>
                    <span class="td style-scope patent-result">
  Particulate preparation for transpulmonary drug delivery of anti-infective molecules for treatment of infectious diseases
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20240000779A1/en"><a id="link" href="#" class="style-scope state-modifier">US20240000779A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2024-01-04</span>
                    <span class="td style-scope patent-result">Compositions of Clofazimine, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods Comprising Them 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/7088297019002533778"><a id="link" href="#" class="style-scope state-modifier">Manniello et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016</span>
                    <span class="td style-scope patent-result">Aerodynamic properties, solubility and in vitro antibacterial efficacy of dry powders prepared by spray drying: Clarithromycin versus its hydrochloride salt</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040022740A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040022740A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-02-05</span>
                    <span class="td style-scope patent-result">Macrolide formulations for inhalation and methods of treatment of endobronchial infections 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2019157453A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2019157453A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-08-15</span>
                    <span class="td style-scope patent-result">Caspofungin compositions for inhalation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20180036958A/en"><a id="link" href="#" class="style-scope state-modifier">KR20180036958A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-04-10</span>
                    <span class="td style-scope patent-result">
  Compositions and methods for using lamellar bodies for therapeutic purposes
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP4209226A1/en"><a id="link" href="#" class="style-scope state-modifier">EP4209226A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-07-12</span>
                    <span class="td style-scope patent-result">Use of polypeptide in drug for preventing and treating pneumonia 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/3456844812322003610"><a id="link" href="#" class="style-scope state-modifier">Zhou et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023</span>
                    <span class="td style-scope patent-result">Polymyxin B sulfate inhalable microparticles with high-lectin-affinity sugar carriers for efficient treatment of biofilm-associated pulmonary infections</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN117899020A/en"><a id="link" href="#" class="style-scope state-modifier">CN117899020A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2024-04-19</span>
                    <span class="td style-scope patent-result">Preparation method and application of antibiotic-carrying mucus-penetrating liposome powder aerosol 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/6091532383039573668"><a id="link" href="#" class="style-scope state-modifier">Wang et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2024</span>
                    <span class="td style-scope patent-result">Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/9273496397754962930"><a id="link" href="#" class="style-scope state-modifier">Gaspar</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016</span>
                    <span class="td style-scope patent-result">Pulmonary targeting and biopharmaceutical evaluation of levofloxacin administered as innovative microsphere aerosols</span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (3)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US37091610P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2010-08-05</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US61/370,916<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2010-08-05</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2012017405A1/en"><a id="link" href="#" class="style-scope state-modifier">PCT/IB2011/053470</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2011-08-04</span>
                    <span class="td style-scope patent-result">Microparticle formulation for pulmonary drug delivery of anti-infective molecule for treatment of infectious diseases 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2013-05-20</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A523</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20130322</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2014-08-02</span>
                    <span class="td nowrap style-scope patent-result">A621</span>
                    <span class="td nowrap style-scope patent-result">Written request for application examination</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A621</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20140801</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-05-20</span>
                    <span class="td nowrap style-scope patent-result">A131</span>
                    <span class="td nowrap style-scope patent-result">Notification of reasons for refusal</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A131</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20150519</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-05-25</span>
                    <span class="td nowrap style-scope patent-result">A977</span>
                    <span class="td nowrap style-scope patent-result">Report on retrieval</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A971007</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20150522</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-07-02</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A523</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20150702</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-09-16</span>
                    <span class="td nowrap style-scope patent-result">A131</span>
                    <span class="td nowrap style-scope patent-result">Notification of reasons for refusal</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A131</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20150915</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2016-03-22</span>
                    <span class="td nowrap style-scope patent-result">A02</span>
                    <span class="td nowrap style-scope patent-result">Decision of refusal</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A02</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20160322</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1172926884" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1172926884" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=930103729" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>